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GENERAL INTRODUCTION
The bones in our body form a unique organ providing structural support, protection 
of vital organs, housing of marrow, and participation in mineral homeostasis. Bone 
consists of extracellular matrix and cells. The extracellular matrix is composed of 35% 
organic material, mainly collagen I, and 65% anorganic material, primarily in the form 
of hydroxyapatite and tricalcium phosphate1. Bone is a living tissue and is characterized 
by the constant adaptation to its mechanical loading environment. Adaptation of 
bone is brought about by the coordinated actions of osteoclasts and osteoblasts, 
which are orchestrated by the most mechanosensitive cells in bone, the osteocytes2. 
Bone remodeling ensures the constant removal of old bone by osteoclasts, and the 
replacement by new bone by osteoblasts, enabling to repair micro-fractures and 
restore the physical integrity or even increase its strength. Osteoblasts are frequently 
embedded in the newly formed bone matrix and become osteocytes. The entombed 
osteocyte cell bodies are positioned in lacunae in the bone matrix and have dentrite-
like projections contacting neighboring osteocytes and bone lining cells (resting 
osteoblasts), at the bone surface, resulting in an effective sensory and signaling 
network1.
Fracture healing
Unlike other scar-forming tissue, bone can regenerate and restore the properties of 
the preexisting bone. Many of the cellular and biochemical actions that occur during 
fracture healing are similar to those that take place during normal growth and 
development. Histological fracture healing can be divided into primary and secondary 
bone healing. Primary bone healing is characterized by the absence of external callus 
formation and the direct formation of lamellar bone and can only take place when 
absolute stability is present, usually through rigid internal fixation, i.e. in compression 
plating of long bones. In clinical practice, primary bone healing is favorable in 
inter-articular fractures, whereas in most other cases external callus formation, as 
seen in secondary bone healing, is preferred. Secondary bone healing occurs through 
a combination of endochondral bone formation and intramembranous or direct 
bone formation without a cartilage intermediate, and is comprised of four phases: 
1) Hematoma formation and inflammatory response leading to increased blood 
flow to the surrounding tissues, macrophages and degranulating platelets releasing 
various cytokines, including platelet-derived growth factor (PDGF), interleukins (IL-1, 
IL-6), prostoglandin E2, and tumor necrosis factor (TNF-α),  inducing various cellular 
responses; 2) Mesenchymal stem cell recruitment, proliferation and differentiation. 
The avascular hypoxic environment within the fracture gap results in cartilaginous 
soft callus formation. Direct intramembranous bone formation may be present at 
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the periosteal site. The soft callus formation and subsequent mineralization provides 
the first provisional stability and allows neo-vascularization; 3) Increase in vascularity 
as a result of angiogenesis and increased blood flow to the fracture side, enabling 
the replacement of the mineralized cartilage matrix by bone, through endochondral 
ossification. Chondrocyte apoptosis occurs readily after the invasion of endothelial 
cells. Osteoclasts resorb the calcified cartilage matrix, followed by the osteoblasts 
depositing woven bone at the fracture ends. Subsequently hard callus is formed 
through endochondral ossification as well as periosteal intramembranous ossification, 
resulting in increased intrinsic fracture stability, and finally bridging of the fracture gap; 
4) After fracture union, all newly formed woven bone is replaced by lamellar bone1. 
The remodeling phase finally restores the bone integrity and mechanical properties to 
the pre-injury situation, a process that can take 1 to 2 years after initial fracture union.
Delayed and/or impaired fracture healing
Fracture healing is a complex process requiring the recruitment of the appropriate 
cells and expression of the appropriate genes at the right time in the right place3. The 
majority of clinical fractures heal spontaneously, only 5-10% of the fractures show 
impaired healing3. Impairment of fracture healing leads to a delay in union or may even 
result in nonunion. Numerous factors are known that may contribute to impairment of 
healing, and can be related to the severity of trauma, fracture treatment, and patient 
co-morbidity4,5. Vascularity plays a crucial role in fracture healing. Absence of sufficient 
fracture stability disrupts the angiogenesis and subsequent blood flow to the fracture 
site6. The hypoxic environment favors cartilage tissue formation instead of osteogenic 
cell differentiation and bone formation. The principal goal of fracture treatment is to 
provide sufficient fracture stability by surgical and/or conservative means7.
An established nonunion is characterized by a total stop of all fracture repair 
processes, without any chance of spontaneous healing. For nonunions, surgical 
treatment by providing stabilization with internal or external fixation devices, 
and removing the necrotic bone tissue with or without bone grafting remains the 
standard8. Fracture healing is modulated in response to external stimuli, such as 
growth factors, hormones, and mechanical forces9. Insight in the molecular biological 
mechanisms involved in fracture healing has resulted in the development of new 
treatment modalities for impaired fracture healing, such as bone morphogenic 
proteins, extracorporeal shock wave treatment, electro-stimulation, and low-intensity 
pulsed ultrasound (LIPUS)10-13. LIPUS and electro-stimulation have the advantage over 
surgery that they are non-invasive, and can be used in an outpatient setting making 
them less expensive14.
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Low-intensity pulsed ultrasound and fracture healing
LIPUS is a form of mechanical energy transmitted transcutaneously by high-frequency 
acoustic pressure waves15. The intensity of LIPUS (30 mW/cm2) is within the range of 
ultrasound intensities used for diagnostic purposes (1–50 mW/cm2) and is regarded 
as non-thermal and non-destructive16. The LIPUS device produces a 200 μs burst of 
1.5 MHz acoustic sine waves, that repeats at a modulation frequency of 1 kHz, and 
provides a peak pressure of 30 mW/cm2. Bone cells are sensitive to strains caused by 
physical loading17,18. Mechanoreceptors convert biophysical stimuli into biochemical 
responses that alter gene expression and cellular adaptation19. Mechanical adaptive 
modeling can promote bone tissue formation by a proliferative response or by a direct 
anabolic effect on bone cells20. The micro-mechanical stress produced by LIPUS 
may provide a surrogate for the forces normally applied on bone by physical loading 
according to Wolff’s law21,22. Although the strain induced by LIPUS at the tissue level 
is several orders of magnitude lower than the peak strains generated by functional 
load bearing17, high frequency low magnitude strains can result in strong regulatory 
signals to bone tissue23-25.
The first successful application of LIPUS in the treatment of delayed union and 
nonunions in the clinical setting was described by Xavier and Duarte in 198326. LIPUS 
has proven to be a safe and easily applicable therapy, requiring only 20 continuous 
minutes of daily treatment on outpatient basis27. Randomized clinical trials on fresh 
fracture healing showed up to 38% acceleration of clinical fracture healing as result of 
LIPUS-treatment28,29. Approval by The Food and Drug Administration for the use of 
LIPUS for acceleration of conservatively managed fresh fracture was obtained in 1994. 
Nolte and colleagues showed that LIPUS can restore the disrupted fracture healing in 
established nonunions30. With further evidence suggesting the healing capacity of 
LIPUS on impaired bone healing, FDA approval was obtained in 2000 for the use of 
LIPUS on established nonunions. 
LIPUS increases prostaglandin E2 production via the induction of cyclooxygenase-2 
in MC3T3-E1 osteoblastic cells in vitro31. PGE2 is a potent inflammation mediator 
that may help migration and proliferation of mesenchymal stem cells31. Outcomes of 
LIPUS treatment of fetal mouse metatarsal rudiments in vitro suggested a direct effect 
of LIPUS on osteoblasts and ossifying cartilage by stimulation of cell activity and/
or differentiation, but not proliferation32,33. In vivo animal studies on the effects of 
LIPUS on fracture healing have shown enhanced mechanical properties of the healing 
callus, as well as more extensive bone bridging at the fracture site15,22,34. Vascularity 
around the fracture site is increased as result of LIPUS stimulation in the osteotomized 
ulna fracture model in dogs35. The positive effect of LIPUS on fracture healing may be 
caused by a stimulation of the different cellular processes involved in fracture repair 
and bone formation, such as angiogenesis, chondrogenesis, and intramembranous 
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and endochondral ossification15. LIPUS enhances and/or accelerates (impaired) clinical 
fracture healing, but the exact mechanism remains unknown. 
Objectives of the thesis
We hypothesized that low-intensity pulsed ultrasound accelerates and/or enhances 
delayed and/or impaired clinical fracture healing, more specific by positively affecting 
different stages of cellular processes involved in fracture repair and bone formation. 
To test this hypothesis, we addressed the following scientific questions:
1.  Is LIPUS effective in the treatment of tibia nonunions in current clinical practice?
2. Is LIPUS as a single treatment effective in the acceleration and/or enhancement 
of fracture union in patients with a delayed union of the non-fixated 
osteotomized fibula?
3.  How does LIPUS affect bone healing at the tissue level in patients with a 
delayed union of the osteotomized fibula?
4.  Is the presence of RUNX2 immunopositive osteogenic cells affected by LIPUS 
treatment in delayed unions of the osteotomized fibula? 
5.  Does LIPUS increase vascularity and blood flow in delayed unions of the 
osteotomized fibula?
6.  Does current evidence support the use of LIPUS for the treatment of fracture 
healing, and if so for which indication is LIPUS most beneficial?
The general aim of this thesis is to examine the effect of low-intensity pulsed 
ultrasound treatment on delayed and/or impaired clinical fracture healing at the tissue 
level, as well as  to determine its effectiveness on acceleration and healing of delayed 
and/or impaired clinical fractures, in order to make suggestions for future treatment 
considerations and clinical applications. More specifically by: 1) Determination of its 
effect on established tibial nonunions in current clinical practice; 2) Determination 
of delayed union healing of the osteotomized fibula clinically after 5 months of 
LIPUS treatment; 3) Assessment of delayed union healing at the bone tissue level by 
histomorphometric and immunohistochemical analysis 2 to 3 months after the start 
of LIPUS treatment; 4) Determination of the present evidence of the effectiveness of 
LIPUS on clinical fracture healing by systematic review and meta-analysis of randomized 
controlled trials. 
Outline of this thesis
Tibia nonunions have a relatively high occurrence rate and cause significant impairment 
to daily functioning. LIPUS has been shown to enhance healing of fresh fractures of 
the tibia. It would be of major clinical importance if LIPUS shows similar enhancing 
effects on the terminated fracture repair process in the tibia. In order to investigate 
the effectiveness of LIPUS on tibial nonunions in daily clinical practice, all consecutive 
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LIPUS treated established nonunion cases from January 2000 until February 2003 in 
The Netherlands were evaluated. LIPUS was the only new treatment intervention  to 
allow the evaluation of its effect as a single treatment option (Chapter 2).
Only one trial reports the clinical outcomes of LIPUS-treatment on nonunions in 
combination with vascularized bone grafting35. In contrast to fresh fracture healing, a 
randomized placebo controlled trial on the isolated effect of LIPUS on impaired bone 
healing may be seen as unethical, because this withholds the sham-treated control 
patient from any other form of treatment. The osteotomized non-fixated fibula, as 
part of a high tibial osteotomy, shows a tendency of delayed union and forms a unique 
clinical model enabling placebo treatment without direct negative consequences and/
or conflicting ethical issues. We investigated the isolated effect and outcome of LIPUS 
treatment on delayed and/or impaired clinical fracture healing in a randomized double 
blind study (Chapter 3).
The positive effect of LIPUS on fracture healing may be caused by a stimulation of 
the different cellular processes involved in fracture repair and bone formation, such as 
angiogenesis, chondrogenesis, and intramembranous and endochondral ossification15. 
In order to better understand how LIPUS affects delayed and or impaired bone 
healing, biopsies of delayed unions of the human osteotomized fibula after a high 
tibial osteotomy were obtained. By using histology and histomorphometric analysis, 
bone formation and bone resorption parameters were determined at the tissue level 
(Chapter 4).
Osteogenic cell proliferation and differentiation play an important role in adequate 
fracture healing, and is target for osteoinductive therapies in delayed fracture healing. 
Mechanical adaptive modeling can promote bone tissue formation by a proliferative 
response or by a direct anabolic effect on bone cells20. RUNX2 is a transcription factor, 
and is regarded as the master gene of osteogenic cell differentiation and bone matrix 
production. Immunolocalization of RUNX2 as an early bone cell marker was performed 
to determine the effect of LIPUS on the presence of osteogenic cells (Chapter 5).
Vascularity is a key factor in fracture healing, and angiogenesis is required for 
osteogenesis. Re-establishment of the circulation is essential in the early stages of 
fracture healing36,37. Whether LIPUS stimulates vascularity by angiogenesis and/or 
blood flow to the fracture site in nonunions is still largely unknown. By using histology 
and histomorphometric analysis, the effect of LIPUS on vascularity was investigated 
(Chapter 6).
Evidence-based medicine forms an important basis to evaluate clinical therapies 
and guide to clinical application. Overall consensus on the effectiveness and indication 
for usage of LIPUS in bone healing remains absent. In order to obtain the best current 
evidence of LIPUS’ clinical healing capacity, as well as to specify its clinical role by 
identification of those fracture cases most beneficial to LIPUS treatment, we carried 
out a systematic review and meta-analysis of randomized controlled trials (Chapter 7).
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Finally we discuss our findings at the tissue level in relation to our clinical outcomes 
of LIPUS-treatment on delayed and/or impaired fracture healing of the osteotomized 
fibula, and current evidence of effectiveness in order to postulate future directions of 
research and clinical application (Chapter 8). 
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ABSTRACT
Background: Low-intensity pulsed ultrasound is effective in fresh fracture healing, 
resulting in a 40% reduction in healing time. The aim of this study is to determine the 
effect of ultrasound treatment on established tibia nonunions. 
Methods: The study group consists of all Dutch patients of posttraumatic consecutive 
nonunion of the tibia, who started their ultrasound treatment between January 2000 
and February 2003. In total, 71 cases have been included, which involve 56 men 
and 15 women. Mean age was 40 years. Low-intensity pulsed ultrasound was the 
only new treatment. Strict criteria of enrollment minimized any spontaneous healing 
chance. According to literature, the spontaneous healing rate was between 5% and 
30%. The study outcome, healed or failed, was the primary efficacy parameter. Thirty 
percent was chosen to represent the maximum expected spontaneous healing and 
was the basis for statistical evaluation. Stratification was performed for the variables at 
the ultrasound treatment start. 
Results: The overall healing rate is 52 of 71 cases (73%). Ultrasound treatment shows 
a statistical significant higher healing rate compared with that of the spontaneous 
healing chance (p<0.0001). Stratification shows no statistical significance for any of 
the variables analyzed. The long-term follow-up shows high compliance rate and no 
re-fractures. 
Conclusion: Tibia nonunions have a high occurrence rate and cause significant 
impairment to daily functioning. This study shows that low-intensity pulsed ultrasound 
is effective in the treatment of established tibia nonunions and can be seen as a good, 
safe, and cheaper alternative to surgery.
22
LIPUS treatment for posttraumatic nonunions of the tibia
Chapter
2
INTRODUCTION
“Fracture healing is an extremely complex process, requiring the recruitment of 
appropriate cells and subsequently expression of the appropriate genes at the right 
time in the right place”, according to Hadjiargyrou et al1. Numerous factors are known 
that may contribute to impaired healing1-3. Factors can be related to the initial trauma, 
fracture treatment, and patient comorbidity. Disruption of this fracture healing 
process can result in delayed union or lead to an established nonunion. An established 
nonunion is characterized by a total stop of all fracture repair processes, without any 
chance of spontaneous healing3. The overall fracture delayed union rate is 5% to 
10%2,4. Prospective surveys of nonoperatively treated tibia fractures show delayed 
union rates up to 25%5-8. These studies demonstrate that initial fracture severity can 
be a prognostic factor for impaired healing. Matter of displacement, comminution, 
and presence of an associated wound as well as soft tissue damage define the severity 
of a fracture in general. Severe displacement, comminution, and an associated wound 
combined can result in a delayed union rate up to 60%7,9.
A nonunion of the tibia has a significant impact on the individual and can prevent 
the patient from functioning normally and result in loss of productivity10. Tibia 
nonunions therefore challenge the clinician to reach a healed outcome as early as 
possible. Surgical treatment, providing stabilization with internal or external fixation 
devices, and removing the necrotic bone tissue with or without bone grafting 
remains the choice of most11. Success however is not always guaranteed, and it is 
not uncommon that more than one surgical intervention is required. Neurovascular 
damage and infection are among the complications related to surgical interventions. 
The literature describes several alternative treatment options for nonunions. 
This includes a range of conservative noninvasive options that affect and stimulate 
bone growth: electrostimulation12-18, extracorporal shock wave therapy19,20, and 
low-intensity pulsed ultrasound4,21-26. Each treatment option has its benefits and 
disadvantages and varies in rate of success depending on the type of problem. 
Low-intensity pulsed ultrasound (Exogen,  Smith & Nephew, Memphis, TN) can be 
seen as a form of mechanical energy transmitted transcutaneously in the form of high 
frequency acoustical pressure waves1. The first successful application of ultrasound 
(30 mW/cm2) in the treatment of delayed union and nonunions in the clinical setting 
was described by Xavier and Duarte in 19834. Ultrasound has proven to be a safe 
and easily applicable therapy, requiring only 20 continuous minutes of daily treatment 
on outpatient basis1,4,27. The clinical proof of effect of ultrasound on bone growth 
and fresh fracture healing of the tibia has been based on numerous randomized 
prospective clinical trials21,22,28. Outcomes of previously mentioned trials show that 
healing time was accelerated by an average of 38%, and that ultrasound diminishes 
23
Chapter 2
the negative effect of smoking on fracture healing29. Evaluating the results as shown 
in the literature, we can conclude that low-intensity pulsed ultrasound stimulates every 
stage of the normal fracture repair process4,21,30,31. It would be of major clinical 
importance if ultrasound shows similar enhancing effects on the delayed or stopped 
fracture repair process in the tibia.
This study incorporates a modified study design used in prior clinical research 
by Nolte et al26. We will evaluate the clinical use of ultrasound for established tibial 
nonunions in the Netherlands. All the cases were consecutive treated nonunion cases 
in the Netherlands in which the patients started their ultrasound treatment after 
January 2000 until February 2003. Low-intensity pulsed ultrasound was the only new 
interventional treatment. Strict criteria of enrollment have been set to minimize any 
spontaneous healing chance.
PATIENTS AND METHODS
The study group consists of all posttraumatic consecutive nonunion cases of the tibia, 
in which the patients started their ultrasound treatment between January 1, 2000 and 
February 1, 2003. The authors (S.R., D.B.) performed a prospective data collection 
according to a preset protocol. Smith and Nephew Netherlands registered all cases of 
ultrasound use in the Netherlands from 1996 until February 2003. The patient database 
enabled us to identify and trace all trauma departments that prescribed ultrasound. 
All enrolled nonunion cases were of nonpathologic traumatic origin. The minimal 
fracture age was set at 6 months and patients had to be skeletally mature. Strict 
criteria for enrollment were set, to make sure all cases were established nonunions. 
The fracture line had to be visible in two orthogonal views and the radiographs could 
not show any healing improvements in the 3 months before the start of ultrasound 
treatment. To preclude any beneficial effect of a surgical intervention, the time 
interval between last surgical intervention and start of low-intensity pulsed ultrasound 
had to be at least 3 months. Patients did not receive any additional cast or surgical 
treatment at the start or during the ultrasound treatment. All pre-existing means of 
immobilization at the start of ultrasound treatment stayed unchanged. Cases were 
excluded for insufficient treatment if treatment was less than 3 months or a new 
treatment intervention was introduced within 3 months after start with ultrasound 
treatment. All tibia nonunion cases that underwent ultrasound treatment and did not 
meet these criteria were excluded. The outcome of the excluded nonunion cases are 
analyzed and reported in a modified intention-to-treat analysis. 
Previous similar case reviews on ultrasound have used a self-paired study design, 
in which each nonunion case serves as its own control24-26. Self-pairing ensures that 
specific differences of the patient are eliminated between treatment and control. The 
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validation of this study design is based on the fact that an established nonunion is 
characterized by a total stop of all fracture repair processes, without any chance of 
spontaneous healing3. However to determine clinically if all fracture repair processes 
indeed have stopped is difficult. Fracture healing can still progress because of late 
endosteal healing, although radiographic healing has ceased32,33. Prospective survey 
of conservatively treated tibia fractures shows fractures can still heal after 1 year 
without any intervention other than immobilization5,6,32. The assessment of fracture 
healing by radiographs, manual stressing, and palpating the nonunion site may lead 
to false positive assumption of a nonunion case. To determine the spontaneous 
healing chance for our study group, we have evaluated the outcomes and criteria of 
enrollment of previous published randomized prospective trials on electrostimulation 
versus conservative treatment16,17. With similar strict criteria of enrollment and initial 
fracture severity, the spontaneous healing rate was estimated between 5% and 30% 
and assumed to be 30% for statistical analyses16,17. 
Trauma departments of 99 clinics (surgical and orthopedic departments) were 
approached and 96 clinics agreed to participate. Clinical records and radiographs 
were provided by the treating physicians and were reviewed on-site for criteria of 
enrollment. One of the authors (S.R., D.B.) assessed every enrolled tibia nonunion case 
according to a preset protocol. The files of all enrolled nonunion cases were verified 
for fracture characteristics, means of reduction and fixation, nonunion characteristics, 
prior interventional nonunion treatment, treatment start, duration, healing outcome, 
and patient characteristics. A senior orthopedic consultant (R.A.) performed the overall 
radiologic assessment of the nonunion healing criteria and an independent radiologist 
(G.G.) performed a secondary independent review. 
The indication and decision to prescribe the use of low-intensity pulsed ultrasound 
was solely judged by the treating surgeon as the best treatment option at that time. 
The treating surgeon was the sole judge of clinical and radiologic healing, and for 
the corresponding end of treatment with ultrasound. All treating surgeons were 
independent of Smith & Nephew, Inc., Memphis, TN. Patients were subjected to 
low-intensity pulsed ultrasound once a day for 20 continuous minutes. The patient 
or the physician could not change device specifications. The ultrasound pressure 
wave signal consisted of a 200-microsecond burst of 1.5 MHz acoustic sine waves, 
which repeated at a modulation frequency of 1 kHz with an intensity of 30 mW/cm2. 
The surgeon marked the skin where the ultrasound transducer had to be placed and 
coupling gel was applied between the skin and the device to ensure effective transfer 
of the acoustic pressure wave to the tissue.
For a nonunion to be considered radiographically healed, three of four cortices 
had to be bridged in two orthogonal views. Nonunion was considered clinically healed 
when there was absence of pain by manual stressing/palpating, and full weight-
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bearing/regular use was achieved. Clinical healing was verified by the assessment of 
the patient’s medical file. Cases were considered a failure when healing criteria were 
not met at the end of ultrasound treatment or a new treatment intervention was 
introduced during ultrasound treatment. 
In total, 123 patients received ultrasound treatment for a tibia nonunion during 
the study period. Seventy-one cases were enrolled and were the basis for evaluation. 
Fifty-two cases were excluded according to the criteria of enrollment. In 6 cases, 
progression of fracture healing was present at start of ultrasound; in 19 cases, prior 
surgery was within 3 months of treatment start; in 12 cases, clinical file or radiographs 
were insufficient; in 12 cases, ultrasound treatment duration was less than 3 months; 
in 2 cases, no approval was given by treating physician; and in 1 case, no consent to 
treat was obtained. The number of included cases was 71, 56 men and 15 women. 
Mean age was 40 years (range, 17-89 years at start of ultrasound treatment). Average 
ultrasound treatment duration for all included cases was 188 days (range, 52-739 
days; median, 160 days). Initial fracture characteristics and severity included 61 
cases (86%) displaced, 53 cases (75%) comminuted, and 48 cases (67%) displaced 
and comminuted. At initial trauma, there were 19 (27%) open fractures: 7 grade I, 9 
grade II, 2 grade IIIA, and 1 grade IIIB (according to Gustillo) 34. Displacement was 
categorized according to percentage of diaphyseal diameter. Displacement was total 
in 11 cases, more than 50% in 14 cases, less than 50% in 38 cases, and none in 
10 cases. Mean fracture age was 257 days (range, 180-781 days; median, 215 days, 
Table 1). Initial fracture treatment was conservative in 19 cases and operative in 52 
cases. Operative procedures included plate and screw osteosynthesis in 9 cases, 
intramedullary osteosynthesis in 27 cases, and external fixation in 16 cases. The 
average number of surgical interventions was 1.2 for the total study group and 1.6 for 
the operative treated group (range, 1-5). Average time interval between last surgical 
intervention and start of ultrasound was 195 days (range, 90-717 days). Of the 19 
initial conservative treated cases, only 1 patient received intramedullary nailing within 
3 months after the initial fracture. Dynamization of the tibia nail was performed before 
the start of ultrasound treatment. In 16 cases, external fixation was applied directly 
after the initial fracture. External fixation was removed before the start of ultrasound 
treatment in five cases. In three of these five cases, a pin tract infection was present at 
time of removal. Fracture stabilization was maintained by conservative means. In two 
infected fracture cases, plate and screw osteosynthesis was applied after the removal 
of the external fixation. Only one patient received intramedullary nailing after external 
fixation. In total, 27 cases were treated with intramedullary nailing. No secondary 
intervention was performed in seven cases. In two cases, the intramedullary nail was 
removed within 6 months because of knee impingement. After removal, fracture 
stabilization was obtained by conservative means. Secondary dynamization of the 
tibia nail was performed in 18 cases. In 14 cases, dynamization was performed within 
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6 months after initial fracture, and in 4 cases, dynamization was performed after 6 
months fracture age. Osteosynthesis by plate and screws was performed in 9 cases. 
One infected fracture case received a secondary intervention by means of external 
fixation. 
The study outcome, healed or failed, was the primary efficacy parameter and 
stratification was performed for the following variables at start of ultrasound 
treatment: gender, age, fracture location, type of immobilization at ultrasound start, 
type of nonunion, fracture age, smoking habit, and body mass index (Table 2). Heal 
time (Table 1) was the secondary efficacy parameter and was defined in days from the 
start until healed outcome. If there was a discrepancy between the investigators and 
independent radiologist with regard to the date of consolidation, the latest date after 
the start of ultrasound treatment was regarded as the date of consolidation.
A questionnaire was sent to all included patients to assess treatment commitment, 
medication use, comorbidity, outcome, and long-term follow-up status. If additional 
information was required, patients were contacted by telephone. Average follow up 
duration was 2.7 years (range, 1.1-4.6 years).
Statistics were presented relating to the central tendency of the data, (i.e. average 
[mean] and median). Percentages of cases were presented as percentage followed by 
the numerator/denominator in parentheses. Standard error of the mean (SEM) was 
the measure of variability presented. The test of whether or not ultrasound treatment 
significantly affected the primary outcome, healed or failed, was conducted using 
a one-sided binomial test of the observed proportion healed versus a prespecified 
proportion with the null hypothesis (proportion healed with ultrasound treatment 
≤30%) and alternative hypothesis (proportion healed with ultrasound >30%). Thirty 
percent was chosen to represent the maximum expected spontaneous healing of a 
nonunion without intervention based on a literature review16,17. Two-sided Kruskal-
Wallis test and Wilcoxon two-sample test were used for testing differences in heal time 
and fracture age among and between strata. Fisher’s exact test was used for testing 
differences in healed proportions among and between strata. Significance level (α) 
was 0.05 for all tests. SAS software (Version 8.2) was used for all statistical analyses35.
RESULTS
The overall healing rate of established tibia nonunions treated with low-intensity pulsed 
ultrasound is 52 of 71 cases or 73%. Figure 1, illustrates the effect of 2 months of 
ultrasound treatment on an established nonunion case. Treatment with low-intensity 
pulsed ultrasound, in combination with pre-existing immobilization (internal/external/
cast/brace) of tibia nonunions shows a statistically significantly higher healing rate 
compared with nonoperative immobilization alone, p<0.0001 (30% maximum healing 
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rate according to literature). Mean healing time (N=52) was 184 days (range, 53-750 
days; Table 1) and the mean treatment duration for failures was 183 days (range, 
101-346 days; median, 120 days). 
An extensive stratification analysis has been performed (Table 2) showing no 
statistically significant difference in healing rate for all evaluated variables: location in 
bone, comminution, open/closed, nonunion type, fracture age, means of fixation at 
ultrasound treatment start, prior surgical procedure interval, patient age, sex, body 
mass index, and smoking habit. Healing time however was significantly shorter for 
hypertrophic nonunions in comparison with oligotrophic and atrophic nonunions 
(p<0.05). Fracture age was significantly longer for patients treated by intramedullary 
nailing in comparison with the other forms of immobilization (p<0.001). 
Despite not being statistically significant, there were some trends suggested by 
the data. Smokers have a lower healing rate (63%) than nonsmokers have (84%). 
Nonunions located in the middle third of the tibia showed a healing rate of only 53% 
Figure 1. Radiographic illustration of a 39 year old male patient treated with low-intensity pulsed ultrasound 
for a tibia nonunion. (A) Radiographs of a left segmental diaphyseal tibia fracture and diaphyseal fibula 
fracture, sustained after a direct kick to the lower leg. (B) Radiographs of an 8 month old oligotrophic tibia 
nonunion at the start of ultrasound treatment. Initial fracture treatment was unreamed intra-medullary 
nailing; followed by dynamization 3 months post fracture. (C) Radiographs of a tibia nonunion, 2 months 
after ultrasound treatment start.
Table 1. Healing Time and Fracture Age 
Healing Time (days) Fracture Age (days)
Mean ± SEM 184 ± 17.8 256.8 ± 14.6
Median 158.5 215
Range 52-739 180-781
Secondary efficacy parameter Healing Time (N=52) and descriptive parameter of Fracture Age (N=71) of 
consecutive tibia nonunions treated with low-intensity pulsed ultrasound in The Netherlands.
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(8 healed and 7 not healed) compared with 89% (8 healed and 1 not healed) for the 
proximally located and 77% (36 healed and 11 not healed) for the distally located 
nonunion (Table 2). Of the six infected nonunions, three patients healed. Of patients 
who were on prescription of acenocoumarol (oral anticoagulant) during ultrasound 
treatment, only one of four patients healed.
The independent radiologic review of all included cases showed no difference in 
healing rate. In 19 cases, there was a discrepancy in date of bone healing based on the 
observations of the radiologist and investigators. The date of bone healing was judged 
earlier by the investigators in 8 cases and judged earlier by the independent radiologist 
in 11 cases. In case of a discrepancy, the date related to the longest healing time 
was used for assessment of secondary efficacy parameter (heal time). In three cases, 
the independent radiologist found fracture healing was progressive before treatment 
start. In one case, the independent radiologist found radiographs insufficient to give 
any judgment. The investigators have reassessed these four cases. The patient follow-
up showed that these patients healed, and treatment duration ranged from 56 days 
to 186 days. The investigators judged enrollment was justified and these cases were 
included in the final assessment.
The long-term follow-up by patient questionnaire of the nonunion cases showed 
no refractures (N=55; 41 healed, and 14 not healed, 75%), 16 patients (11 healed 
and 5 not healed, 69%) were lost for long-term follow-up. One patient received a 
correction osteotomy for a malunion. Total compliance to ultrasound treatment was 
good and 98% of the patients used the device for the recommended six to seven 
times a week. No adverse responses were reported. In total, 52 cases were excluded 
according to the criteria of enrollment. Thirty-nine excluded patients were available for 
long-term follow-up, 20 patients healed and 19 failed (13 excluded patients were lost 
to follow-up). The most conservative analysis of effectiveness (termed the intention-to-
treat analysis) combined the study group and not included cases for a total 110 cases 
(13 patients lost to follow-up). The combined analysis shows a healing rate of 65% (72 
healed and 38 not healed). In comparison with nonoperative immobilization alone, the 
modified healing rate of ultrasound therapy remains statistically significantly higher 
(p<0.0001).
DISCUSSION
Fractures of the tibia are the most common fractures of the long bones. The delayed 
union rate is relatively high and the nonunion rate is 1% to 3%8. Tibia nonunions 
cause impairment of daily functioning and demand adequate treatment to reach a 
healed outcome as soon as possible. The literature describes a range of treatment 
options for the tibial nonunion. In many cases, the chosen treatment option is related 
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Table 2. Stratification of Patient and Fracture Characteristics
Strata: Total Healed Failed % Healed p-valuea Heal Time 
Mean (days)
p-valueb Fx. Age 
Mean (days)
p-valueb
Location in Bone: 0.16 0.70 0.70
Proximal 9 8 1 89% 153 258
Middle 15 8 7 53% 186 266
Distal 47 36 11 77% 191 258
Comminuted: 0.76 0.45 0.85
Yes 53 38 15 72% 192 257
No 18 14 4 78% 161 256
Open / Closed: 0.36 0.72 0.76
Open fractures 19 12 7 63% 210 248
Closed fractures 52 40 12 77% 177 260
Nonunion Type: 0.94 0.03 0.18
Hypertrohfic 17 13 4 77% 128 314
Atrophic 24 17 7 71% 183 225
Oligotrophic 30 22 8 73% 218 249
Fracture Age: 0.40 0.22 n.a.
6-9 months 56 43 13 77% 190 209
>9-12 mnd 10 6 4 60% 121 334
>1-2 year 3 2 1 67% 297 554
>2 year 2 1 1 50% 91 765
Fixation: 0.92 0.73 < 0.001
Conservative 26 20 6 77% 170 216
Internal OS 9 7 2 78% 201 224
IMOS 27 19 8 70% 196 320
External fixation 9 6 3 67% 155 219
Prior Surgery: 0.29 n.a. 0.13
12 wks-1year 52 38 14 73% 186 260
>1-2 years 1 0 1 0% 717
Patient Age: 0.39 0.28 0.15
17-29 27 18 9 67% 171 268
30-49 22 17 6 74% 224 277
50-65 13 14 2 88% 139 219
>65 5 3 2 60% 250 225
Sex: 0.06 0.25 0.74
Males 56 38 18 68% 186 256
Females 15 14 1 93% 179 258
BMIc: 0.30 0.11 0.30
<18.5 1 0 1 0% n.a. 324
18.5<25 26 18 8 69% 209 247
25<30 17 14 3 82% 130 241
30+ 11 9 2 82% 212 262
Smokingc: 0.12 0.34 0.54
Smoking 24 15 9 63% 196 249
no 31 26 5 84% 176 251
Stratification analysis of consecutive tibia nonunions treated with low-intensity pulsed ultrasound in The 
Netherlands. a, Fisher’s exact test; b, Wilcoxon two-sample test/Kruskal-Wallis test ( for 3 or more  variables); 
c, N=55; n.a., not applicable; Fx, fracture; OS, osteosynthesis; IMOS, intramedullary osteosynthesis. 
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Strata: Total Healed Failed % Healed p-valuea Heal Time 
Mean (days)
p-valueb Fx. Age 
Mean (days)
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Proximal 9 8 1 89% 153 258
Middle 15 8 7 53% 186 266
Distal 47 36 11 77% 191 258
Comminuted: 0.76 0.45 0.85
Yes 53 38 15 72% 192 257
No 18 14 4 78% 161 256
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Open fractures 19 12 7 63% 210 248
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Hypertrohfic 17 13 4 77% 128 314
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Oligotrophic 30 22 8 73% 218 249
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6-9 months 56 43 13 77% 190 209
>9-12 mnd 10 6 4 60% 121 334
>1-2 year 3 2 1 67% 297 554
>2 year 2 1 1 50% 91 765
Fixation: 0.92 0.73 < 0.001
Conservative 26 20 6 77% 170 216
Internal OS 9 7 2 78% 201 224
IMOS 27 19 8 70% 196 320
External fixation 9 6 3 67% 155 219
Prior Surgery: 0.29 n.a. 0.13
12 wks-1year 52 38 14 73% 186 260
>1-2 years 1 0 1 0% 717
Patient Age: 0.39 0.28 0.15
17-29 27 18 9 67% 171 268
30-49 22 17 6 74% 224 277
50-65 13 14 2 88% 139 219
>65 5 3 2 60% 250 225
Sex: 0.06 0.25 0.74
Males 56 38 18 68% 186 256
Females 15 14 1 93% 179 258
BMIc: 0.30 0.11 0.30
<18.5 1 0 1 0% n.a. 324
18.5<25 26 18 8 69% 209 247
25<30 17 14 3 82% 130 241
30+ 11 9 2 82% 212 262
Smokingc: 0.12 0.34 0.54
Smoking 24 15 9 63% 196 249
no 31 26 5 84% 176 251
Stratification analysis of consecutive tibia nonunions treated with low-intensity pulsed ultrasound in The 
Netherlands. a, Fisher’s exact test; b, Wilcoxon two-sample test/Kruskal-Wallis test ( for 3 or more  variables); 
c, N=55; n.a., not applicable; Fx, fracture; OS, osteosynthesis; IMOS, intramedullary osteosynthesis. 
to the nonunion characteristics, and the 
personal preference and experience of the 
clinician. Surgical treatment with or without 
autologous bone grafting, as mentioned 
before, is still the treatment choice of most 
with regard to tibial nonunions11. Reamed 
(exchanged) intramedullary nailing for 
aseptic nonunions of the tibial diaphysis show 
excellent healing rates36,37. Intramedullary 
nailing however has its limitations in the 
infected nonunion. Plate osteosynthesis 
requires opening the nonunion site, which can 
cause neurovascular damage and carries the 
risk of secondary infection. Autologous bone 
grafting requires an additional operation site 
and has its related comorbidity.38 The major 
advantage of lowintensity pulsed ultrasound 
over surgical therapy is that it is not related 
to any risk or comorbidity. Secondly, daily 
treatment takes only 20 minutes, resulting 
in a high level of patient compliance, and is 
performed on an outpatient basis so it does 
not require any hospitalization. 
Barker et al. has critically stated that 
immobilization itself could be largely39, 
if not completely, responsible for the 
healing of nonunited fractures of the tibia. 
Immobilization is one of the key factors 
for fracture healing. On the other hand, 
fracture healing by immobilization alone, is 
not guaranteed in fractures that show severe 
initial fracture characteristics5,9,16,17,40. The 
study of Sharrard has shown us that with 
strict criteria of enrollment17, immobilization 
by surgical cast or brace will only demonstrate 
progression in fracture healing in 30% of 
tibial delayed-union cases (8% according 
to independent radiologic review). Our 
case review of consecutively treated tibia 
nonunions with ultrasound shows a healing 
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rate of 73%. This is a significantly (p<0.0001) higher healing rate compared with 
conservative treatment and well over the spontaneous healing rate noted between 
5% and 30% in the literature16,17. Although this study was non-randomized, the 
presented outcomes justify adjunctive ultrasound treatment of nonunion over 
immobilization alone. Total treatment costs of ultrasound therapy are a fraction of 
surgical interventions41. 
No similar review study on ultrasound has reported on this large a sample size of 
tibia nonunions23-26. Previous review studies on ultrasound treatment of nonunions 
showed an overall healing percentage from 70% up to 85%23-26. The results of the 
present study are therefore in accordance with the literature. The stratification analysis 
shows no statistically significant difference in healing rate. Comorbidity and medication 
use do not negatively influence the outcome with ultrasound treatment. Nonunions 
in smokers show a trend of lower healing rate and reflect what is recognized in the 
general fracture population: that fractures in smokers heal at a slower rate42. 
During the past few decades a number of noninvasive treatment options for 
enhancing bone growth have come along, including extracorporeal shock wave and 
electrostimulation19,20, and low-intensity pulsed ultrasound. Although shock wave 
therapy is regarded as noninvasive, treatment of the tibial nonunion is performed 
under general or spinal anesthesia and demands at least 1 day of hospitalization. It 
is not uncommon that more than one treatment session is required. The success rate 
of shockwave therapy is significantly less for atrophic nonunions in comparison with 
hypertrophic nonunions18. Secondly there is no uniformity of the amount of shock 
waves needed. Reported success rates are up to 80%19,20,43. Pulsed electromagnetic 
field (PEMF) is a noninvasive treatment modality, requiring daily treatment on an 
outpatient basis. Scott et al. reported the results of the treatment of 23 tibial nonunions 
with electrical capacitive coupling16, in a blinded prospective randomized trial. This 
trial showed a statistically significantly higher healing rate in the actively treated group. 
The effectiveness of PEMF however is in direct relation to the daily treatment duration 
and therefore requiring many hours every day18. Unlike PEMF, ultrasound requires only 
20-minutes of treatment each day. 
From this review (consecutively enrolled, conservatively treated tibia nonunions 
with ultrasound in the Netherlands), we conclude that low-intensity pulsed ultrasound 
is effective in the treatment of established nonunions of the tibia. It is a good 
alternative to surgical therapy, with lower costs and reduced risk of complications as 
well as having an excellent rate of patient compliance. With regard to the design of the 
study; a randomized prospective trial on tibia nonunion would be even more valuable 
than the self paired study design. However it is ethically impossible for us to administer 
sham treatment to patients with nonunions. Nevertheless this review demonstrates 
low-intensity pulsed ultrasound to be an effective and useful treatment modality of 
tibia nonunions in daily clinical practice.
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ABSTRACT
Background: Low-intensity pulsed ultrasound (LIPUS) is frequently used in clinical 
practice to treat impaired and/or delayed fracture healing, but its effectiveness is 
unclear. Therefore we aimed to investigate the effectiveness of LIPUS as a single 
treatment option to accelerate and/or enhance fracture union in patients with a 
delayed union of the fibula enrolled in a randomized clinical trial.
Methods: The delayed union of the non-fixated osteotomized fibula after a standard 
high tibial osteotomy was used as clinical model to compare fractures of similar 
type and nature. In total 20 patients (6 male, 14 female; age 41-63 years) with an 
average fracture age of 7 months showing a delayed union of the fibula were enrolled, 
and assigned to the double-blinded allocated treatment intervention (10 LIPUS, 10 
controls). Patients received 5 months of LIPUS- or sham-treatment. Fracture healing 
was assessed by radiographical and physical examination in 7 LIPUS-treated patients 
and 8 controls. Both groups of patients were similar with regard to gender, age, 
medication use, and co-morbidity. 
Results: The primary analysis did not show a difference in number of healed cases 
between LIPUS-treated and sham-treated controls. Independent radiographical 
assessment showed that LIPUS decreased healing time by 29% (not significant) at 5 
months, and by 57% (p=0.023) at 1 year after the start of LIPUS-treatment. Subjective 
clinical signs of fracture healing, i.e. pain at weight-bearing and manual stressing of 
the delayed union site, were similar in LIPUS-treated patients and controls. No direct 
relation was seen between the variables evaluated (age, gender, co-morbidity, use of 
medication) and final clinical outcome. 
Conclusion: Our data show that LIPUS-treatment is effective in accelerating delayed 
and/or impaired fracture healing. However, as a single treatment option LIPUS does 
not directly contribute to improved fracture union when sufficient stability is absent as 
in the non-fixated delayed union of the fibula. 
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INTRODUCTION
Insight in the molecular biological mechanisms involved in fracture healing has resulted 
in the development of new treatment modalities for impaired fracture healing, such as 
bone morphogenic proteins, extracorporeal shock wave treatment, electro-stimulation, 
and low-intensity pulsed ultrasound (LIPUS)1. LIPUS is a form of mechanical energy 
transmitted transcutaneously by high frequency acoustic pressure waves, and is 
regarded as nonthermal and nondestructive2,3. The micro-mechanical stress produced 
by LIPUS may provide a surrogate for the forces normally applied on bone by physical 
loading according to Wolff’s law4.  Since 90% of all fresh fractures heal spontaneously 
without any form of delay, it is the delayed and/or impaired fracture healing that could 
benefit most from LIPUS enhancing capacities5.
Randomized controlled clinical trials on fresh fracture healing showed up to 38% 
acceleration of clinical fracture healing as result of LIPUS-treatment6,7. Previous 
reports on the effect of LIPUS on nonunion cases shows it is capable to restore the 
disrupted fracture healing present8-10. LIPUS may enhance delayed fracture healing 
by increased bone formation and advanced bridging of the fracture gap11,12. In 
contrast to fresh fracture healing, a randomized placebo controlled trial on the isolated 
effect of LIPUS on impaired bone healing may be seen as unethical, because this 
withholds the sham-treated control patient from any other form of treatment. In total, 
2 randomized trials reported on the healing capacity of LIPUS on impaired clinical 
fracture healing11,13. Only one trial reported the final clinical outcomes as result of 
LIPUS-treatment in scaphoid nonunions, which was combined with vascularized bone 
grafting13. A randomized controlled clinical trial evaluating the effectiveness of LIPUS 
as a single treatment option for delayed and/or impaired fracture healing is still absent. 
The aim of the present study was to investigate the effectiveness of LIPUS-treatment 
as a single treatment option in the acceleration and/or enhancement of fracture union 
in patients with a delayed union of the osteotomized non-fixated fibula treated in a 
randomized controlled clinical trial.
PATIENTS AND METHODS
Study design
A prospective, two-center, randomized (1:1), double blind, placebo-controlled, parallel-
group, clinical trial was conducted in the Netherlands. Participation hospitals were 
the Tergooi Hospitals location Hilversum, and the Spaarne Hospital, Hoofddorp. 
Trial approval and registration was obtained from the Medical Ethical Review Board 
of the VU University Medical Centre, Amsterdam, registration number 2004-005. 
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The delayed union of the fibula after a high tibial osteotomy was used as model 
to compare fractures of similar type and nature. The procedure of a standard A.O. 
(Arbeitsgemeinschaft für Osteosynthesefragen) closed wedge high tibial osteotomy 
for medial located osteoarthritis of the knee includes a standardized diaphyseal 
non-fixated sliding oblique osteotomy of the proximal to middle third of the fibula, 
which shows a tendency of impaired healing (Figure 1) 4. Patients were treated with 
or without LIPUS for a period of 5 months. We calculated that 20 participants were 
needed for this study, based on an expected accelerating effect of LIPUS on fracture 
healing of 30-40%, a SD of 25%, a two-sided 5% significance level, and a power of 
80%6,7,14. The anticipated drop out level was 10-20%. Radiographic follow-up was 
performed up to 1 year after treatment cessation. Long-term follow up was performed 
by telephonic inquiry as well as review of the patient’s clinical files (mean follow-up 
duration: control 5.0 years, LIPUS 4.8 years).
Figure 1. Radiographical evaluation of the effect of low-intensity pulsed ultrasound  (LIPUS) treatment 
on a delayed union of the osteotomized fibula. (A) Anterior to posterior X-rays of the left tibia and fibula 
of a 52 year old female patients, after a standard A.O. (Arbeitsgemeinschaft für Osteosynthesefragen) 
closed wedge high tibial osteotomy, and diaphyseal non-fixated sliding oblique osteotomy of the fibula 
(rectangle), for medial located osteoarthritis of the knee. (B) At the start of low-intensity pulsed  ultrasound 
treatment, 6 months after the fibula osteotomy, a hypertrophic delayed union was present. Abundant 
callus formation is seen, but absence of cortical bridging as shown by radiolucent area (arrow) between 
the fracture ends. (C) Five months of treatment with LIPUS resulted in increased bone formation as 
shown by the increase in fracture callus formation (arrow), but failure of fracture union. (D) The absence 
of sufficient fracture stability in the in the non-fixated osteotomized fibula resulted in a hypertrophic 
nonunion, 1 year after the start of LIPUS-treatment.
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Criteria of enrolment
Eligible patients for participation in this study were all skeletally mature adults aged 
18 to 75 with a delayed union of the fibula after a high tibial osteotomy. Delayed 
union was defined as the absence of cortical bridging of the osteotomized fibula in 2 
orthogonal X-ray views taken at least 6 months after a high tibial osteotomy. Exclusion 
criteria were pregnancy and lactation, pathologic and/or metabolic bone disease, use 
of long-term calcium channel blockers or bisphosphonates, apparent alcoholism and/
or nutritional deficiency, and related factors that would prevent adherence to the 
protocol. Written informed consent was obtained from all patients participating in the 
study.
Randomization and allocation
Computerized randomization was performed for blocks of 8 devices (1:1) by the 
Exogen® device manufacturer (Smith & Nephew Inc., Memphis, TN, USA). Devices 
were shipped as blocks of 8 devices (4 active, 4 control) to each investigational center, 
and dispatched in order of inclusion. The allocation sequence remained concealed to 
all investigators and patients participating in the trial upon termination of the study 
treatment phase of the patients enrolled. 
Study procedures
The patients enrolled in the clinical trial used the Exogen® low-intensity pulsed 
ultrasound device at home for a daily 20-minute treatment over a 5 month period. 
Placebo devices were identical in every aspect to active-LIPUS devices except for the 
fact that did not generate an ultrasound signal. The LIPUS device produced a 200 μs 
burst of 1.5 MHz acoustic sine waves that repeated at a modulation frequency of 1 
kHz, and provided a peak pressure of 30 mW/cm². The ultrasound signal produced is 
not detectable to the human senses. Duration of a single daily 20-minute treatment 
and the total number of treatments was registered by the Exogen® device, and used 
for evaluating compliance to treatment.
A routine set of X-rays of the fibula in 2 orthogonal views (anterior to posterior 
and axial projection) was taken at each monthly evaluation. Individual experience of 
pain or discomfort at the delayed union site in rest, at weight bearing, or at manual 
palpation, was determined by the use of a visual analogue scale (VAS). 
Two to 4 months after the start of LIPUS treatment, a biopsy was taken from 
the delayed union of the fibula. The biopsy procedure was part of a more extensive 
study protocol to investigate how LIPUS affects bone healing at the tissue level. The 
procedure and outcomes have been reported previously12,15.
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Outcome assessment
The primary study outcome measures were healing rate and healing time. Healed 
outcome was based on the radiographical aspect of bridging of at least 3 of 4 cortices 
of a delayed union. Healing time was the time needed to reach a healed outcome 
from the start of study treatment. Evaluation of the radiographs was performed by an 
independent senior radiologic consultant (GG). Clinical fracture healing examination 
was performed by the executing researcher (SR).
Statistics
Statistical analysis of the data was performed using Mann–Whitney U test for 
non-parametric analysis, with SPSS 14.0 software (SPSS Inc., Chicago, Illinois). 
Although patient population was normally distributed, the relative small number of 
trial participants determined the use of a non-paramatic statistical test. A p-value of 
<0.05 was considered significant.
RESULTS
Patients were recruited over a 2-year period (April 2004 - April 2006). In total 24 
patients were considered eligible for enrolment in the present study (Figure 2). Twenty 
patients were included, and assigned to the allocated treatment intervention (10 
LIPUS, 10 controls; age 41-63 years). In the control group, 1 patient withdrew from 
the study shortly after informed consent was obtained. In retrospect, 1 delayed union 
in the control group did not meet the radiological inclusion criteria as judged by the 
independent radiological consultant, and was seen as not eligible and excluded from 
the study. Two patients in the active treatment group without any discomfort of their 
fibula delayed union did not comply with the daily treatment scheme and scheduled 
outpatient visits, and were therefore excluded from the study. One Exogen® device 
malfunctioned shortly after the start of treatment in the active group, and the delayed 
union was excluded from the primary analysis. One patient (control) emigrated and 
was lost for long-term (>1year) follow-up. 
Table 1, shows the baseline demographics of all enrolled patients, as well as 
treatment allocation and final outcome. Mean fracture age at the start of treatment 
for non-excluded patients was 193 days (range 180-214, median 193 days, n=8) for 
the sham-treated controls, and 201 days (range 180-270, median 187 days, n=7) for 
the LIPUS-treated patients. 
The rate of healing was not increased as result of 5 months of treatment with 
LIPUS. At cessation of LIPUS treatment, radiographical healing was seen in 4 of the 
LIPUS-treated delayed unions (n=7), as well as in 4 of the sham-treated delayed unions 
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(n=8, Figure. 3). One year after treatment start, 7 of the 8 delayed unions in the control 
group showed healing, whereas the total number of healed delayed unions treated 
with LIPUS remained 4 out of 7. Long term follow up (>1 year) showed one remaining 
stiff nonunion in the control group. In the LIPUS-treated group, 2 of the 3 failures 
finally received internal fixation and healed, whereas one delayed union spontaneously 
healed more than one year after the cessation of LIPUS therapy. 
Assessment for eligibility of patients >6 months after high tibial ostyeotomy  (n=52)
 
Excluded  (n=32)
•   No delayed union of the fibula (n=28)
•   Declined to participate (n=4)
  
  
Allocated to Placebo-treatment (n=10)
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  Excluded (n=2)
* Consent withdrawal (n=1)
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Allocated to LIPUS-treatment (n=10)
Received allocated intervention (n=8) Received allocated intervention (n=7)
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Primary analysis (n=8) Primary analysis (n=7)
 Intention to treat (n=9)    
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Figure 2. Flow diagram of a prospective, randomized, placebo-controlled, parallel-group, clinical trial 
investigating the effect of low-intensity pulsed ultrasound (LIPUS) treatment for delayed unions of the 
non-fixated osteotomized fibula after high tibial osteotomy. n, number of patients with a delayed union.
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Table 1. Patient and fracture characteristics of trial participants with a delayed union of the non-fixated 
osteotomized fibula, enrolled and allocated to treatment intervention with low-intensity pulsed ultrasound 
or sham-treatment with a placebo device.
Treat-
mod
Hospital Sex Age #-Age 
(days)
Rad-
aspect
Biopsy 
Date
(days)
Smok Body
Mass
Index
Cardio-
vascular
Disease
Post
Meno-
pause
Work
Comp
Com-
pliance
(%)
Healing 
Status
Healing 
Time
(days)
LIPUS SH M 63 274 hyper 75 yes 27 no n.a. no 74 healed 90
“ TGH* M 63 201 atroph n.a. no 28 no n.a. yes n.a. failure n.a.
“ TGH* M 63 331 hyper 125 yes 26 no n.a. no 94 healed 269
“ TGH* M 57 283 hyper n.a. yes 43 yes n.a. no n.a. healed 235
“ SH M 42 190 hyper 94 yes 42 no na yes 79 healed 106
“ TGH F 43 187 hyper 61 no 35 yes yes no 93 failure n.a.
“ TGH F 46 185 atroph 84 no 32 yes no yes 68 failure n.a.
“ TGH F 52 209 hyper 90 no 31 no yes no 81 failure n.a.
“ SH F 63 180 hyper 117 no 37 yes yes yes 66 healed 42
“ SH F 57 180 atroph 90 no 29 no no no 99 healed 81
Control TGH M 61 187 atroph 82 no 30 yes n.a no 97 healed 228
“ TGH F 48 183 atroph 72 no 32 yes yes no 93 healed 281
“ SH F 54 180 hyper 83 no 30 yes yes no 96 healed 95
“ TGH F 57 199 hyper 87 no 34 yes yes no 54 healed 98
“ SH F 41 198 hyper 60 no 32 no no no 60 healed 126
“ TGH F 53 183 hyper 88 no 29 yes yes yes 97 healed 351
“ TGH F 57 202 hyper 81 no 37 no yes no 89 failure n.a.
“ SH* F 56 180 hyper n.a. no 33 no yes no n.a. failure n.a.
“ SH* F 53 205 n.a. n.a. no 23 yes no no n.a. n.a. n.a.
“ TGH F 44 214 hyper 89 no 32 no no no 76 healed 128
Healing status and healing time is presented at 1 year after trial enrolment. Treat-mod, Treatment 
modality; LIPUS, low-intensity pulsed ultrasound; SZ, Spaarne Hospital, Hoofddorp, The Netherlands; 
TGH, Tergooi Hospitals, location Hilversum, The Netherlands; M, male; F, female; #-Age, Fracture age; 
Rad-aspect, Radiological aspect; hyper, hypertrophic, artoph, atrophic; Smok, Smoking; Work Comp, 
Worker Compensation;  n.a., not applicable; *, excluded from primary analysis.
At the end of 5 months of treatment with or without LIPUS, the healing time was 
slightly but not significantly decreased by 29% as a result of LIPUS-treatment (control, 
n=4, 112 ± 9 days; LIPUS, n=4, 80 ± 14 days; mean ± SEM; p=0.083; Figure. 4A). 
LIPUS-treatment however showed significantly decreased the healing time by 57% at 
1 year after treatment start (control, n=7, 187 ± 38 days; LIPUS, n=4, 80 ± 14 days; 
mean ± SEM; p=0.023; Figure. 4B).
Clinical fracture healing (no pain) at 5 months of treatment was seen in 3 
LIPUS-treated patients, but only in 1 control patient. No difference was observed 
between LIPUS-treated patients and sham-treated controls with regard to the 
decrease of the VAS-score from the start to the end of the treatment phase for pain 
at weight-bearing, pain at palpation, and pain at rest (data not shown). Two patients 
(1 control, 1 LIPUS) did not show any complaints at the start as well as at the end 
of the study treatment. Patient-related variables and co-morbidity, as well as delayed 
44
LIPUS stimulation of delayed unions of the fibula, a RCT 
Chapter
3
Table 1. Patient and fracture characteristics of trial participants with a delayed union of the non-fixated 
osteotomized fibula, enrolled and allocated to treatment intervention with low-intensity pulsed ultrasound 
or sham-treatment with a placebo device.
Treat-
mod
Hospital Sex Age #-Age 
(days)
Rad-
aspect
Biopsy 
Date
(days)
Smok Body
Mass
Index
Cardio-
vascular
Disease
Post
Meno-
pause
Work
Comp
Com-
pliance
(%)
Healing 
Status
Healing 
Time
(days)
LIPUS SH M 63 274 hyper 75 yes 27 no n.a. no 74 healed 90
“ TGH* M 63 201 atroph n.a. no 28 no n.a. yes n.a. failure n.a.
“ TGH* M 63 331 hyper 125 yes 26 no n.a. no 94 healed 269
“ TGH* M 57 283 hyper n.a. yes 43 yes n.a. no n.a. healed 235
“ SH M 42 190 hyper 94 yes 42 no na yes 79 healed 106
“ TGH F 43 187 hyper 61 no 35 yes yes no 93 failure n.a.
“ TGH F 46 185 atroph 84 no 32 yes no yes 68 failure n.a.
“ TGH F 52 209 hyper 90 no 31 no yes no 81 failure n.a.
“ SH F 63 180 hyper 117 no 37 yes yes yes 66 healed 42
“ SH F 57 180 atroph 90 no 29 no no no 99 healed 81
Control TGH M 61 187 atroph 82 no 30 yes n.a no 97 healed 228
“ TGH F 48 183 atroph 72 no 32 yes yes no 93 healed 281
“ SH F 54 180 hyper 83 no 30 yes yes no 96 healed 95
“ TGH F 57 199 hyper 87 no 34 yes yes no 54 healed 98
“ SH F 41 198 hyper 60 no 32 no no no 60 healed 126
“ TGH F 53 183 hyper 88 no 29 yes yes yes 97 healed 351
“ TGH F 57 202 hyper 81 no 37 no yes no 89 failure n.a.
“ SH* F 56 180 hyper n.a. no 33 no yes no n.a. failure n.a.
“ SH* F 53 205 n.a. n.a. no 23 yes no no n.a. n.a. n.a.
“ TGH F 44 214 hyper 89 no 32 no no no 76 healed 128
Healing status and healing time is presented at 1 year after trial enrolment. Treat-mod, Treatment 
modality; LIPUS, low-intensity pulsed ultrasound; SZ, Spaarne Hospital, Hoofddorp, The Netherlands; 
TGH, Tergooi Hospitals, location Hilversum, The Netherlands; M, male; F, female; #-Age, Fracture age; 
Rad-aspect, Radiological aspect; hyper, hypertrophic, artoph, atrophic; Smok, Smoking; Work Comp, 
Worker Compensation;  n.a., not applicable; *, excluded from primary analysis.
Figure 3. Cumulative percentages of radiographically healed delayed unions of the fibula treated with or 
without low-intensity pulsed ultrasound (LIPUS), as a function of time. Graph is showing 57% of fibula 
delayed unions treated with LIPUS healed after 106 days versus 25% of the sham-treated controls.
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union characteristics and clinical outcome are shown in Table 1. The distribution of 
variables among the 2 study groups, as well as the medication usage were similar, with 
the exception of smoking (medication data not shown). Two smokers were among 
the LIPUS-treated delayed unions evaluated. No direct relation was seen between 
specific medication usage (inhalation of steroids, thrombocyte aggregation inhibitors, 
non-steroidal anti-inflammatory drugs, and anti-hypertensive drugs; data not shown), 
patient variables, delayed union characteristics, and study primary outcome measures. 
The modified analysis (intention to treat analysis) included 10 controls and 9 
LIPUS-treated delayed unions, and was identical to the primary analysis regarding the 
number of healed cases and time to healing after 5 months of treatment with or 
without LIPUS. One year after treatment start, 6 of the LIPUS-treated delayed unions 
and 7 delayed unions in the sham-treated control group healed. Time to healing 
showed no significant decrease (control, 187 ± 38 days; LIPUS 137 ± 38 days; mean ± 
SEM; p=0.199).
 
Figure 4. Effect of low-intensity pulsed ultrasound (LIPUS) on time to healing of delayed unions of the 
osteotomized fibula. Box-plot showing median (bold line) and inter-quartile range (box) and outliers of the 
fibula delayed union healing time at 5 months of treatment with or without LIPUS (A), and at 1 year after 
treatment start (B). *Significant effect of LIPUS on decrease in healing time, p<0.05.
LIPUS treatment itself did not result in any adverse events, and patients regarded 
the Exogen® device easy in usage. Overall compliance to the daily treatment scheme 
was good to excellent, with only 1 exception in the control group. The biopsy 
procedure incorporated in the trial design showed an increased risk on temporal palsy 
of the deep peroneal nerve.
DISCUSSION 
Medical ethical considerations play an important role in trial design. It is considered 
unethical to provide placebo treatment over a prolonged period of time, when fracture 
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healing is already delayed. In contrast, the delayed union of the fibula formed a unique 
clinical model, enabling placebo treatment without direct negative consequences and/
or conflicting ethical issue. The present study is the first randomized trial to report 
on the isolated effect and outcome of LIPUS treatment on delayed and/or impaired 
clinical fracture healing.
The primary outcome measure healing rate did not show a difference between 
LIPUS-treated delayed unions and sham-treated controls. Patient-related variables, 
co-morbidity, as well as delayed union characteristics were comparable among the 2 
study groups, and no direct relation was seen with regard to the outcome. In contrast 
to our present finding we previously showed that LIPUS increases the healing rate in 
established nonunions8,10. The cause of impaired fracture healing is multi-factorial, 
i.e. initial fracture severity, stability, as well as patient related co-morbidity may play 
an important role in a final outcome and time to healing16. Although a small amount 
of the axial-load is transferred to the fibula, it will result in shear and translational 
forces at the oblique osteotomy, making it prone for impairment of fracture healing17. 
Adequate stability is one of the principles in fracture healing18. In the case series 
of tibia nonunions which were successfully treated by LIPUS, delayed union stability 
was maintained by earlier performed operative fixation or conservative cast/brace 
immobilization10. The identification of related co-factors negatively influencing 
fracture healing and outcome may provide an indication of the expected success rate 
with LIPUS-therapy. Our findings show that LIPUS treatment, as a single treatment 
option, did not lead to increased fracture consolidation in delayed unions of the 
non-fixated fibula.
One year after start of treatment, the time to healing of all healed fibula delayed 
unions was significantly decreased by LIPUS-treatment. This finding is in line with 
the previously reported accelerating effect of LIPUS on fresh fracture healing6,7. 
The acceleration of fracture union is likely the result of enhanced bridging of the 
fracture gap by LIPUS as result of increasing bone formation and mineralization11,12. 
Bone formation plays a crucial role in fracture healing, however with the absence 
of sufficient stability, may only results in a hypertrophic nonunion. LIPUS-treatment 
therefore can provide a valuable contribution in acceleration of the fracture healing 
process present by increasing bone formation, but this may not result in union, as 
shown in the non-fixated fibula delayed union. 
Acceleration of delayed fracture healing by LIPUS was slightly but not significant 
increased at the end of the 5 months of LIPUS-treatment when compared to 
sham-treatment. In retrospect, the treatment phase of 5 months incorporated in 
present study design was adequate for LIPUS to render its effect, but too short to 
evaluate the anticipated natural healing tendency of the untreated controls, as shown 
by the additional healing of 3 controls within 6 months after the end of the treatment 
phase, versus none of the LIPUS-treated failures.
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In the present study, functional use and weight bearing were not restricted, and 
none of the patients experienced true functional limitation except for pain at the 
delayed union site at treatment start. Advanced clinical fracture healing by LIPUS may 
be suggested, as more LIPUS-treated patients (3) were free of pain after 5 months of 
treatment than controls (1). Functional outcome measurement however was biased 
by the fact that a biopsy was taken during the treatment phase. Although functional 
outcome measurements are of significant importance to evaluate the effectiveness 
of clinical therapies, they are less suited to evaluate the effectiveness of LIPUS on the 
enhancement of fracture healing in the delayed unions of the fibula19. 
In conclusion, LIPUS-treatment can accelerate delayed and fracture healing, but as 
a single treatment option, did not lead to increased fracture union in delayed unions 
of the fibula. LIPUS-treatment may therefore provide a valuable contribution to the 
acceleration of delayed and/or impaired fracture healing, but when sufficient fracture 
stability is absent may not result the enhancement of fracture union, as shown in the 
non-fixated delayed union of the fibula. 
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ABSTRACT
Introduction: Low-intensity pulsed ultrasound (LIPUS) accelerates impaired fracture 
healing, but the exact mechanism is unknown. The aim of this study was to investigate 
how LIPUS affects bone healing at the tissue level in patients with a delayed union 
of the osteotomized fibula, by using histology and histomorphometric analysis to 
determine bone formation and bone resorption parameters.
Materials and Methods: Biopsies were obtained from 13 patients (9 female, 4 
male; age 42-63) with a delayed union of the osteotomized fibula after a high tibial 
osteotomy, treated for 2-4 months with or without LIPUS in a randomized prospective 
double-blind placebo-controlled trial. In the histological sections of the delayed union 
biopsies, 3 areas of interest were distinguished, i.e. 1) area of new bone formation 
at the fracture ends, 2) area of cancellous bone, and 3) area of cortical bone. 
Histomorphometrical analysis was performed to determine bone formation and bone 
resorption parameters. (as well as angiogenesis)
Results: In LIPUS-treated delayed unions, endosteal callus formation by direct bone 
formation without a cartilage intermediate as well as indirect bone formation was 
observed, while in untreated controls only indirect bone formation was observed. In 
the area of new bone formation, LIPUS significantly increased osteoid thickness by 
47%, mineral apposition rate by 27%, and bone volume by 33%. No increase in the 
number of blood vessels was seen in the newly formed bony callus. In the area of 
cancellous bone, bone volume was significantly increased by 17% whereas no effect 
on osteoid thickness and mineral apposition rate was seen. LIPUS did not affect 
osteoid volume, osteoid maturation time, number of osteocytes, osteocyte lacunae, or 
osteoclast-like cells in any of the areas of interest.
Conclusions: Our results suggest that LIPUS accelerates clinical fracture healing of 
delayed unions of the fibula by increasing osteoid thickness, mineral apposition rate, 
and bone volume, indicating increased osteoblast activity, at the front of new bony 
callus formation. Improved stability and/or increased blood flow, but probably not 
increased angiogenesis, might explain the differences in ossification modes between 
LIPUS-treated delayed unions and untreated controls. 
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INTRODUCTION
Fracture healing is a complex process requiring the recruitment of the appropriate 
cells and expression of the appropriate genes at the right time in the right place1. 
The majority of clinical fractures heal spontaneously, only 5-10% of the fractures 
show impaired healing1.  Impairment of fracture healing leads to a delay in union 
or may even result in nonunion. The goal of therapy for fracture healing in general 
is to provide sufficient fracture stability by conservative or surgical means. Unstable 
fracture results in delayed consolidation, i.e. as occurs in the osteotomized non-fixated 
fibula2. If fracture healing is impaired, it can be initiated or enhanced by surgical and/
or non-surgical means1. 
Fracture healing is modulated in response to external stimuli, such as growth 
factors, hormones, and mechanical forces1,3. Insight in the molecular biological 
mechanisms involved in fracture healing has resulted in the development of new 
treatment modalities for impaired fracture healing, such as bone morphogenic 
proteins, extracorporeal shock wave treatment, electro-stimulation, and low-intensity 
pulsed ultrasound (LIPUS)4-8. LIPUS and electro-stimulation have the advantage over 
surgery that they are non-invasive, do not cause any side affects, and can be used in 
an outpatient setting making them less expensive9,10. 
LIPUS (30 mW/cm2) is a form of mechanical energy transmitted transcutaneously 
by high frequency acoustic pressure waves11. The intensity of LIPUS (30 mW/cm2) is 
within the range of ultrasound intensities used for diagnostic purposes (1-50 mW/
cm2) and is regarded as non-thermal and non-destructive9,12. Bone cells are sensitive 
to strains caused by physical loading13,14. Mechanoreceptors convert biophysical 
stimuli into biochemical responses that alter gene expression and cellular adaptation15. 
The micro-mechanical stress produced by LIPUS may provide a surrogate for the 
forces normally applied on bone by physical loading according to Wolffs’ law16,17. 
Although the strain induced by LIPUS at the tissue level is several orders of magnitude 
lower than the peak strains generated by functional load bearing13, high-frequency 
low-magnitude strains can result in strong regulatory signals to bone tissue18-20. 
LIPUS increases prostaglandin E2 production via the induction of cyclooxygenase-2 
in MC3T3-E1 osteoblastic cells in vitro21. LIPUS treatment of mouse bone-marrow-
derived ST2 cells upregulates osteocalcin and IGF-I mRNA levels in a biphasic manner, 
suggesting an anabolic effect of LIPUS on osteoblast activity22. In vivo animal studies 
on the effects of LIPUS on fracture healing have shown enhanced mechanical 
properties of the healing callus11,17,23, as well as more extensive bone bridging at 
the fracture site11. LIPUS may affect different processes involved in fracture healing 
as shown by increased vascularity around the fracture site in the osteotomized ulna 
fracture model in dogs24. Randomized clinical trials showed acceleration of clinical 
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fracture healing by LIPUS in fresh fractures and osteotomies2,25,26. LIPUS also restores 
disrupted fracture repair in nonunion cases5,6. The exact mechanism by which LIPUS 
affects clinical bone healing is however still unknown.
The positive effect of LIPUS on fracture healing may be caused by a stimulation of 
the different cellular processes involved in fracture repair and bone formation, such as 
angiogenesis, chondrogenesis, and intramembranous and endochondral ossification11. 
Therefore, the aim of the present study was to investigate how LIPUS affects bone 
healing at the tissue level in patients with a delayed union of the osteotomized fibula, 
by determining bone formation and bone resorption parameters using histology and 
histomorphometric analysis.
MATERIALS AND METHODS
Patient selection
Biopsies of delayed unions of the human osteotomized fibula after a high tibial 
osteotomy were obtained from 9 female and 4 male patients (age 42-63 year) treated 
with or without LIPUS (7 LIPUS, 6 controls) in a randomized prospective double-blind 
placebo-controlled clinical trial (Table 1). The procedure of a closed high tibial osteotomy 
for medial located osteoarthritis of the knee included a diaphyseal non-fixated oblique 
osteotomy of the fibula. The osteotomized fibula has a tendency of impaired healing 
resulting in a delay in union2. Patients treated by high tibial osteotomy were evaluated 
6 months post-surgery with regard to healing status of the fibula. The patients were 
invited to participate in this study if radiological healing of the fibula was not yet 
Table 1. Patient and fracture characteristics at trial inclusion, and duration of LIPUS treatment of delayed 
unions of the osteotomized fibula at the time of the biopsy procedure.
Treatment 
modality
Sex Age Smoking Fracture age 
(days)
Delayed union 
type
Treatment time 
(days)
LIPUS M 63 yes 274 hypertrophic 75
“ F 43 no 187 hypertrophic 61
“ M 63 yes 331 hypertrophic 115
“ F 46 no 185 atrophic 84
“ F 52 no 209 hypertrophic 90
“ M 42 yes 190 hypertrophic 94
“ F 57 no 180 atrophic 90
Control M 61 no 187 atrophic 87
“ F 48 no 183 atrophic 72
“ F 54 no 180 hypertrophic 83
“ F 53 no 183 hypertrophic 88
“ F 57 no 202 hypertrophic 81
“ F 44 no 214 hypertrophic 89
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accomplished within 6 months. After informed consent was obtained, patients were 
submitted to either treatment by LIPUS or sham-treatment by a placebo device. 
Mean fracture age at inclusion was 192 days (range 180-214, median 185 days) for 
the sham-treated controls, and 222 days (range 180-331, median 190 days) for the 
LIPUS-treated patients. Trial approval was obtained from the Medical Ethical Review 
Board of the Vrije Universiteit Medical Center, registration number 2004-005.
LIPUS treatment
The patients enrolled in the clinical trial used the EXOGEN 2000+® low-intensity 
pulsed ultrasound device (Smith & Nephew Inc, Memphis, TN, USA) at home for a 
daily 20-minute treatment. The LIPUS device produced a 200 μs burst of 1.5 MHz 
acoustic sine waves, that repeated at a modulation frequency of 1 kHz, and provided 
a peak pressure of 30 mW/cm². The LIPUS device registered the duration of a single 
daily 20-minute treatment and the total number of treatments. Computerized 
randomization of active and placebo devices was performed, and devices were 
distributed among patients in the order of inclusion of the patients in the clinical trial. 
Unblinding of the trial was performed after completion of the histomorphometric and 
histologic analysis, and after all patients included in the trial completed their 5 month 
clinical treatment phase.
Biopsy procedure
Two to 4 months after the start of LIPUS treatment, a biopsy was taken from the 
delayed union of the fibula. Patients received LIPUS treatment for 87 days (range 
61-115, median 90 days) or sham-treatment for 83 days (range 72-89, median 85 
days). To determine the mineral apposition rate (MAR), patients received 200 mg 
tetracycline 4 times per day for two consecutive days, at 3 weeks and 1 week in 
advance of the biopsy procedure27. The standardized biopsy procedure (Figure 1) was 
performed under general or spinal anaesthesia, with the use of a hollow trephine burr 
(ITI-Straumann, Basel, Switzerland) (Figure 1). The hollow trephine burr (2.5 mm inner 
diameter, 3.5 mm outer diameter) was placed in a drilling device, and drilling was 
performed in a straight angle to the longitudinal axis of the fibula. The direction of 
drilling with the trephine burr was from the lateral towards the medial cortex of the 
fibula. The diameter of all harvested cylindrical biopsies was 2.5 mm, while the biopsy 
length ranged from 5-15 mm. 
Histology
All biopsies of the delayed unions of the fibula were immediately fixed in 4% 
formaldehyde solution in 0.1 M phosphate buffer, pH 7.3, at 4°C for 24 hours. 
The biopsies were then rinsed 3 times with 0.1 M phosphate buffer and stored in 
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70% ethanol at 4°C, until ready to be embedded. All biopsies were embedded in 
methylmethacrylate without decalcification27. Longitudinal sections of 5 μm thickness 
were made using a heavy duty Jung K microtome (R. Jung, Heidelberg, Germany). 
Three sets of 4 consecutive sections were collected, with a distance of 305 μm 
between the last section of one set and the first section of the following set. 
One section of each set of consecutive sections was stained with Goldner’s 
trichrome method in order to distinct mineralized (green) and non-mineralized 
(red) bone tissue. Another section was stained with toluidine blue (0.1% in H2O) to 
determine the presence of chondrogenic tissue28. A third section was stained for 
tartrate resistant acid phosphate (TRAP) to detect any osteoclast-like cells. Finally, 
one section was used for fluorescence microscopy to visualize tetracycline labeling to 
determine the mineral apposition rate (MAR).
Figure 1. Biopsy procedure in a delayed union of a human osteotomized fibula after a high tibial osteotomy 
procedure. (A) Anterior to posterior X-ray of the left tibia and fibula of a 52 year old female patient 
with a hypertrophic delayed union of the fibula. The delayed union is characterised by a discontinuity of 
the cortices, as shown by the radiolucent area (rectangle). (B) Magnification of the hypertrophic delayed 
union area of the fibula (rectangle in Fig 1A). The direction of drilling with the hollow trephine burr (2.5 
mm inner diameter, 3.5 mm outer diameter) from the lateral towards the medial cortex of the fibula is 
indicated by the dotted lines. (C) Three Homan retractors were placed around the anterior and posterior 
cortex to expose the fibula delayed union site. The arrow indicates the location of the fibula delayed union. 
The hollow trephine burr was placed in a drilling device, and drilling was performed in a straight angle to 
the longitudinal axis of the fibula. (D) Cylindrical biopsy of a delayed union of a human fibula, 2.5 mm core 
diameter after retrieval from the hollow trephine burr.
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Histologic and histomorphometric analysis
All analyses were performed using a Leica DMRA microscope connected to a computer 
using an electronic stage table, and a Leica DC 200 digital camera27. All measurements 
were done using the Leica QWin© computer program (Leica Microsystems Image 
Solutions, Rijswijk, The Netherlands). For every biopsy three Goldner trichrome-stained 
sections were analyzed, with a 305 μm interval between each section. Within each 
section, 3 areas of interest were distinguished with regard to the bone architecture and 
histological appearance (Figure 2). The fracture end was used as a distinct landmark 
Figure 2. Histological section of a biopsy of a delayed union of a human fibula showing the 3 areas of 
interest for histologic and histomorphometric analysis. The 3 areas of interest are: 1) Area of new bone 
formation, 2) Area of cancellous bone, 3) Area of cortical bone. (1) The area of new bone formation 
represents the newly formed bony callus over a width of 600 μm to the fibrous and/or cartilaginous tissue 
adjacent to the fracture ends. New trabeculae (arrows) are formed by endochondral ossification replacing 
the cartilage matrix adjacent to the fracture end. (2) The area of cancellous bone consists of lamellar bone 
and more recently formed woven bone trabeculae divided by large areas of soft connective tissue. (3) 
Haversian canals surrounded by lamellar bone (osteons) form the structural elements of cortical bone, in 
the area of cortical bone. Goldner’s trichrome stained section; osteoid and soft tissue, red; mineralized 
bone, green; cell nuclei, black. Original magnification, x 50; Scale bar, 500 μm.
and guideline to indicate the beginning of the area of new bone formation. The areas 
of interest were: 1) area of new bone formation, representing the newly formed 
bony callus within 0.6 mm distance from the fracture ends, 2) area of cancellous 
bone, and 3) area of cortical bone. Using these 3 areas of interest we were able to 
account for the differences in bone density and metabolic capacity between cortical, 
cancellous and newly formed bony callus at the fracture ends. In eight cases cortical 
bone tissue was lost during the biopsy procedure, and therefore the histological 
sections of these biopsies did not represent the area of cortical bone. In the area of 
cancellous and cortical bone, 2-4 measurement fields were selected for measurement 
of histomorphometric parameters. The number of fields was depended on the length 
of the biopsy. The measurement fields were evenly distributed along the longitudinal 
plane of the sections. In the area of new bone formation two measurement fields 
were selected, which were evenly distributed along the fracture plane. Nomenclature, 
symbols, and units used are as recommended by the Nomenclature Committee of the 
American Society for Bone and Mineral Research29. Bone volume (BV) was calculated 
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as the amount of mineralized bone tissue (Mineralized volume, Md.V) plus the amount 
of osteoid tissue (Osteoid volume, OV) as a percentage of the total tissue volume (BV/
TV x 100%). The absolute osteoid volume was calculated as the amount of osteoid 
tissue as a percentage of the total tissue volume (OV/TV x 100%). The relative osteoid 
volume was calculated as percentage of the total bone volume (OV/BV x 100%). For 
every measurement field, osteoid thickness (O.Th) was calculated by averaging the 
osteoid thickness values (10 to 30 measurements obtained at fixed intervals along the 
osteoid surface). Within the area of new bone formation, osteoid thickness refers to 
mean thickness of the seam of osteoid located at or closest to the fracture end. The 
number of osteocytes (N.Ot) as well as the number of osteocyte lacunae (N.lac) were 
expressed per area of mineralized bone tissue (mm2). The number of TRAP-positive 
cells was also expressed per total tissue area (mm2).
The rate of bone formation was expressed as the mineral apposition rate 
(MAR). The MAR is the average distance between the corresponding edges of two 
consecutive fluorescent bone labels divided by the number of days between start 
of first administration period of tetracycline (3 weeks before taking the biopsy), and 
second administration period of tetracycline (1 week before taking the biopsy)27. The 
distance of consecutive fluorescent tetracycline labels was measured in unstained 
sections using an excitation wavelength of 354-425 nm and emission wavelength 
of 470 nm. In the area of new bone formation, distance measurements of double 
tetracycline labels were performed at or closest to the fracture ends. The MAR was 
determined in 12 patients enrolled in the study. In one LIPUS-treated patient the MAR 
could not be determined, since the patient did not receive tetracycline. 
To asses the effect of LIPUS on angiogenesis, a quantitative analysis was performed 
to assess the number of blood vessels in the area of new bone formation. Immediately 
adjacent to the fracture end and within the fracture gap, we could not indentify 
mature blood vessels. The determination of the number of blood vessels was therefore 
restricted to the soft connective tissue within the newly formed fracture callus. The 
number of blood vessels (N.Bv) was  expressed per area of soft connective tissue 
(mm2)30. 
Statistical analysis
Statistical analysis of the data was performed using a Student’s independent t-test 
(two-tail). The values of the histomorphometric parameters are expressed as mean ± 
SEM. A p-value of < 0.05 is considered significant. 
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RESULTS
Area of new bone formation
All biopsies showed vital fracture ends with low numbers of osteocyte lacunae, as well 
as bony callus formation by osteoblasts which deposit osteoid at the fracture ends 
(Figure 3). The area of new bone formation showed endosteal callus formation in all 
13 biopsies (6 control, 7 LIPUS). In all controls, cartilage was present adjacent to the 
fracture ends (Figure 3A-C). Four controls showed endochondral ossification, in which 
the (mineralized) cartilage matrix containing hypertrophic chondrocytes is resorbed by 
TRAP-positive cells (Figure 3C), followed by the deposition of osteoid by osteoblasts at 
the surface of the eroded cartilage. Two controls showed complete mineralization of 
the cartilage matrix, which contained chondrocyte-like cells and smaller osteocyte-like 
cells. No TRAP-positive cells were present in the histological sections of these 2 controls 
(data not shown). Cartilage was present in 4 biopsies of LIPUS-treated delayed unions. 
These biopsies showed endochondral ossification as well as direct (intramembranous) 
bone formation (data not shown). The other 3 biopsies of LIPUS-treated delayed unions 
showed only direct bone formation (Figure 3D-F). One delayed union case treated with 
LIPUS showed consolidation of the fracture ends on the radiographs taken one week 
in advance of the biopsy procedure. The histological sections of this clinically healed 
delayed union showed bridging trabeculae at the fracture ends, alternated by areas of 
new bone formation to obtain complete bridging (data not shown).
In the area of new bone formation, LIPUS treatment resulted in a 47% increase 
(p<0.05) in osteoid thickness (Table 2). A discrepancy was seen in osteoid thickness 
of a clinically healed LIPUS-treated delayed union (10.1 μm), and clinically non-healed 
LIPUS-treated delayed unions (mean 18.1 μm; range 15.1-22.0 μm). In the newly formed 
bony callus, total bone volume and mineralized volume were increased by respectively 
33% and 34% (p<0.05), whereas the absolute osteoid volume was slightly (26%) but 
not significantly increased as a result of LIPUS treatment. The relative osteoid volume 
remained unchanged in the area of new bone formation (Table 2). LIPUS did not 
affect the number of osteocytes nor the number of empty osteocyte lacunae per area 
of mineralized bone tissue (Table 2). Four of the 6 controls showed the presence of 
TRAP-positive cells. In 3 controls TRAP-positive cells were present in all 3 evaluated 
sections while in one control TRAP-positive cells were present in only one section. The 
3 controls showing TRAP-positive cells in all evaluated sections showed high numbers 
of TRAP-positive cells (range 13-30/mm2, mean 19/mm2), which were associated 
with resorption of the cartilage matrix adjacent to the fracture ends. TRAP-positive 
cells were present in 3 of the 7 biopsies of LIPUS-treated delayed unions. In these 3 
biopsies, only 1 of the 3 sections per biopsy showed TRAP-positive cells (range 2-5/
mm2, mean 4/mm2). Statistical analysis did not reveal any differences between the 
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Figure 3. Histological sections of delayed unions of the human fibula treated with or without LIPUS 
showing differences in type of bone formation in the area of new bone formation. (A, B, C) Consecutive 
sections of an untreated control biopsy showing endochondral ossification. (A) Newly formed woven 
bone replaces the cartilage matrix (CAR) at the fracture end. Osteoblasts deposit osteoid at the woven 
bone surface (black arrows). (B) The cartilage matrix adjacent the fracture end contains high numbers 
of hypertrophic chondrocytes (white arrows). (C) TRAP-positive osteoclast-like cells (red arrows) resorb 
the mineralized cartilage matrix. (D, E, F) Consecutive sections of a LIPUS-treated delayed union 
showing direct (intramembranous) bone formation. (D) Osteoblasts (black arrows) located in the soft 
connective tissue (SCT), deposit osteoid at the woven bone surface. (E) Cartilage tissue with hypertrophic 
chondrocytes is absent adjacent the fracture end. (F) TRAP-positive osteoclast-like cells are absent. A, D, 
Goldner’s trichrome stained sections; osteoid and soft tissue, red; mineralized tissue, green. B, E, Toluidine 
blue-stained sections; cartilage, dark-purple; bone, blue. C, F, TRAP-stained sections; TRAP-positive cells, 
red; bone, soft tissue, green. Original magnification, x 400. Scale bar, 50 μm.
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number of osteoclast-like cells in the biopsies of the delayed unions treated by LIPUS 
when compared to the untreated controls (Table 2). Tetracycline labeling of the newly 
formed and mineralizing woven bone at the front of new bony callus formation was 
evident. The tetracycline labeling of the newly deposited woven bone was diffuse, 
and in some biopsies the adjacent calcified cartilage matrix also displayed tetracycline 
labeling. Double tetracycline labeling was visible in the newly formed bone enabling 
us to determine the rate of bone formation (MAR). The MAR was increased by 27% 
(p<0.05, Table 2) in the biopsies of LIPUS-treated delayed unions when compared 
to untreated controls. The osteoid maturation time (Omt, calculated as O.Th/MAR), 
which is the time interval between the onset of matrix deposition and the onset of 
mineralization, was not affected by LIPUS treatment (control, 6.3 ± 0.7 days; LIPUS 
7.1 ± 0.6 days; mean ± SEM; p=0.42). The number of blood vessels per area of soft 
connective tissue within the area of new bone formation showed a slight but not 
significant increase of 8% as a result of LIPUS treatment (control, 39.5 ± 7.4 /mm2; 
LIPUS 42.7 ± 10.2 /mm2; mean ± SEM, p=0.81). Three of the 7 patients treated with 
LIPUS were smokers whereas the untreated control patients did not smoke. Smoking 
however did not affect the outcome of the histomorphometric parameters analyzed in 
biopsies of LIPUS-treated delayed unions (data not shown).
Area of cancellous bone
Within the area of cancellous bone, bone volume was increased by 17% and 
mineralized volume by 20% (p<0.001) whereas osteoid thickness and MAR remained 
unchanged as a result of LIPUS treatment (Table 2). LIPUS-treated delayed unions 
and untreated controls showed similar values for osteoid thickness and MAR in the 
area of cancellous bone, and these values were similar to those found for untreated 
controls in the area of new bone formation (Table 2). None of the other evaluated 
histomorphometric parameters in the area of cancellous bone showed a significant 
difference between the LIPUS-treated delayed unions and the untreated controls 
(Table 2). Bone remodelling was present in the area of cancellous bone as shown by 
the formation of osteoid and the presence TRAP-positive osteoclast-like cells (Table 2). 
Biopsies of 3 controls showed in all sections TRAP-positive osteoclast like cells (range 
2-8/mm2, mean 4/mm2), whereas in only one section of one LIPUS-treated delayed 
union TRAP-positive osteoclast like cells (5/mm2) were present. 
Area of cortical bone
Few osteoid seams and low numbers of osteoblasts were present at the surface of the 
Haversian canals, indicating low bone-forming activity in the area of cortical bone. In 
this bone area no significant differences between LIPUS-treated delayed unions and 
controls were found regarding the histomorphometric parameters evaluated (Table 
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2). For LIPUS treated delayed unions and untreated controls osteoid thickness and 
MAR were approximately 40% lower in the area of cortical bone than in the area of 
cancellous bone (table 2). Osteoid maturation time remained unchanged in cortical 
bone tissue (control, 8.1 ± 0.1 days; LIPUS 8.4 ± days; Mean ± SEM) when compared to 
cancellous bone tissue (control, 8.5 ± 0.9 days; LIPUS 7.9 ± 0.6 days). No TRAP-positive 
osteoclast-like cells were present in histological sections of LIPUS-treated delayed 
unions or untreated controls. 
DISCUSSION
In this study histomorphometric and histologic analysis was performed to determine 
bone formation and resorption parameters in LIPUS-treated delayed unions of the 
osteotomized fibula and sham-treated controls in a double blind clinical trial. This 
allows us to report for the first time on the influence of LIPUS treatment on clinical 
fracture healing at the tissue level. To account for the differences in bone density and 
bone surface area as well as amount of soft tissue between cortical, cancellous and 
newly formed bony callus at the fracture end, 3 areas of interest were distinguished 
within the histological sections of the retrieved biopsies. The areas of interest were: 
1) area of new bone formation, representing the newly formed bony callus within 0.6 
mm distance from the fracture ends, 2) area of cancellous bone, and 3) area of cortical 
bone. All retrieved biopsies showed a vital fracture and new bony callus formation, 
although fracture healing was impaired in the delayed unions of the osteomized 
Table 2. Histomorphometric data of delayed unions of the osteotomized fibula treated with or without 
LIPUS.
Area of new bone formation Area of cancellous bone Area of cortical bone
Control 
(n = 6)
LIPUS 
(n = 7)
p-value Control 
(n = 6)
LIPUS 
(n = 7)
p-value Control 
(n = 2)
LIPUS 
(n = 3)
p-value
Age (Mean ± SD) 52 ± 6 52 ± 9 52 ± 6 52 ± 9 52 ± 12 52 ± 11
Male/Female 1M / 5F 3 M / 4F 1M / 5F 3M / 4F 1M / 1F 2 M / 1F
BV/TV (%) 39.8 ± 3.1 52.9 ± 3.5 0.02* 58.3 ± 1.5 70.0 ± 2.1 <0.01* 88.1 ± 2.6 78.0 ± 4.3 0.16
Md.V/TV (%) 34.5 ± 2.9 46.2 ± 3.9 0.04* 54.3 ± 2.0 64.8 ± 2.3 <0.01* 88.6 ± 2.6 77.6 ± 4.5 0.17
OV/TV (%) 5.3 ± 0.4 6.7 ± 1.7 0.46  3.9 ± 0.8 3.1 ± 0.8 0.46 0.5 ± 0.2 0.4 ± 0.2 0.88
OV/BV (%) 13.7 ± 1.2 13.3 ± 3.2 0.91  6.9 ± 1.5 4.6 ± 1.1 0.24 0.6 ± 0.3 0.6 ± 0.3 0.91
O.Th (μm) 11.5 ± 1.9 16.9 ± 1.4 0.04* 13.5 ± 1.9 13.1 ± 1.5 0.88 7.3 ± 0.9 8.3 ± 0.8 0.48
(n = 2)
MAR (μm/day)  1.8 ± 0.1 2.3 ± 0.2 0.04* 1.6 ± 0.1 1.6 ± 0.1 0.91 0.9 ± 0.1 1.1 ± 0.0 0.55
(n = 6) (n = 6) (n = 6) (n = 6) (n = 2) (n = 1)
N.Oc/T.Ar  (/mm2) 9.6 ± 4.8 0.5 ± 0.3 0.12 2.0 ± 1.2 0.3 ± 0.3 0.15  
N.Ot/Md.Ar (/0.01mm2) 4.1 ± 0.4 3.9 ± 0.2 0.54 3.4 ± 0.3 3.3 ± 0.3 0.82 1.2 ± 0.1 1.7 ± 0.4 0.29
N.Lac/Md.Ar (/0.01mm2) 0.1 ± 0.1 0.2 ± 0.1 0.33 0.2 ± 0.1 0.1 ± 0.0 0.56 0.6 ± 0.1 0.3 ± 0.2 0.37
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Histomorphometric data is presented for the 3 areas of interest: 1) 
area of new bone formation, representing the newly formed bony 
callus within 0.6 mm distance from the fracture ends, 2) area of 
cancellous bone, and 3) area of cortical bone. BV/TV, bone volume 
of total tissue volume (%); Md.V/TV, mineralized volume (%); OV/
TV, absolute osteoid volume (%); OV/BV, relative osteoid volume 
(%); O.Th, osteoid thickness (μm); MAR, mineral apposition rate 
(μm/day); N.Oc/T.Ar, number of osteoclasts per tissue area (mm2); 
N.Ot/Md.Ar, number of osteocytes per mineralized tissue area 
(0.01 mm2); N.Lac/Md.Ar, number of empty osteocyte lacunae 
per mineralized tissue area (0.01 mm2). Values are mean ± SEM. 
Statistical analysis of the data was performed using two-tailed 
Student’s independent t-test. * Significant effect of LIPUS, p<0.05.
fibula. The present study suggests that LIPUS accelerates clinical fracture healing by 
increasing bone formation through increased osteoblast activity. Direct (endosteal) 
bone formation was only observed in the LIPUS-treated delayed unions, which might 
be explained by increased  stability and/or blood flow.
LIPUS treatment resulted in a significant increase in bone volume of the newly 
formed bony callus, and a significant increase in osteoid thickness at the front of new 
bony callus formation. This increased osteoid thickness was not caused by impaired 
mineralization of the newly deposited osteoid at the fracture ends, since LIPUS 
treatment also significantly increased the mineral apposition rate, and did not change 
osteoid maturation time. The increase in osteoid thickness as a result of increased 
osteoid apposition suggests an anabolic effect of LIPUS on the activity of osteoblasts. 
Cultured mouse bone marrow-derived ST2 cells have been shown to respond to LIPUS 
with elevated levels of IGF, osteocalcin, and bone sialoprotein mRNA, suggesting that 
LIPUS induces a direct anabolic reaction of osteogenic cells leading to bone matrix 
formation22. The nature of the LIPUS-induced anabolic response is of a nature similar 
to that in physically loaded bone22. The accelerated fracture repair and distraction 
osteogenesis by LIPUS depend on the stimulation of osteoblastic cells at relatively early 
stages of osteogenic lineage22,31. LIPUS treatment of fetal mouse metatarsal rudiments 
in vitro has been shown to stimulate endochondral ossification, which resulted from 
a direct effect of LIPUS on osteoblasts and ossifying cartilage by stimulation of cell 
activity and/or differentiation, but not proliferation32,33. This may explain our current 
findings that LIPUS increased osteoid thickness and mineral apposition rate at the 
front of new bony callus formation, whereas no increase in osteoid thickness and 
Table 2. Histomorphometric data of delayed unions of the osteotomized fibula treated with or without 
LIPUS.
Area of new bone formation Area of cancellous bone Area of cortical bone
Control 
(n = 6)
LIPUS 
(n = 7)
p-value Control 
(n = 6)
LIPUS 
(n = 7)
p-value Control 
(n = 2)
LIPUS 
(n = 3)
p-value
Age (Mean ± SD) 52 ± 6 52 ± 9 52 ± 6 52 ± 9 52 ± 12 52 ± 11
Male/Female 1M / 5F 3 M / 4F 1M / 5F 3M / 4F 1M / 1F 2 M / 1F
BV/TV (%) 39.8 ± 3.1 52.9 ± 3.5 0.02* 58.3 ± 1.5 70.0 ± 2.1 <0.01* 88.1 ± 2.6 78.0 ± 4.3 0.16
Md.V/TV (%) 34.5 ± 2.9 46.2 ± 3.9 0.04* 54.3 ± 2.0 64.8 ± 2.3 <0.01* 88.6 ± 2.6 77.6 ± 4.5 0.17
OV/TV (%) 5.3 ± 0.4 6.7 ± 1.7 0.46  3.9 ± 0.8 3.1 ± 0.8 0.46 0.5 ± 0.2 0.4 ± 0.2 0.88
OV/BV (%) 13.7 ± 1.2 13.3 ± 3.2 0.91  6.9 ± 1.5 4.6 ± 1.1 0.24 0.6 ± 0.3 0.6 ± 0.3 0.91
O.Th (μm) 11.5 ± 1.9 16.9 ± 1.4 0.04* 13.5 ± 1.9 13.1 ± 1.5 0.88 7.3 ± 0.9 8.3 ± 0.8 0.48
(n = 2)
MAR (μm/day)  1.8 ± 0.1 2.3 ± 0.2 0.04* 1.6 ± 0.1 1.6 ± 0.1 0.91 0.9 ± 0.1 1.1 ± 0.0 0.55
(n = 6) (n = 6) (n = 6) (n = 6) (n = 2) (n = 1)
N.Oc/T.Ar  (/mm2) 9.6 ± 4.8 0.5 ± 0.3 0.12 2.0 ± 1.2 0.3 ± 0.3 0.15  
N.Ot/Md.Ar (/0.01mm2) 4.1 ± 0.4 3.9 ± 0.2 0.54 3.4 ± 0.3 3.3 ± 0.3 0.82 1.2 ± 0.1 1.7 ± 0.4 0.29
N.Lac/Md.Ar (/0.01mm2) 0.1 ± 0.1 0.2 ± 0.1 0.33 0.2 ± 0.1 0.1 ± 0.0 0.56 0.6 ± 0.1 0.3 ± 0.2 0.37
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mineral apposition rate was found in the older or pre-existing bone. Our data shows 
that LIPUS affects clinical fracture healing at the bone tissue level, and underscores 
that the acceleration of clinical fracture healing by LIPUS, as least in part, depends on 
the stimulation of osteoblastic cells22,31,33.
LIPUS did not affect osteoblast activity in the area of cancellous bone nor in the 
area of cortical bone. Bone volume was significantly increased in the area of cancellous 
bone formation as a result of LIPUS treatment, but this increase was less profound 
than in the area of new bone formation. LIPUS did not affect any of the other bone 
formation and bone resorption parameters. These findings could relate to LIPUS 
specifically affecting osteoblast differentiation as has been suggested previously32,33, 
but it is also possible that a large part of the given energy remitted by LIPUS does 
not penetrate the intact bone31,34. Interestingly, the biopsy retrieved from one 
LIPUS-treated delayed union showing partial bridging of the fracture ends did not 
show increased osteoblast activity when compared to the other LIPUS-treated delayed 
unions. This suggest that LIPUS is effective in stimulating osteoid deposition at the 
front of bony callus formation during the consolidation phase, but that it has little or 
no effect on bone remodelling.
In LIPUS-treated delayed unions, direct bone formation without a cartilage 
intermediate as well as endochondral ossification was observed, while untreated 
controls only showed endosteal callus formation through endochondral ossification. 
In distraction osteogenesis, a shift from endochondral ossification to predominantly 
intramembranous bone formation occurs in time35. Bone healing in a delayed union of 
the osteotomized fibula may resemble bone healing in distraction osteogenesis. The 
initial displacement of the fracture ends after a non-fixated fibula osteotomy results in 
a gap between the fracture ends2, and therefore bone healing must occur through 
replacement of fibrous or cartilagenous tissue by bone tissue within the fracture 
gap. The profound cartilage matrix mineralization and absence of TRAP-positive 
osteoclast-like cells in 2 biopsies from untreated non-unions suggests transchondroid 
bone formation. This type of bone formation, in which a tissue intermediate between 
cartilage and bone is formed, has been shown in the distraction gap during distraction 
osteogenesis of rat tibiae35. Intramembranous bone formation as seen in delayed 
unions after 2 to 4 months of LIPUS treatment could therefore reflect a more advanced 
stage of fracture healing in comparison to untreated controls. 
Bone healing in delayed unions of the human fibula may resemble bone healing 
as seen in distraction osteogenesis, but there is one major difference. Distraction 
osteogenesis is a controlled procedure were certain fracture stability is maintained 
by surgical means, whereas the non-fixated fibula osteotomy provides an unstable 
fracture2. Excess motion at the fracture site of fibular bone is related to disruption 
of vasculature and blood supply, resulting in a hypoxic environment favourable for 
formation of cartilaginous tissue36,37. Alterations in the mechanical environment 
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by advanced union and/or increased bone volume of the bone fracture ends could 
therefore enable blood vessel formation and invasion of fibrous and/or cartilaginous 
tissue within the fracture gap. The oxygenic environment may lead to intramembranous 
bone formation through differentiation of mesenchymal cells into osteoblasts, 
but not chondrocytes36. LIPUS treatment stimulated bone bridging at the fracture 
site in a rat closed femoral fracture model11. The stimulation of bridging by LIPUS 
was accompanied by a significant increase in maximum torque and stiffness11. The 
differences in ossification modes between LIPUS-treated delayed unions and untreated 
controls, as observed in the current study, might also be explained by improved 
mechanical stability. 
Vascular invasion of the fibrous and/or cartilagenous tissue within the fracture gap 
may result in an oxygenic environment suitable for intramembranous bone formation36. 
LIPUS increased blood flow around the fracture site in a dog osteotomized ulna fracture 
model, suggesting that LIPUS stimulates vascularity during fracture healing24. Analysis 
of neovascularization within the newly formed fracture callus within the area of new 
bone formation, showed no significant increase in numbers of blood vessels per area 
of soft connective tissue. Increased blood flow around the fracture site could provide 
an explanation for the endosteal callus formation without a cartilage intermediate 
as observed in the LIPUS-treated delayed unions in this study. Our findings however 
suggest that a possible increase in blood flow to and around the fracture gap site is 
probably not related to an increase in new blood vessel formation within the newly 
formed fracture callus.
In conclusion, our results show that LIPUS accelerates clinical fracture healing of 
delayed unions of the fibula by increasing osteoid thickness, mineral apposition rate, 
and bone volume, indicating increased osteoblast activity, at the front of new bony 
callus formation. Improved stability and/or increased blood flow, but probably not 
increased angiogenesis, might explain the differences in ossification modes between 
LIPUS-treated delayed unions and untreated controls.
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ABSTRACT
Introduction: Osteogenic cell proliferation and differentiation plays an important role 
in adequate fracture healing, and is target for osteoinductive therapies in delayed 
fracture healing. The aim of this study was to investigate whether low-intensity 
pulsed ultrasound enhances fracture healing at the tissue level in patients with 
a delayed union of the osteotomized fibula through an effect on the presence of 
RUNX2 immunopositive osteogenic cells. The effect was studied in both atrophic and 
hypertrophic delayed unions.
Materials and Methods: Biopsies were obtained from 6 female and 1 male patient 
(age 43-63) with a delayed union of the osteotomized fibula after a high tibial 
osteotomy treated for 2-4 months with or without low-intensity pulsed ultrasound in 
a randomized prospective double-blind placebo-controlled trial. Immunolocalization 
of RUNX2 protein was performed to identify osteogenic cells. Histomorphometrical 
analysis was performed to determine the number of cells expressing RUNX2 located 
within and around the newly formed woven bone at the fracture end (area of new 
bone formation), and up to 3 mm distance of the fracture end. 
Results: Cells expressing RUNX2 were present in all histological sections of control 
and low-intensity pulsed ultrasound-treated bone evaluated. Within the area of new 
bone formation, RUNX2 immunopositive cells were found in the undifferentiated soft 
connective tissue, at the bone surface (presumably osteoblasts), and within the newly 
formed woven bone. Low-intensity pulsed ultrasound treatment of fibula delayed 
unions significantly reduced the number of RUNX2 immunopositive cells within the soft 
connective tissue at the fracture ends, whereas the number of RUNX2 immunopositive 
cells at the bone surface was not affected. The number of RUNX2 immunopositive 
cells were similar for the atrophic and hypertrophic delayed unions. 
Conclusions: Immunolocalization of RUNX2 positive cells in delayed unions of the 
fibula reveals that delayed clinical fracture healing does not result in impairment of 
osteogenic cell proliferation and/or differentiation at the tissue level, even if delayed 
unions are clinically regarded as atrophic. Reduced numbers of osteogenic RUNX2 
immunopositive cells within the soft connective tissue, and unchanged numbers of 
RUNX2 immunopositive cells at the bone surface, implicates that low-intensity pulsed 
ultrasound does not increase osteogenic cell presence, but likely affects osteogenic 
cell differentiation.
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INTRODUCTION
Fracture healing is a complex process requiring the recruitment of the appropriate 
cells and expression of the appropriate genes at the right time in the right place1. 
Osteogenic cell proliferation and differentiation play a central role in adequate 
fracture healing to increase extracellular bone matrix production2. The majority of 
clinical fractures heal spontaneously, i.e. only 5-10% of the fractures show impaired 
healing1. Impairment of fracture healing leads to a delay in union or may even result 
in nonunion. If fracture healing is impaired, it can be initiated or enhanced by surgical 
and/or non-surgical means1. 
Fracture healing is modulated in response to external stimuli, such as growth 
factors, hormones, and mechanical forces1,3. Insight in the molecular biological 
mechanisms involved in fracture healing has resulted in the development of new 
treatment modalities for impaired fracture healing, such as bone morphogenic 
proteins, extracorporeal shock wave treatment, electro-stimulation, and low-intensity 
pulsed ultrasound (LIPUS)4-8. LIPUS and electro-stimulation have the advantage over 
surgery that they are non-invasive, do not cause any side effects, and can be used in 
an outpatient setting making them less expensive9,10. LIPUS is a form of mechanical 
energy transmitted transcutaneously by high frequency acoustic pressure waves11. The 
intensity of LIPUS (30 mW/cm2) is within the range of ultrasound intensities used for 
diagnostic purposes (1-50 mW/cm2). Diagnostic ultrasound is regarded as non-thermal 
and non-destructive9. LIPUS stimulation may result in a fractional temperature rise, 
however its mechanism of action is likely of non-thermal origin12. 
Bone cells are sensitive to strains caused by physical loading13,14. Mechanoreceptors 
convert biophysical stimuli into biochemical responses that alter gene expression and 
cellular adaptation15. The mechanical adaptive modelling can promote bone tissue 
formation by a proliferative response or by a direct anabolic effect on bone cells16. 
The micro-mechanical stress produced by LIPUS may provide a surrogate for the 
forces normally applied on bone by physical loading according to Wolff’s law17,18. 
Although the strain induced by LIPUS at the tissue level is several orders of magnitude 
lower than the peak strains generated by functional load bearing13, high-frequency 
low-magnitude strains can result in strong regulatory signals to bone tissue14,19,20. 
LIPUS increases prostaglandin E2 production via the induction of cyclooxygenase-2 
in MC3T3-E1 osteoblastic cells in vitro21. PGE2 is a potent inflammation mediator that 
may help migration and proliferation of mesenchymal stem cells21. Outcomes of LIPUS 
treatment of fetal mouse metatarsal rudiments in vitro suggested  a direct effect 
of LIPUS on osteoblasts and ossifying cartilage by stimulation of cell activity and/or 
differentiation, but not proliferation22,23. In clinical fracture healing, LIPUS has been 
shown to increase bone volume, osteoid thickness and mineral apposition rate in the 
71
Chapter 5
area of fracture healing, indicating increased osteoblast activity24. Mechanical forces 
can promote bone tissue formation by a proliferative response or by a direct anabolic 
effect on bone cells2. The positive effect of LIPUS on clinical fracture healing may be 
caused by a stimulation of the different processes involved in fracture repair and bone 
formation. 
RUNX2 is regarded as the master gene of osteogenic cell differentiation and bone 
matrix production. RUNX2 is a transcription factor, required for the activation of 
osteoblast differentiation and is crucial for the regulation of genes responsible for the 
production of bone specific proteins (collagen type 1, osteocalcin, osteopontin and 
bone sialoprotein)25,26. Without RUNX2 expression no bone will be formed. RUNX2 
is also thought to be the target of a mechanical signal by which physical stimulation 
dictates the cellular and metabolic activities of osteoblasts27. Stimulation of rat bone 
marrow stromal cells and human osteoblasts with LIPUS resulted in a time-dependant 
increase in cellular RUNX2 expression28. It is therefore possible that LIPUS affects 
fracture healing by affecting RUNX2 expressing cells.
The aim of this study was to investigate whether LIPUS enhances fracture healing 
at the tissue level in patients with a delayed union of the osteotomized fibula through 
an effect on the presence of RUNX2 immunopositive osteogenic cells. We studied the 
effect in both atrophic and hypertrophic nonunions.
MATERIALS AND METHODS
Clinical study procedures
The present study utilizes a clinical delayed union model of the fibula, which has 
been  reported previously24. The clinical study procedures also have been described in 
detail24. In short, biopsies of delayed unions of the human osteotomized fibula after 
a high tibial osteotomy were obtained from 6 female patients and 1 male patient (age 
43-63 year) treated with or without LIPUS (3 LIPUS-treated, 4 untreated controls) in 
a randomized prospective double-blind placebo-controlled clinical trial (Table 1). The 
patients enrolled in the clinical trial used the EXOGEN 2000+® low-intensity pulsed 
ultrasound device (Smith & Nephew Inc, Memphis, TN, USA) at home for a daily 
20-minute treatment. Active and placebo devices were identical in every way (they had 
the same visual, tactile, and auditory signals) except for the ultrasound signal emitted. 
The active LIPUS device produced a 200 μs burst of 1.5 MHz acoustic sine waves, that 
repeated at a modulation frequency of 1 kHz, and provided a peak pressure of 30 mW/
cm². Mean fracture age at inclusion was 195 days (range 180-214, median 193 days) 
for the sham-treated controls, and 233 days (range 180-331, median 187 days) for the 
LIPUS-treated patients. Delayed unions were classified as atrophic when clear callus 
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formation on the clinical radiographs was absent, and no healing progression was 
seen on X-rays taken before inclusion in the trial6. Two to 4 months after the start of 
LIPUS or sham treatment, a biopsy was taken from the delayed union of the fibula. The 
standardized biopsy procedure was performed under general or spinal anaesthesia, 
with the use of a hollow trephine burr (2.5 mm inner diameter, 3.5 mm outer diameter, 
ITI-Straumann, Basel, Switzerland), which resulted in cylindrical biopsies of 2.5 mm in 
diameter. The direction of drilling was in a straight angle to the fibula axis, from the 
lateral to medial cortex, crossing the fracture plane at an angle of approximately 45°. 
The biopsy specimen contained (pre-existing) cortical bone, (pre-existing) cancellous 
bone, and newly formed fracture callus at the fracture end with the adjacent fibrous/
cartilaginous tissue of the fracture gap. The histological biopsies showed endosteal 
callus formation, but not periostal/cortical fracture bridging. Similar heterogeneous 
tissue samples were obtained, as was verified by post-biopsy X-rays. Comparison 
among biopsies was based on distinctive histological landmarks identifying the areas 
of interests, as has been described previously24. Patients received LIPUS treatment 
for 89 days (range 61-115, median 90 days) or sham-treatment for 81 days (range 
Figure 1. Immunolocalization of cells expressing RUNX2 in newly formed bony callus at the fracture ends 
of fibula delayed unions in patients treated with or without LIPUS. (A) Control section. Many cells localized 
within the soft connective tissue (SCT) of newly formed bone show immunopositive staining for RUNX2 
(brown nuclei/cytoplasm, black arrows). Strong expression of RUNX2 is found in cells at the woven bone 
surface (presumably osteoblasts, white arrows). Within the newly formed woven bone (WB), (young) 
osteocytes (grey arrows) also display immunopositive staining for RUNX2. (B) Section of  a LIPUS-treated 
delayed union, showing less RUNX2 immunopositive cells within the soft connective tissue and newly 
formed woven bone in comparison with controls. Original magnification, x200; Scale bar, 50 μm.
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72-89, median 82 days). Two of the three LIPUS-treated patients, and two of the four 
sham-treated controls included in this study showed healing at 5 months of treatment 
(Table 1). Trial approval was obtained from the Medical Ethical Review Board of the VU 
University Medical Center, registration number 2004-005.
Fixation and embedding
All biopsies of the delayed unions of the fibula were immediately fixed in 4% 
formaldehyde solution in 0.1 M phosphate buffer, pH 7.3, at 4°C for 24 hours. 
The biopsies were rinsed with 0.1 M phosphate buffer, and then decalcified with 
5% EDTA,1% formaldehyde at pH 7.3 at 4°C for 8 weeks. After rinsing with 0.1 M 
phosphate buffer, these biopsies were dehydrated through ethanol 90% and 100% 
and cleared twice in xylene, and finally embedded in molten paraffin at 56°C. Sections 
of 6-7 μm thickness were cut with a microtome, mounted on polylysine-coated glass 
slides, and dried overnight in a 37°C stove to prepare for immunohistochemistry as 
described below.
Immunohistochemistry 
Tissue sections were deparaffinised in xylene and rehydrated in successively decreasing 
grades of aqueous ethanol solution29,30. After three repeated washes with phosphate 
buffered saline (PBS), sections were subjected to antigen retrieval by placing them in 
citrate buffer at boiling temperature for 20 min. Endogenous peroxidase was quenched 
by incubation in 3% H2O2 in PBS for 3 min, followed by 3 repeated washes with PBS. 
Sections were blocked with 30% normal horse serum for 30 min at room temperature. 
Incubation with the primary antibody to RUNX2 (mouse recombinant monoclonal 
antibody Pebp2αA, kindly provided by K. Sasaguri, Kanagawa Dental School, Japan) at 
Table 1. Patient and fracture characteristics at trial inclusion, duration of LIPUS treatment of delayed 
unions at the time of the biopsy procedure, histomorphometric data, and clinical outcome of delayed 
unions of the osteotomized fibula treated with or without LIPUS. 
Treatment 
modality
Sex Age Smoking Fracture age 
(days)
Delayed union
type
Treatment  
time (days)
N.RUNX2+/SCT.Ar 
(0.01mm2)
N.RUNX2+/BS 
(0.1mm)
BV/TV (%) Clinical outcome 
at 5 months  
LIPUS F 43 no 187 hypertrophic 61 9.8 1.9 52.9 Failed
“ M 63 yes 331 hypertrophic 115 0.9 0.4 49.7 Healed
“ F 57 no 180 atrophic 90 3.0 1.3 41.7 Healed
Control F 48 no 183 atrophic 72 12.5 1.7 36.7 Failed
“ F 54 no 180 hypertrophic 83 20.0 3.3 35.7 Healed
“ F 57 no 202 hypertrophic 81 14.3 1.6 44.1 Failed
“ F 44 no 214 hypertrophic 89 10.8 1.1 28.8 Healed
Histomorphometric data is presented for the area of new bone formation, representing the newly 
formed bony callus within 0.6 mm distance from the fracture ends. N.RUNX2+/SCT.Ar, number of 
cells immunopositive for RUNX2 per area of soft connective tissue; N.RUNX2+/B.Pm, number of cells 
immunopositive for RUNX2 per bone perimeter; BV/TV, bone volume of total tissue volume.
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Table 1. Patient and fracture characteristics at trial inclusion, duration of LIPUS treatment of delayed 
unions at the time of the biopsy procedure, histomorphometric data, and clinical outcome of delayed 
unions of the osteotomized fibula treated with or without LIPUS. 
Treatment 
modality
Sex Age Smoking Fracture age 
(days)
Delayed union
type
Treatment  
time (days)
N.RUNX2+/SCT.Ar 
(0.01mm2)
N.RUNX2+/BS 
(0.1mm)
BV/TV (%) Clinical outcome 
at 5 months  
LIPUS F 43 no 187 hypertrophic 61 9.8 1.9 52.9 Failed
“ M 63 yes 331 hypertrophic 115 0.9 0.4 49.7 Healed
“ F 57 no 180 atrophic 90 3.0 1.3 41.7 Healed
Control F 48 no 183 atrophic 72 12.5 1.7 36.7 Failed
“ F 54 no 180 hypertrophic 83 20.0 3.3 35.7 Healed
“ F 57 no 202 hypertrophic 81 14.3 1.6 44.1 Failed
“ F 44 no 214 hypertrophic 89 10.8 1.1 28.8 Healed
Histomorphometric data is presented for the area of new bone formation, representing the newly 
formed bony callus within 0.6 mm distance from the fracture ends. N.RUNX2+/SCT.Ar, number of 
cells immunopositive for RUNX2 per area of soft connective tissue; N.RUNX2+/B.Pm, number of cells 
immunopositive for RUNX2 per bone perimeter; BV/TV, bone volume of total tissue volume.
1:800 dilution, was performed overnight in a humidified chamber at 4°C. After rinsing 
the sections were allowed to react with biotinylated horse anti-mouse IgG. After 
rinsing again, sections were incubated with ABC peroxidase (Elite kit, Vector Labs, 
Burlingame, CA, USA) according to the manufacturer’s instruction. Development was 
carried out with a DAB peroxidase substrate kit (Vector Labs, Burlingame, CA, USA). 
Sections were counterstained with methyl green for 5 min, mounted in 50% glycerol, 
and covered with a glass cover slip. Positive cells stained brown, while negative cells 
only showed blue/green nuclei and no brown cytoplasm. Negative control sections 
were incubated with normal mouse IgG replacing the primary antibody.
Histomorphometric analysis
All analyses were performed using a Leica DMRA microscope connected to a computer 
using an electronic stage table, and a Leica DC 200 digital camera24. All measurements 
were done using the Leica QWin© computer program (Leica Microsystems Image 
Solutions, Rijswijk, The Netherlands). Histomorphometric analysis was performed to 
determine the number of cells expressing RUNX2 located within and around the newly 
formed woven bone at the fracture end, and up to 3 mm distance of the fracture 
end. The fracture end was used as a distinct landmark and guideline to indicate the 
beginning of the area of new bone formation24. The areas of interest were the area 
of new bone formation, representing the newly formed bony callus within 0.6 mm 
distance from the fracture ends, and the consecutive measurement fields of 0.6 mm 
in length, up to 3 mm distance from the fracture ends. Nomenclature, symbols, and 
units used are as recommended by the Nomenclature Committee of the American 
Society for Bone and Mineral Research31. The total number of RUNX2 immunopositive 
cells (N.RUNX2+) was expressed per area of soft connective tissue (0.01 mm2). 
Number of RUNX2 immunopositive cells at the bone surface (presumably osteoblasts) 
was expressed per bone perimeter (0.1mm). Number of RUNX2 positive osteocytes 
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(N.Ot(RUNX2+)) was expressed as percentage of the total number of osteocytes 
(N.Ot(RUNX2+)/N.Ot x 100%). 
The mouse recombinant monoclonal antibody Pebp2αA is a specific antibody to 
RUNX2. It has been well characterized as previously reported32, and was also used on 
clinically derived human tissue33. Optimizing cellular staining quality and background 
reduction resulted in a staining procedure which involved antigen retrieval. It should be 
noted that our antibody detects all RUNX2 isotypes. Type II (til-1 isoform) expression 
has been found exclusively in osseous tissues, and type I (Pebp2αA isoform) expression 
has been detected in both osteoblast progenitor cells and in nonosseous murine 
tissues, including lung, liver, muscle, and skin34. Accordingly, it is conceivable that in 
our study the immunostaining observed in blood vessels and other non-osseous tissues 
represent the non-osseous isoform I32. Increase in staining intensity with osteogenic 
differentiation is due to staining with type II. Endothelial cells were identified based on 
their histological appearance, i.e. lining blood vessel lumina. The endothelial cells lining 
blood vessels were not incorporated in the quantitative analysis on RUNX2 positive 
cells. The osteoblastic nature of the cells identified as RUNX2 immunopositive cells at 
the bone surface was made based on morphological and histological criteria35.
Statistical analysis
Statistical analysis of the data was performed using a Student’s independent t-test 
(two-tail). The values of the histomorphometric parameters are expressed as mean ± 
SEM. A p-value of < 0.05 is considered significant. 
RESULTS
Cells expressing RUNX2 were present in all histological sections from untreated and 
LIPUS treated bone evaluated. In some biopsies, the soft connective and/or cartilaginous 
tissue within the fracture gap was lost, and only a small area of soft connective and/
or cartilaginous tissue adjacent to the newly formed bony callus remained. In this soft 
connective and/or cartilaginous tissue adjacent to the fracture ends only few RUNX2 
immunopositive cells were observed, which were all located within the vicinity of the 
fracture ends (data not shown). At the fracture ends, endosteal callus formation was 
seen in all 7 biopsies (4 control, 3 LIPUS-treated). All controls showed endochondral 
ossification, whereas biopsies of LIPUS-treated delayed unions showed direct bone 
formation as well. Within the area of new bone formation, RUNX2 immunopositive 
cells were found in the undifferentiated soft connective tissue, at the bone surface, 
and within the newly formed woven bone (Figure 1A-B). 
Strong expression of RUNX2 was found in cells located at the woven bone 
surface (presumably osteoblasts) and in cells within the proximity of the osteoblastic 
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layer (presumably pre-osteoblasts) (Figure 2A). The presence of cuboidal-shaped 
osteoblasts lining seams of osteoid suggested active bone formation. Many of the 
young osteocytes embedded in osteoid or still located close to the bone surface 
also showed RUNX2 expression (Figure 2A). Apart from RUNX2 immunopositive 
osteogenic cells, RUNX2 immunopositive staining was also detected in the endothelial 
lining of young blood vessels (Figure 2A). Some of the osteocytes located in the 
newly formed woven bone had a round shape with abundant cytoplasm. The newly 
Figure 2. Immunolocalization of cells expressing RUNX2 in newly formed bony callus at the fracture 
ends of fibula delayed unions. (A) Many of the cells localized within the soft connective tissue (SCT) 
show immunopositive staining for RUNX2 (brown nuclei/cytoplasm, black arrows). Strong expression of 
RUNX2 is found in cuboidal-shaped cells (presumably osteoblasts, white arrows) lining seams of osteoid, 
suggesting that active bone formation is present. Numerous young osteocytes embedded in osteoid or 
located in the woven bone (WB) still close to the bone surface, also show RUNX2 expression (grey arrows). 
Apart from staining osteogenic cells, RUNX2 immunopositive staining is also detected in the endothelial 
(purple arrow) lining of young blood vessels. (B) Some of the osteocytes located in the newly formed 
woven bone have a round shape with abundant cytoplasm (grey arrows). The newly formed woven 
bone containing these large “hypertrophic” osteocytes, seems to be the subject of remodelling activities 
as it attracts numerous of osteoclasts (red arrows). (C) Some of these large osteocytes with abundant 
cytoplasm showed dendrite-like cytoplasmic projections. Rectangle (dashed line), osteocyte; Rectangle 
(solid line), high magnification osteocyte. Arrows indicate dendrite-like cytoplasmic projections towards 
the bone surface. (D) One of the controls was an atrophic delayed union, but this did not result in an 
arrest of proliferation and/or recruitment of osteogenic cells, as illustrated by the bone formation and/or 
remodelling activities present in the form of a cutting cone. (E) With increasing distance from the fracture 
end (4.2 mm), the number of RUNX2 immunopositive staining cells, as well as the intensity of staining 
decreases. (F) Within the cartilage matrix (CAR) adjacent newly formed bony callus, only few hypertrophic 
chondrocytes (black arrows) are immunopositive. (G) Negative control stained with a control IgG, note the 
absence of RUNX2 immunopositive staining. A,B,D-G, Original magnification x200; Scale bar, 100 μm. C, 
Original magnification x400; Scale bar, 50 μm.
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formed woven bone containing these large “hypertrophic” osteocytes, seems to be 
the subject of remodelling activities as it attracts numerous osteoclasts (Figure 2B). 
Dendrite-like cytoplasmic projections were seen in young osteocytes located in the 
vicinity of the bone surface (Figure 2C). This type of woven bone, containing large 
hypertrophic osteocytes, might be transchondric bone, which is an intermediate 
between bone and cartilage, as we also reported previously24. One of the controls 
was an atrophic delayed union, but this did not result in an arrest of proliferation and/
or recruitment of osteogenic cells. The atrophic control showed active bone formation 
as well as remodelling activities (Figure 2C). With increasing distance from the fracture 
end, the number of RUNX2 immunopositive cells as well as the intensity of staining 
decreased (Figure 2D). Only few hypertrophic chondrocytes located within the vicinity 
of the fracture end stained positive for RUNX2 (Figure 2E). Control sections in which 
the primary RUNX2 antibodies had been replaced by non-immune IgG were negative 
(Figure 2F). 
In the area of new bone formation, the number of cells expressing RUNX2 within 
the soft connective tissue was 69% lower (p<0.05) as result of LIPUS stimulation (Figure 
3A). The number of RUNX2 immunopositive cells at the bone surface (presumably 
osteoblasts, Figure 3B), and the percentage of RUNX2 immunopositive osteocytes 
showed no significant difference between LIPUS-treated bone and untreated 
controls (Figure 3C). In both treatment and control group, there was a wide range 
with regard to percentage of RUNX2 expressing osteocytes (control, range 5-72%; 
LIPUS, range 1-27%). When referring to collected data of our previously reported 
histomorphometrical study24, and correcting for delayed unions not evaluable in the 
present study, in the select specimens LIPUS significantly increased mineralized bone 
volume by 41% (control, 31.0 ± 2.7%; LIPUS 43.8 ± 2.7%; mean ± SEM; p=0.021). The 
increased mineralized bone volume was accompanied by a 33% borderline significant 
increase of total bone volume (p=0.053, Figure 3D). 
Among the controls, no difference was seen in number of RUNX2 immunopositive 
cells within the soft connective tissue of the atrophic delayed union when compared to 
the other hypertrophic delayed unions (atrophic, 12.5 ± 5.7 /0.01 mm2; hypertrophic, 
15.0 ± 2.7 /0.01 mm2; mean ± SEM; p=0.74). Furthermore the number of RUNX2 
immunopositive cells at the bone surface was similar for the atrophic and hypertrophic 
delayed unions (atrophic, 1.7 ± 0.1 /0.1 mm2; hypertrophic, 2.0 ± 0.7 /0.1 mm2; mean 
± SEM; p=0.52). Among the LIPUS-treated delayed unions, the delayed union type 
did also not affect numbers of RUNX2 immunopositive cells per soft connective tissue 
area (atrophic, 3.0 ± 0.9 /0.01 mm2; hypertrophic, 5.3 ± 3.1 /0.01 mm2; mean ± SEM; 
p=0.51), and bone surface perimeter (atrophic, 1.3 ± 0.9 /0.1 mm2; hypertrophic, 1.1 
± 0.7 /0.4 mm2; mean ± SEM; p=0.86).
In the LIPUS treated as well as in the control group, the total number of RUNX2 
immunopositive cells declined with regard to increasing distance from the fracture 
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ends (Figure 4A-B). Within 3 mm of the fracture ends the number of RUNX2 expressing 
cells within the soft connective tissue showed a decrease of 87% in biopsies from 
patients treated with LIPUS, whereas in the untreated controls only a decrease of 47% 
was seen (Figure 4A). At 3 mm distance of the fracture end, the number of RUNX2 
expressing cells within the soft connective tissue was 92% lower (p<0.05) in the 
LIPUS-treated delayed unions. Within 3 mm of the fracture end, the number of RUNX2 
immunopositive cells at the bone surface showed a decrease of 75%, whereas in the 
controls a decrease of only 25% was seen (Figure 4B). At 3 mm distance of the fracture 
end, the data suggest a trend toward decreased numbers of RUNX2 immunopositive 
cells at the bone surface for the LIPUS treated patients (decrease of 80%, p=0.11) 
when compared to the controls. Only one LIPUS treated delayed union showed some 
RUNX2 staining at 3 mm distance of the fracture end. No immunopositive staining 
was seen in osteocytes after 1.2 mm distance from the fracture end in LIPUS-treated 
delayed unions, whereas in the control group  immunopositive staining of osteocytes 
remained up to 3 mm distance of the fracture ends.
Figure 3. Histomorphometric data of the localization of RUNX2 immunopositive cells within the area of 
new bone formation in delayed unions of the fibula treated with or without LIPUS. (A). Number of cells 
immunopositive for RUNX2 per area of soft connective tissue (N.RUNX2+/SCT.Ar). (B) Number of cells 
immunopositive for RUNX2 per bone perimeter (N.RUNX2+/B.Pm). (C) Number of RUNX2 immunopositive 
osteocytes as percentage of total number of osteocytes (N.Ot-RUNX2+/N.Ot x 100). (D) Bone volume as 
percentage of total tissue volume (BV/TV x100), data refers to collected data of a previously performed 
histomorphometrical study (Rutten et al. 2008). Values are mean ± SEM. Statistics: Student’s independent 
t-test, two-tailed. *p<0.05.
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DISCUSSION
In this study immunolocalization of RUNX2 as early bone cell marker was performed 
to determine the presence of osteogenic cells in LIPUS-treated delayed unions of the 
osteotomized fibula and sham-treated controls in a double blind clinical trial. The 
clinical model for delayed fracture healing, which we reported previously24, allows 
us to report on bone healing and osteogenic potential present at the tissue level 
in fractures of over 8 months of age. Secondly this delayed fracture healing model 
offers us the unique possibility to investigate the effect of LIPUS, as a single treatment 
option, on clinical bone healing at the tissue level. Histomorphometrical analysis 
was performed to determine the number of cells expressing RUNX2 located within 
and around the newly formed woven bone at the fracture end (area of new bone 
formation), and up to 3 mm distance of the fracture end. Although clinical fracture 
healing was impaired in the delayed unions of the osteotomized fibula, cells expressing 
RUNX2 were present in all histological sections evaluated. Impaired clinical fracture 
healing therefore does not result in impairment of osteogenic cell proliferation and/or 
osteoblast differentiation at the tissue level. Two of the three LIPUS-treated patients, 
and two of the four sham-treated controls included in this study showed healing at 
5 months of treatment. Biopsies were taken in an early treatment phase, while the 
clinical outcomes refer to a later date/phase. The present study cannot conclude 
that LIPUS is effective in augmenting the delayed healing response as compared to 
Figure 4. Histomorphometric data of the 
localization of RUNX2 immunopositive cells 
up to 3 mm distance from the fracture 
ends, in delayed unions of the fibula treated 
with or without LIPUS. (A) Number of cells 
immunopositive for RUNX2 per area of soft 
connective tissue (N.RUNX2+/SCT.Ar). (B) 
Number of cells immunopositive for RUNX2 
per bone perimeter (N.RUNX2+/B.Pm). 
Values are mean ± SEM. Statistics: Student’s 
independent t-test, two-tailed. *p<0.05. 
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the sham-treated controls. Our findings show that LIPUS does not enhance fracture 
healing through increased osteogenic cell presence, but likely enhances osteoblast 
differentiation. 
LIPUS treatment resulted in a significant lower number of cells expressing RUNX2 
within the soft connective tissue (69%, p<0.05) of the newly formed woven bone at the 
fracture ends. LIPUS stimulation can induce an inflammatory and proliferative response 
by an increase in prostaglandin E2 production in mouse MC3T3-E1 osteoblastic cells in 
vitro21. Our current findings however show that the previously reported increased bone 
formation in delayed unions of the human fibula by LIPUS treatment24, is not associated 
with an increase in osteogenic cell population. Although osteogenic cell proliferation 
plays an important role in the fracture healing response1,2, the enhancement of cell 
proliferation may however be limited to the early phase of fracture healing when cell 
proliferation is most active. The clinical study design did not allow us to take biopsies 
at different time points, i.e. not at the start of the treatment phase or during the 
treatment phase, nor at the end of the treatment phase. Differences in number of 
RUNX2 immunopositive cells as a result of LIPUS treatment as found in the present 
study may also relate to a more advanced or later phase in fracture healing as result of 
LIPUS treatment. Prolonged stimulation with LIPUS (2-3 months) of cell cultures of a 
mouse osteoblastic cell line and human periosteal cells, does not result in a proliferative 
response36,37. LIPUS treatment of fetal mouse metatarsal rudiments in vitro has been 
shown to stimulate endochondral ossification, which resulted from a direct effect 
of LIPUS on osteoblasts and ossifying cartilage by stimulation of cell activity and/or 
differentiation, but not proliferation22,23. Our findings therefore suggest that in the 
impaired clinical fracture healing, the mechanism of action by which LIPUS enhances 
fracture healing does not involve a proliferative response.
The number of RUNX2 immunopositive cells at the bone surface (presumably 
osteoblasts) showed no significant difference between LIPUS-treated bone and 
untreated controls, whereas the number of cells expressing RUNX2 within the 
soft connective tissue at the fracture ends was significantly lower by 69% in 
the LIPUS-treated delayed unions. These findings suggest that LIPUS enhances 
osteogenic cell differentiation in impaired clinical fracture healing. LIPUS is capable to 
enhance osteogenic cell differentiation in animal and human cell cultures studies36-
38. Furthermore as result of enhanced osteogenic cell differentiation by LIPUS, a 
proliferative response to increase osteogenic cell number and subsequent osteoblast 
number at the bone surface as seen in the controls may therefore be absent in the 
LIPUS-treated delayed unions. Our findings therefore suggest that LIPUS enhances 
osteoblast differentiation but not proliferation in clinical fracture healing. 
RUNX2 is regarded as the master gene of osteogenic cell differentiation and bone 
matrix production. Activation of RUNX2 increases osteocalcin and collagen I gene 
expression39,40. With increasing distance from the fracture end, the number of RUNX2 
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immunopositive cells, as well as the intensity of staining decreased in LIPUS-treated 
delayed unions and untreated controls. Decreased cellular staining intensity suggests a 
decrease of cellular RUNX2 expression. Proliferation and differentiation of osteogenic 
cells play an important role in the recruitment of new osteoblastic cells at and near 
the fracture end, as was also seen in our findings. With increasing distance from the 
fracture end, an osteogenic cell population is already present, and osteoid formation 
is restricted to remodelling activities. This explains our findings that with increasing 
distance from the fracture end, the number of RUNX2 immunopositive cells, as well as 
the intensity of staining decreased.
RUNX2 is thought to be the target of a mechanical signal by which physical 
stimulation dictates the cellular and metabolic activities of osteoblasts27. Chen et 
al. suggested that a specific pathway through RUNX2 expression is involved in the 
promotion of osteogenic transcription by LIPUS15. Cell culture studies show that LIPUS 
is capable of influencing cellular RUNX2 expression15,28,36. Stimulation of rat bone 
marrow stromal cells and human osteoblasts with LIPUS resulted in a time-dependant 
increase in cellular RUNX2 expression. Increased bone formation as found in our 
previously reported work, may suggest an increase cellular RUNX2 expression as 
result of LIPUS stimulation, since it is essential for the production of bone specific 
proteins24-26. The outcome of a decreased number of RUNX2 positive cells in 
combination with an increase in bone volume and mineralized volume as result of 
LIPUS treatment may appear contradicting. RUNX2 immunolocalization however can 
only identify cells expressing RUNX2, but can not quantify cellular RUNX2 expression. 
Although LIPUS does not increase numbers of cells expressing RUNX2, we cannot 
exclude that these cells indeed have increased RUNX2 expression, which may result in 
increased bone formation.
No RUNX2 immunopositive staining was seen in osteocytes beyond 1.2 mm distance 
from the fracture end in LIPUS-treated delayed unions, whereas in the control group 
immunopositive osteocytes remained up to 3 mm distance of the fracture ends. At 3 
mm of the fracture ends, a significant higher number of RUNX2 positive cells was seen 
in the soft connective tissue of controls when compared to the LIPUS-treated delayed 
unions. Our findings suggest a relationship with regard to RUNX2 immunopositive 
osteocytes and osteogenic cell  proliferatation. RUNX2 is a transcription factor for 
osteoblast differentiation and plays a role in the maintainance of their differentiated 
state25,26. In the control group relatively young osteocytes are embedded, but still no 
terminal differentiation has occurred as shown by the RUNX2 expression, which may 
be related to an active signalling process which stimulates osteogenic cell proliferation. 
Conditioned medium from the osteocytic MLO-Y4-cell line added to mouse bone 
marrow cultures, in which mesenchymal stem cells were induced to osteoblasts, 
showed increased mesenchymal stem cell proliferation41. Another study showed that 
mechanical stimulation of osteocytes resulted in an opposite reaction, i.e. osteocytes 
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subjected to pulsating fluid flow inhibit proliferation but stimulate differentiation of 
osteoblasts in vitro via soluble factors42. LIPUS may therefore have a direct effect 
on osteogenic cells by stimulating osteoblastic differentiation but may also indirectly 
affect osteogenic cell proliferation and differentiation through affecting osteocytes. 
The osteocytes are believed to perceive the stress put on the bone tissue leading to 
deformation (strain) and to transfer signals through their canalicular network to the 
effector cells at the bone surface, the bone forming osteoblasts and bone degrading 
osteoclasts43. Our findings therefore may illustrate an effect of LIPUS on osteocytes, 
resulting in terminal differentiation of osteocytes and inhibiting a proliferative response.
The etiology of atrophic nonunion is not well understood; they are often thought 
to be nonreactive and metabolically inactive. Among the controls, no difference was 
seen in number of cells expressing RUNX2 within the soft connective tissue of the 
atrophic delayed union when compared to the other hypertrophic delayed unions. 
Our findings show that impaired fracture healing does not lead to a decline in 
number of osteogenic cells, even if the fracture is radiographical regarded as atrophic. 
Furthermore an increase in osteogenic cell population does not necessary relate to 
increased bone formation, as may be concluded when comparing data from the 
present study with our previous report on the stimulating effect of LIPUS on bone 
volume, osteoid thickness and mineral apposition rate24. Inducing fracture healing in 
atrophic nonunions by osteoinductive therapies1, should be carefully considered since 
the number of osteogenic precursor cells in delayed union does not seem to correlate 
with increased bone formation and number of osteoblasts. 
In conclusion, immunolocalization of RUNX2 positive cells in delayed unions of 
the fibula reveals that delayed clinical fracture healing does not result in impairment 
of osteogenic cell proliferation and/or osteoblast differentiation at the tissue level, 
even if delayed unions are clinically regarded as atrophic. Reduced numbers of 
osteogenic RUNX2 immunopositive cells within the soft connective tissue, and 
unchanged numbers of RUNX2 immunopositive cell at the bone surface, implicates 
that low-intensity pulsed ultrasound does not increase osteogenic cell presence, but 
likely affects osteogenic cell differentiation. 
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ABSTRACT
Background: Disturbed vascularity leads to impaired fracture healing. Since 
low-intensity pulsed ultrasound (LIPUS) increases new bone formation in delayed 
unions, we investigated whether LIPUS affects vascularity in delayed union of the 
osteotomized fibula. LIPUS-induced bone formation was correlated to increased 
vascularity and blood flow by using histology, immunohistochemistry, and histomor-
phometric analysis. Blood vessel parameters were analysed as well as their correlation 
with bone formation and resorption parameters for both healed and failed-to-heal 
delayed unions, since it is known that in the long run some delayed unions heal 
spontaneously without LIPUS treatment while not all delayed unions heal after LIPUS 
treatment. 
Methods: Thirteen patients with delayed unions of the osteotomized fibula were 
treated for 2-4 months with or without LIPUS in a randomized prospective double-
blind placebo-controlled trial. Parameters of blood vessel formation were measured 
and related to histomorphometric bone characteristics of newly formed bone in 
histological sections of fibular biopsies. LIPUS-treated delayed unions and sham-treated 
delayed unions as well as healed delayed unions and failed-to-heal delayed unions 
were compared. 
Results: The volume density of blood vessels was increased in LIPUS-treated delayed 
unions compared to sham-treated controls. LIPUS did not change blood vessel 
number, but significantly increased blood vessel size. Healed delayed unions as well 
as LIPUS-treated and sham-treated delayed unions showed significant correlations 
between blood vessel size and osteoid volume. Failed-to-heal delayed unions showed 
significant correlations between mineral apposition rate and blood vessel size, and 
between osteoclast number and blood vessel number. 
Conclusions: Our results suggest that LIPUS enhances vascularity in delayed unions 
of the osteotomized fibula by increased blood flow and perfusion through increasing 
blood vessel size. We conclude that LIPUS only enhances fracture healing in patients 
showing a correlation between vascularization and osteoid volume at the tissue level, 
but not in patients in which this correlation is lacking.
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INTRODUCTION
Fracture healing requires the recruitment of appropriate cells and expression of 
appropriate genes at the right time in the right place1. Most clinical fractures heal 
spontaneously1. Impairment of fracture healing, appearing at 5-10% of the fractures, 
leads to a delay in union or may even result in a nonunion. The goal of therapy 
for fracture healing in general is to provide sufficient fracture stability and healthy 
bone tissue by conservative or surgical means. Unstable fracture results in delayed 
consolidation. 
Low-intensity pulsed ultrasound (LIPUS) is a non-invasive treatment modality to 
stimulate fracture healing2-8. The intensity of LIPUS therapy is in the range of ultrasound 
intensities used for diagnostic applications (1-50 mW/cm2)8. This therapy transmits 
mechanical energy transcutaneously by high frequency acoustic pressure waves2,9. 
LIPUS (30 mW/cm2) is considered as non-thermal and non-destructive. Heating of the 
tissues is less than 1°C and negligible, and therefore no temperature-driven elevated 
cell activity occurs as result of LIPUS treatment8. The underlying mechanisms of the 
stimulatory effects of LIPUS on vascularity and osteogenesis are complex and not yet 
precisely understood2. 
LIPUS provides low magnitude high frequency mechanical stimulation which 
accelerates fracture healing and stimulates osteogenesis3-6,8,10,11. The mechanical 
energy from LIPUS is detected by mechanoreceptors that convert biophysical stimuli 
into biochemical responses to initiate changes in gene expression and cellular 
adaptation8,12,13. The stimulatory effect of LIPUS on endochondral ossification is likely 
due to stimulation of bone cell differentiation, but not to changed cell proliferation11. 
In human delayed unions of the osteotomized fibula we also demonstrated that 
LIPUS does not increase osteogenic cell presence, but likely affects osteogenic cell 
differentiation14. 
Vascularity plays an important role in fracture healing by angiogenesis and 
blood flow to the fracture site. Re-establishment of the circulation is essential in 
the early stages of fracture healing15,16. Several studies suggest a relationship 
between mechanical loading and angiogenesis12,15,17. Angiogenesis is required for 
osteogenesis15. Treatment of fractures with vascular endothelial growth factor (VEGF) 
improves bone healing, leading to improved mechanical strength and increased callus 
mineralization18. Inhibition of angiogenesis completely prevents fracture healing16. 
Stability and load are important for the angiogenic component of fracture repair and 
are indispensable for exercise-induced bone gain15,17. LIPUS induces angiogenesis 
and improves tissue perfusion of moderate and severe limb ischemia and stimulates 
osteoblasts to respond rapidly with increased NO production and angiogenic gene 
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expression in rats12,19. Whether LIPUS also stimulates vascularization in patients with 
nonunions is still largely unknown.
LIPUS affects bone healing at the tissue level in patients with a delayed union of 
the fibula by increasing bone formation through increased osteoblast activity20. Given 
the relevance of blood flow to the fracture site in the fracture healing process, we 
speculated that LIPUS treatment affects the vascularity around the fracture gap thereby 
enhancing fracture healing. The aim of the present study was to investigate whether 
LIPUS increases vascularity and blood flow in delayed union of the osteotomized fibula, 
and if LIPUS-increased bone formation is correlated to increased vascularity and blood 
flow, by using histology and histomorphometric analysis. Blood vessel parameters were 
analysed as well as their correlation with bone formation and resorption parameters 
for both healed and failed-to-heal delayed unions, since it is known that in the long 
run some delayed-unions heal spontaneously without LIPUS treatment while not all 
delayed unions heal after LIPUS treatment.
MATERIALS AND METHODS
Patient selection 
Biopsies of delayed-unions of the human osteotomized fibula after a high tibial 
osteotomy were obtained from 9 female and 4 male patients (age 42-63) treated 
with or without LIPUS (7 LIPUS, 6 controls) in a randomized prospective double-blind 
placebo-controlled clinical trial20. The procedure of a closed high tibial osteotomy for 
medial located osteoarthritis of the knee included a diaphyseal non-fixated oblique 
osteotomy of the fibula. When radiological healing of the fibula was not accomplished 
within 6 months, patients could participate in this study after informed consent was 
obtained. Mean fracture age at inclusion was 192 days (range 180-214, median 185 
days) for the sham-treated controls, and 222 days (range 180-331, median 190 days) 
for the LIPUS-treated patients. The trial was registered at the Medical Ethical Review 
Board of the VU University Medical Center (2004-005). The patients were recruited 
before 2005 at the Spaarne Hospital (Hoofddorp) and Tergooi Hospitals (Hilversum), 
The Netherlands.
In accordance to the CONSORT (CONsolidated Standards of Reporting Trials) 
Statement the flow diagram presenting information about enrollment, intervention 
allocation, follow-up and analysis was composed (Figure 1). The anticipated stimulatory 
effect of LIPUS on fracture healing was 30% to 40% with an estimated standard 
deviation of 25%3,5. A total of 20 patients would provide 80% power at a 5% 
significance level. S. Rutten assessed 52 patients at the Spaarne Hospital (Hoofddorp) 
and Tergooi Hospitals (Hilversum), The Netherlands, for eligibility in this study and 
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offered LIPUS intervention to 10 patients and placebo-intervention to another 10 
patients. Biopsies obtained from 7 LIPUS- treated patients and 6 placebo-treated 
patients fulfilled the criteria for analysis (Figure 1).
CONSORT 2010 Flow Diagram 
Assessed for eligibility (n=52) 
Excluded  (n=32) 
♦   Not meeting inclusion criteria (n=28) 
♦   Declined to participate (n= 4) 
 
Analysed  (n=6) 
♦ Excluded from analysis (biopsy lost due to 
breaking) (n=2) (no delayed union/false 
inclusion) (n=1) 
Lost to follow-up (n=0) 
Discontinued intervention (n=0) 
Allocated to placebo-intervention (n=10) 
♦ Received allocated intervention (n=9) 
♦ Did not receive allocated intervention 
(consent withdrawn) (n=1) 
Lost to follow-up (n=0) 
Discontinued intervention (non-compliant)(n=2) 
Allocated to LIPUS-intervention (n=10) 
♦ Received allocated intervention (n=10) 
♦ Did not receive allocated intervention (n=0) 
Analysed  (n=7) 
♦ Excluded from analysis (biopsy lost due to 
breaking (n= 1) 
 
Allocation 
Analysis 
Follow-Up 
Randomized (n=20) 
Enrollment 
Figure 1. Patient flow through the study.
LIPUS treatment
The Exogen 2000+® LIPUS device (Smith & Nephew Inc., Memphis, TN, USA) was 
used at home during 20 min per day for 5 months20. The LIPUS device produced a 
200 μs burst of 1.5 MHz acoustic sine waves, that repeated at a modulation frequency 
of 1 kHz and provided a peak pressure of 30 mW/cm2. Computerized randomization 
of active and placebo devices was performed by the Exogen® device manufacturer 
(Smith & Nephew Inc.). The devices were blinded for both investigators and patients 
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participating in the trial and were distributed among patients in order of inclusion 
in the trial.  The trial was unblinded after completion of the histomorphometric 
and histologic analysis, and after all patients completed 5 months LIPUS treatment. 
Radiographs were taken to diagnose if the delayed unions were healed or failed-to-
heal.
Biopsy procedure 
Patients received LIPUS treatment for 87 days (range 61-115, median 90 days) or 
sham-treatment for 83 days (range 72-89, median 85 days). To determine the mineral 
apposition rate (MAR), patients received 200 mg tetracycline 4 times per day for two 
consecutive days, at 3 weeks and 1 week in advance of the biopsy procedure21. A 
biopsy was taken under general or spinal anaesthesia with the use of a hollow trephine 
burr (ITI-Straumann, Basel, Switzerland) as described earlier20. One delayed-union case 
treated with LIPUS showed radiographic consolidation when the biopsy was taken.
Histology
The biopsies were fixated in 4% formaldehyde in 0.1 M phosphate buffer at pH 7.3 
and 4°C for 24 h. For histomorphometric analysis, the biopsies were embedded in 
methylmetacrylate without decalcification21. Longitudinal 5 μm thick sections were 
cut, and 3 sections at 305 μm distance from each other were stained with Goldner’s 
trichrome method (mineralized tissue: green; osteoid: red). For immunohistochemistry, 
the biopsies were decalcified with 5% EDTA, 1% formaldehyde at pH 7.3 at 4°C for 
8 weeks. Biopsies were dehydrated by ethanol, cleared in xylene, and embedded in 
paraffin at 56°C. Sections of 6-7 μm thickness were cut, mounted on polylysine-coated 
glass slides, and dried overnight in a 37°C stove.
Histomorphometric analysis
Three Goldner trichrome-stained sections per patient were quantitatively measured at 
200x magnification by a Leica DMRA microscope connected to Leica Qwin computer 
software (Leica Microsystems Imaging Solutions, Cambridge, UK).  Blood vessel 
formation was measured in the zone of newly formed bone, which represents the 
far most active bone area within 2.5 mm from the fracture end (Figure 2). To account 
for differences in differentiation, the zone of newly formed bone was divided into 3 
domains with regard to the bone architecture and histological appearance. Domain-1 
was located within 0.6 mm distance from the fracture end, domain-2 was located from 
0.6-1.3 mm distance from the fracture end, and domain-3 was located from 1.8-2.5 
mm distance from the fracture end, just before the end of the zone of newly formed 
bone (Figure 2). Since reliable quantification of very small blood vessels in domain-
1 was not possible, we did not further analyze this area. For our measurements we 
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used therefore domain-2 and domain-3 which allowed to distinguish relatively “young” 
versus “old” bone.
Definition of blood vessels and blood vessel parameters was according to Amir 
et al.22. The number of blood vessels and soft connective tissue parameters were 
quantified (Figure 3). Volume density of blood vessels was calculated as total blood 
vessel area/total soft connective tissue area x 100% (Blv.V/SCT.V x 100%). Blood 
Figure 2. Histological section of a biopsy of a delayed union of a human fibula showing the zone of newly 
formed bone, which represents the far most active bone area within 2.5 mm from fracture end. The zone 
of newly formed bone was divided into 3 domains with regard to the bone architecture and histological 
appearance: 1) domain-1 is located wihin 0.6 mm distance from the fracture end, 2) domain-2 is located 
from 0.6 - 1.3 mm distance from fracture end, 3) domain-3 is located from 1.8 - 2.5 mm distance from 
fracture end. Goldner’s trichrome stained section; osteoid and soft tissue, red; mineralized bone, green; 
cell nuclei, black. Original magnification x50.
Figure 3. Drawing of the area of blood vessels for vascular histomorphometry. (A) Histological section. (B) 
Histological section with blood vessels indicated. Goldner’s trichrome stained section; blood vessel, BLV; soft 
connective tissue, SCT; osteoid, red; mineralized bone, green; cell nuclei, black. Original magnification x200.
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vessel size was calculated as the total blood vessel area/total number of blood vessels 
expressed as μm2 (Blv.Ar/N.Blv). The number of blood vessels per unit soft connective 
tissue was determined per mm2 (N.Blv/SCT.Ar (/mm2). 
The data obtained from the 3 sections of each patient were averaged. The 
results of the present study were related to results of the histomorphometric bone 
characteristics in the new bone area obtained in our previous study on the effects of 
LIPUS on bone formation in delayed-unions20. Nomenclature, symbols, and units used 
are as recommended by the Nomenclature Committee of the American Society for 
Bone and Mineral Research23. The following parameters, as decribed earlier20, were 
measured: Bone volume (BV): amount of mineralized tissue (Mineralized volume, Md.V) 
plus the amount of osteoid tissue (Osteoid volume OV) as a percentage of the total 
tissue volume (BV/TV x 100%). Absolute osteoid volume: amount of osteoid tissue 
as a percentage of the total tissue volume (OV/TV x 100%). Relative osteoid volume: 
the amount of osteoid tissue as a percentage of the total bone volume (OV/BV x 
100%). Osteoid thickness (O.Th): average of the osteoid thickness. Mineral apposition 
rate (MAR): average distance between corresponding edges of two consecutive 
fluorescent bone labels divided by the number of days between start of the first 
administration period of tetracycline and the start of the second administration period 
of tetracycline20,21. TRAP-positive osteoclasts (N.Oc): number expressed per total 
tissue area (mm2) (N.Oc/T.Ar). 
Immunohistochemistry
Tissue sections were deparaffinized, rehydrated, and subjected to antigen retrieval 
in 10 mM citrate buffer (pH 6.0) of 60°C for 48 h. Sections were incubated in 50 
mM NH4CL for 10 min to inactivate formalin, blocked in 0.5% BSA for 30 min, and 
incubated with the primary antibody to laminin, a basement membrane component 
of vessels (catalog number ab 11575; laminin was purified from the basement 
membrane of Englebreth Holm-Swarm (EHS) sarcoma (mouse)), at 1:25 dilution, for 
2 hours at room temperature.  The second antibody goat anti-rabbit IgG-HRP (horse 
radish peroxidase) (Envision kit, Dako, Carpinteria, CA) was applied according to the 
manufacturer’s instruction. After development with DAB substrate, sections were 
counterstained with hematoxylin. The basement membrane stained brown in laminin-
positive cells.
Statistical analysis
Data are expressed as mean ± SEM. Univariate Analysis of Variance (UNI-ANOVA) 
was performed for sham-treated and LIPUS-treated patients, and for failed-to-heal 
delayed unions and healed delayed unions. Pearson correlation test was used to 
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examine correlation between blood vessel and bone formation parameters. p<0.05 
was considered statistically significant.
RESULTS  
Histology
Blood vessels were found throughout the zone of newly formed bone in biopsies from 
both sham-treated and LIPUS-treated patients.  In domain-1 active bone formation 
was observed by osteoblasts depositing osteoid at the bone surface (Figure 4). 
Controls showed only endochondral ossification at the fracture ends, while direct/
intramembranous bone formation was also seen in biopsies of the LIPUS-treated 
delayed unions20. Blood vessels were present in close vicinity to active ostoblasts 
depositing osteoid. In domain-1 numerous small developing blood vessels were seen 
in sham-treated delayed-unions, and even more in LIPUS-treated delayed unions 
(Figure 5A,B). In domain-2 large blood vessels were clearly visible in sham-treated and 
LIPUS-treated nonunions (Figure 5C,D). The LIPUS-treated delayed unions showed 
increased blood vessel density and size compared to sham-treated delayed unions 
(Figure 5).
Figure 4. Histological section of a biopsy of a delayed union of a human fibula showing domain-1. High 
cell density and a number of clusters of osteoblasts surrounded by osteoid.  (A) sham-treated delayed 
unions; (B) LIPUS-treated delayed unions. Arrows indicate osteoblasts. Osteoid, red; mineralized bone, 
green; cell nuclei, black. Original magnification x200.
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Histomorphometry
UNI-ANOVA showed no interaction effects between LIPUS-treated and sham-treated 
delayed unions and between failed-to-heal and healed delayed unions (Table 1). 
In domain-2, LIPUS increased blood vessel size by 70% (p= 0.021) compared to 
sham-treatment (Table 1). LIPUS also resulted in a trend of increased volume density 
of blood vessels by 65% (ns, p=0.259) compared to sham-treatment (Table 1). The 
number of blood vessels was similar in domain-2 and domain-3 of LIPUS-treated 
and sham-treated delayed unions (Table 1). In domain-3, LIPUS resulted in a trend 
of increased volume density of blood vessels by 60% (ns, p=0.239) and a trend of 
Figure 5. Immunostained histological section of a biopsy of a delayed union of a human fibula. (A) 
domain-1, sham-treated; (B) domain-1, LIPUS-treated. Small developing blood vessels (brown) can be 
seen. (C) domain-2, sham-treated; (D) domain-2, LIPUS-treated. The LIPUS-treated delayed-unions  showed 
increased blood vessel size. Original magnification x200.
98
LIPUS stimulation increases vascularity in delayed unions of the fibula 
Chapter
6increased blood vessel size of 64% (ns, p= 0.163) compared to sham-treated delayed unions (Table 1).
Healed delayed unions showed a trend of increased volume density of 62% (ns, 
p=0.239) and number of vessels by 62% (ns, p=0.282) compared to failed-to heal 
delayed unions in domain-2 (Table 1). The blood vessels size was similar for failed-to-
heal delayed-unions and healed delayed unions in domain-2 and domain-3, comparable 
to the volume density in domain-3 (Table 1). A trend of increased number of blood 
vessels by 64% (ns, p=0.163) was found in healed delayed unions compared to failed-
to-heal delayed unions in domain-3 (Table 1).
Significant Pearson correlations between blood vessel parameters and bone 
formation parameters were found in domain-3 for histomorphometric bone 
characteristics of sham-treated and LIPUS-treated patients (Table 2). Blood vessel size 
correlated positively with absolute osteoid volume (ρ=0.827, p=0.042) and relative 
osteoid volume (ρ=0.871, p=0.024) in sham-treated patients (Table 2). LIPUS-treated 
Table 1: Histomorphometric data of blood vessels of delayed unions of the osteotomized fibula analysed 
by treatment (with or without LIPUS) and by healing status (failed or healed)
Sham-treated 
N = 6
LIPUS-treated 
N = 7
Uni-anova
Male / Female 1M / 5F 3M / 4F
Age (Mean ± Sd) 52 ± 8 52 ± 9
Domain Blood vessel parameter Mean ± SEM Mean ± SEM p-value
2 Blv.V/SCT.V (%) 7.15 ± 1.54 11.78 ± 2.96 0.259
Blv.Ar/N.Blv (μm2) 1811 ± 320 3023 ± 333   0.021 *
N.Blv/SCT.Ar (/mm2) 48.47 ± 9.11 44.80 ± 12.81 0.640
3 Blv.V/SCT.V (%) 5.86 ± 1.75 9.37 ± 1.49 0.239
Blv.Ar/N.Blv (μm2) 1524 ± 229 2492 ± 534 0.163
N.Blv/SCT.Ar (/mm2) 35.04 ± 6.89 46.19 ± 10.25 0.446
Failed
N = 5
Healed
N = 8
Uni-anova
Male/ Female 0M / 5F 4M / 4F
Age (Mean ± Sd) 51 ± 7 53 ± 9
Sham-treated/LIPUS-treated 2/3 4/4
Domain Blood vessel parameter Mean ± SEM Mean ± SEM p-value
2 Blv.V/SCT.V (% 6.97 ± 1.92 11.31 ± 2.59 0.239
Blv.Ar/N.Blv (μm2) 2778 ± 551 2267 ± 317 0.524
N.Blv/SCT.Ar (/mm2) 33.70 ± 11.52 54.48 ± 9.86 0.282
3 Blv.V/SCT.V (% 7.78 ± 2.51 7.73 ± 1.33 0.949
Blv.Ar/N.Blv (μm2) 2391 ± 646 1829 ± 360 0.552
N.Blv/SCT.Ar (/mm2) 29.36 ± 7.34 48.35 ± 8.51 0.163
Histomorphometric data is presented for domain-2 and domain-3 in the zone of newly formed. Blv.V/
SCT.V (%), volume density of blood vessels (%); Blv.Ar/N.Blv (μm2), blood vessel size (mm2); N.Blv/SCT.Ar 
(/mm2), number of blood vessels per mm2 soft connective tissue.
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patients showed a significant positive correlation between blood vessel size and 
relative osteoid volume (ρ=0.774, p=0.041; Table 2). 
In domain-2, significant positive correlations between blood vessel size and 
mineral apposition rate (ρ=0.968, p=0.007), and between number of blood vessels 
and number of TRAP-positive cells (ρ= 0.912, p=0.031) were found in failed-to-heal 
delayed unions (Table 3). The healed delayed unions showed significant positive 
correlations in domain-2 between volume density of blood vessels and bone volume 
(ρ=0.800, p=0.017), between volume density of blood vessels and mineralized volume 
(ρ=0.904, p=0.002), and between number of blood vessels and mineralized bone 
volume (ρ=0.780, p=0.022) (Table 3). In domain-3 the healed delayed unions showed 
Table 2: Pearson correlations between blood vessel parameters and bone formation parameters in 
domain-2 and domain-3 for sham-treated delayed unions and LIPUS-treated delayed unions in biopsy of 
the human fibula.
Sham-treated LIPUS-treated
Domain-2 Domain-3 Domain-2 Domain-3
ρ p-value ρ p-value ρ p-value ρ p-value
Blv.V/SCT.V BV/TV -0.173 0.743 -0.015 0.977  0.409 0.362 -0.546 0.205
Md.V/TV -0.206 0.696 -0.151 0.775  0.483 0.272 -0.451 0.310
OV/TV  0.306 0.556  0.747 0.088 -0.282 0.540 -0.082 0.861
OV/BV  0.203 0.700  0.643 0.168 -0.345 0.448  0.072 0.879
O.Th -0.595 0.213 -0.032 0.953 -0.027 0.954 -0.316 0.490
MAR -0.644 0.167 -0.034 0.949  0.531 0.278  0.225 0.668
N.Oc/T.Ar  0.410 0.419  0.637 0.174  0.192 0.679  0.500 0.253
Blv.Ar/N.Blv BV/TV -0.442 0.380 -0.034 0.949 -0.079 0.867 -0.415 0.354
Md.V/TV -0.397 0.436 -0.200 0.704 -0.081 0.862 -0.647 0.116
OV/TV -0.458 0.361  0.827 0.042*  0.028 0.953  0.656 0.110
OV/BV  0.006 0.990  0.871 0.024*  0.135 0.773  0.774 0.041*
O.Th -0.677 0.139  0.293 0.573  0.061 0.897  0.417 0.352
MAR -0.319 0.538  0.376 0.462  0.637 0.174  0.283 0.587
N.Oc/T.Ar -0.128 0.809  0.411 0.419  0.747 0.054  0.527 0.224
N.Blv/SCT.Ar BV/TV  0.264 0.613 -0.154 0.771  0.332 0.467  0.039 0.935
Md.V/TV  0.241 0.645 -0.248 0.636  0.435 0.329  0.281 0.542
OV/TV  0.429 0.396  0.547 0.262 -0.331 0.468 -0.582 0.170
OV/BV -0.076 0.886  0.500 0.313 -0.419 0.349 -0.605 0.150
O.Th -0.054 0.919  0.025 0.963 -0.116 0.804 -0.551 0.200
MAR -0.415 0.413 -0.008 0.988  0.130 0.806  0.044 0.933
N.Oc/T.Ar  0.416 0.412  0.319 0.538 -0.099 0.832 -0.105 0.823
Pearson correlation coefficients (ρ) between blood vessel parameter and bone formation parameter are 
presented for the domain-2 and domain-3 in the zone of the newly formed bone. Blv.V/SCT.V, volume 
density of blood vessels (%); Blv.Ar/N.Blv, blood vessel size (mm2); N.Blv/SCT.Ar, number of blood 
vessels per soft connective tissue area (/mm2); BV/TV, bone volume of total tissue volume (%); Md.V/TV, 
mineralized volume (%); OV/TV, absolute osteoid volume (%); OV/BV, relative osteoid volume (%); O.Th, 
osteoid thickness (μm); MAR, Mineral Apposition Rate (μm/day); N.Oc/T.Ar, number of TRAP-positive cells 
per tissue area (/mm2). * Significant correlation, p<0.05. 
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significant positive correlations between blood vessel size and absolute osteoid volume 
(ρ=0.901, p=0.002), and between blood vessel size and relative osteoid volume 
(ρ=0.901, p=0.002; Table 3). 
Table 3: Pearson correlations between blood vessel parameters and bone formation parameters in 
domain-2 and domain-3 for delayed unions that failed-to-heal and healed delayed unions in biopsy of the 
human fibula.
 Failed-to-heal Healed
Domain-2 Domain-3 Domain-2 Domain-3
ρ p-value ρ p-value ρ p-value ρ p-value
Blv.V/SCT.V BV/TV -0.755 0.140 -0.645 0.240  0.800 0.017*  0.369 0.369
Md.V/TV -0.786 0.115 -0.663 0.222  0.904 0.002*  0.342 0.407
OV/TV  0.777 0.122  0.622 0.263 -0.232 0.580  0.056 0.895
OV/BV  0.809 0.097  0.681 0.205 -0.486 0.222 -0.012 0.978
O.Th -0.156 0.802 -0.175 0.778  0.213 0.612  0.274 0.512
MAR -0.031 0.960  0.334 0.582  0.688 0.088  0.369 0.415
N.Oc/T.Ar  0.250 0.685  0.092 0.882  0.031 0.942  0.329 0.425
Blv.Ar/N.Blv BV/TV  0.179 0.773 -0.329 0.589  0.268 0.521  0.120 0.776
Md.V/TV  0.100 0.872 -0.391 0.515  0.236 0.574 -0.201 0.634
OV/TV  0.311 0.611  0.621 0.264  0.094 0.825  0.904 0.002*
OV/BV  0.300 0.624  0.643 0.242  0.021 0.961  0.901 0.002*
O.Th  0.631 0.254  0.375 0.534 -0.144 0.733  0.578 0.133
MAR  0.968 0.007*  0.816 0.092  0.271 0.557  0.056 0.906
N.Oc/T.Ar -0.814 0.094 -0.438 0.461  0.027 0.949  0.243 0.562
N.Blv/SCT.Ar BV/TV -0.727 0.164 -0.613 0.272  0.626 0.097  0.494 0.213
Md.V/TV -0.663 0.223 -0.578 0.308  0.780 0.022*  0.671 0.069
OV/TV  0.209 0.735  0.288 0.639 -0.365 0.374 -0.495 0.212
OV/BV  0.274 0.656  0.368 0.542 -0.608 0.110 -0.638 0.088
O.Th -0.827 0.084 -0.654 0.231  0.251 0.549  0.112 0.792
MAR -0.719 0.171 -0.161 0.796  0.406 0.367  0.568 0.184
N.Oc/T.Ar  0.912 0.031*  0.502 0.389 -0.092 0.829 -0.005 0.991
Pearson correlation coefficients (ρ) between blood vessel parameter and bone formation parameter are 
presented for the domain-2 and domain-3 in the zone of the newly formed bone. Blv.V/SCT.V, volume 
density of blood vessels (%); Blv.Ar/N.Blv, blood vessel size (mm2); N.Blv/SCT.Ar, number of blood 
vessels per soft connective tissue area (/mm2); BV/TV, bone volume of total tissue volume (%); Md.V/TV, 
mineralized volume (%); OV/TV, absolute osteoid volume (%); OV/BV, relative osteoid volume (%); O.Th, 
osteoid thickness (μm); MAR, Mineral Apposition Rate (μm/day); N.Oc/T.Ar, number of TRAP-positive cells 
per tissue area (/mm2). * Significant correlation, p<0.05. 
DISCUSSION
Histomorphometric and histological analysis of bone biopsies of LIPUS-treated and 
sham-treated delayed unions of the osteotomized fibula was performed to evaluate 
the effect of LIPUS-treatment on vascularity in a double-blind randomized clinical 
trial. Since blood vessel formation is closely related to bone formation, and since both 
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blood vessel formation and bone formation are stimulated by mechanical loading, 
we hypothesized that LIPUS-treatment accelerates fracture healing by initiating 
increased blood supply in and/or to the fracture gap, followed by new bony callus 
formation. LIPUS initiated improved blood supply by enlarging blood vessel size, which 
enables increased blood flow resulting in a higher oxygen delivery and increased 
bone formation in and/or around the fracture gap. The increased osteoid volume in 
healed delayed unions, LIPUS-stimulated delayed unions, and sham-treated delayed 
unions can largely be explained by increased blood flow and perfusion. We conclude 
that LIPUS only enhances fracture healing in patients showing a correlation between 
vascularization and osteoid volume at the tissue level, but not in patients in which this 
correlation is lacking. 
Histology showed a cell rich area with active osteoid-depositing osteoblasts and 
only very small blood vessels next to the fracture gap. Mechanical adaptation of bone 
is mediated by vascular endothelial growth factor (VEGF), which is upregulated by 
mechanical loading17. LIPUS increases VEGF mRNA, blood flow, and angiogenesis in 
rats19, which agrees with our findings that LIPUS increases blood vessel size. Formation 
of blood vessels precedes bone growth in the fracture gap22. Interestingly the number 
of very small newly formed blood vessels next to the fracture gap seemed higher after 
LIPUS treatment.
Early bone formation necessitates high energy consumption, requiring adequate 
blood supply22. We found that LIPUS increased blood vessel size. This suggests that 
oxygen diffuses to the hypoxic fracture gap resulting in an oxygen-rich environment, 
which allows, in combination with a stable mechanical environment, direct bone 
formation without cartilage intermediate19,24,25. The rate of the blood flow is directly 
proportional to the fourth power of the vessel radius (Poiseuille’s Law), which indicates 
that the blood vessel diameter  is a determinant factor in the rate of blood flow through 
a vessel. Earlier we speculated that endosteal callus formation without a cartilage 
intermediate is the result of increased blood flow around the fracture site, which is 
not necessarily related to increased new blood vessel formation20. This study indeed 
demonstrated a significant increase in blood vessel size resulting in an increased blood 
supply in the LIPUS-treated delayed unions. 
To better understand why some sham-treated delayed unions healed and some 
LIPUS-treated delayed unions failed-to-heal, we divided the delayed-unions into ‘failed-
to-heal delayed unions’ and ‘healed delayed unions’. The failed-to-heal delayed unions 
did not show significant correlation between blood vessel parameters and osteoid 
volume, while a significant correlation was found in sham-treated, LIPUS-treated, and 
healed delayed unions in domain-3. Re-establishment of the circulation is essential to 
the early stages of fracture healing15,16. The key elements blood supply and stability 
ensure the timely and accurate reconstitution of bone tissue15. Angiogenesis is 
required for osteogenesis15. Our findings suggest that an increase in osteoid volume, 
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necessary for fracture healing, can be largely explained by increased blood flow 
and perfusion. The failed-to-heal delayed unions did not demonstrate a significant 
correlation between vessel parameter and osteoid, suggesting that blood flow and 
perfusion was not sufficient. However, the increased vascularization in failed-to-
heal delayed unions might be responsible for the increased mineral apposition rate, 
since there was a significant positive correlation between mineral apposition rate and 
blood vessel size, as well as for increased number of bone resorbing osteoclasts, since 
a significant positive correlation between number of blood vessels and number of 
osteoclasts was observed. Therefore we speculate that in the failed-to-heal delayed 
unions sufficient blood flow and perfusion in domain-2 would attract osteoclasts 
interfering with fracture healing and osteoid apposition, resulting in a non-significant 
correlation between vessel parameter and osteoid volume in domain-3. 
In conclusion, this study shows that LIPUS improves blood supply in bone from 
patients with a delayed-union of the osteotomized fibula by increasing blood vessel 
size, which is essential for accelerated fracture healing. An increased osteoid volume 
in healed delayed-unions, LIPUS-stimulated delayed unions, and sham-treated delayed-
unions can largely be explained by increased blood flow and perfusion. We conclude 
that LIPUS only enhances fracture healing in patients showing a correlation between 
vascularization and osteoid volume at the tissue level, but not in patients in which this 
correlation is lacking.
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ABSTRACT
Introduction: Low-intensity pulsed ultrasound (LIPUS) is frequently used to enhance 
or accelerate fracture healing, but its clinical role and effectiveness as a treatment 
modality remains uncertain. We carried out a systematic review and meta-analysis of 
randomized controlled trials to determine the efficiency of LIPUS on bone healing and/
or fracture union, as well as functional recovery.
Methods: The databases of Pubmed/Medline, Cochrane Clinical Trial Register, CINAHL, 
Web of Knowledge, Embase, and LILACS were searched for trials concerning LIPUS 
stimulation and bone healing or fracture repair, in any language, published from the 
inception of the database to March 2012. Eligible studies were randomized controlled 
trials that enrolled patients with any type of fracture, delayed union or nonunion, 
and randomly assigned them to LIPUS treatment or sham-treatment (controls). Two 
reviewers independently agreed on eligibility, assessed methodological quality, and 
extracted outcome data. All relevant outcomes were pooled, and a meta-analysis was 
performed.
Results: The initial search resulted in 282 articles. Twenty unique randomized trials 
were selected for analysis after the search of all databases (18 trials), and inclusion 
of 2 original unpublished unique randomized controlled clinical trials by the authors. 
In 9 trials the time to radiographic fracture union was the primary outcome measure 
evaluated. After pooling the time-to-radiographical healing data in the combined 
patient population (n=402), LIPUS treatment resulted in a mean reduction (p=0.0006) 
in healing time of 42.2 days (95% confidence interval 18.1 to 66.3 days; I2=94%; 
heterogeneity P<0.00001). Most reduction in time-to-radiological union by LIPUS 
treatment was seen in fractures with long natural healing tendency. Two trials only 
evaluating functional recovery were unable to demonstrate a beneficial effect of 
LIPUS (n=127). Low quality evidence from 9 trials suggests that LIPUS accelerates 
callus maturation in distraction osteogenesis, and high quality evidence from 2 trials 
suggests that LIPUS enhances fracture healing through increased bone formation in 
delayed and/or impaired bone healing. 
Discussion: LIPUS effectively reduces the time-to-radiographical fracture union. Only 
few trials evaluated functional recovery, and were unable to demonstrate a beneficial 
effect of LIPUS on functional recovery in fracture healing. A decreased time-to-
radiographical union resulting from LIPUS treatment may allow for earlier functional 
use, but future studies of high quality should focus on the functional outcome to 
reliably confirm the clinical effectiveness of LIPUS on fracture and/or bone healing. 
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INTRODUCTION
Fracture healing is an unique and successful process, nevertheless 5-10% of fractures 
show a delay in healing after initial surgical or non-surgical treatment1. Impairment 
of fracture healing leads to a delay in union or may even result in nonunion. Impaired 
fracture healing has a significant socioeconomical impact, and may lead to a personal 
tragedy2. Nowadays, enhancement and acceleration of fracture healing to prevent 
a delay in union or to treat impaired fracture healing forms a multi-billion industry3. 
A survey among Canadian trauma surgeons shows that non-invasive bone healing 
accelerating devices for tibial fractures are widely used4. Low-intensity pulsed 
ultrasound (LIPUS) forms one of the currently available non-invasive bone healing 
enhancing devices besides electro-stimulation (pulsed electro- magnetic field, PEMF). It 
affects fracture healing through high frequency acoustic pressure waves (30 mW/cm2) 
delivered transcutaneously to the fracture site. The micro-mechanical stress produced 
by LIPUS may provide a surrogate for the forces normally applied on bone by physical 
loading, and leads to bone adaptation according to Wolff’s law5.
A randomized clinical trial by Heckman and colleagues showed that LIPUS treatment 
accelerated fracture healing in fresh tibial fractures6. This randomized trial provided 
important evidence of the effectiveness of LIPUS in clinical fresh fracture healing, 
and approval by the Food and Drug Administration (FDA) for the use of LIPUS for 
acceleration of conservatively managed fresh fractures was obtained in 1994. Further 
evidence showing that LIPUS stimulates bone healing in patients with impaired bone 
healing led to FDA approval in 2000 for the use of LIPUS in established nonunions5. 
LIPUS-treatment has shown to stimulate bone formation in human cell culture studies, 
animal in-vivo studies, and in patients suffering from delayed union of the fibula7-9. 
Recently The National Institute for Health and Clinical Excellence (NICE) has 
advised healthcare professionals in the UK that LIPUS represents a safe and effective 
treatment option to reduce the healing time in patients with bone fractures10. In most 
randomized controlled clinical trials, acceleration of radiographical bony union is the 
primary outcome measure to evaluate the effectiveness of LIPUS as clinical therapy for 
fracture repair3. The outcome of a previously performed meta-analysis demonstrated 
conflicting results and only moderate to very low quality evidence3. Ideally future 
randomized controlled trials should report on important patient outcomes, i.e. return 
to function, as well as (radiographical) fracture union, to determine the effectiveness 
of LIPUS in fracture repair.
LIPUS is frequently used to enhance or accelerate fracture healing, but its clinical 
use and effectiveness as a treatment modality remains uncertain. We carried out 
a systematic review and meta-analysis of randomized controlled clinical trials to 
determine the efficiency of LIPUS on bone healing and/or fracture union, as well as 
functional recovery.
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MATERIALS AND METHODS
Eligibility criteria
The search of the literature performed for this review was limited to published 
and unpublished original randomized or quasi-randomized controlled clinical trials 
concerning LIPUS treatment of adult patients with all types of fractures, delayed unions 
or nonunions, and osteotomies. Quasi-randomization was used to allocate patients to 
a treatment; this was not strictly random, e.g. date of birth, hospital record number, or 
alteration were used. Expert opinions, systematic reviews, and narrative review articles 
were excluded. There was no language restriction; all relevant articles were translated.
Article inclusion was limited to those concerning adults (skeletal mature) with any 
type of fracture, delayed union or nonunion, or osteotomy, and subjected to LIPUS 
treatment (1-50 mW/cm2) or to sham-treatment by a placebo device. Patients with a 
metabolic and/or pathologic bone disease were excluded. Delayed union was defined 
as no union for 3 months, and nonunion was defined as healing without union for a 
period of 9 months or no healing progression at 6 months of fracture age. 
Comparison and outcome measures evaluated 
Articles were included if LIPUS treatment was compared with sham-treatment 
or placebo for fresh fractures and/or osteotomies, distraction osteogenesis, and 
delayed unions/nonunions. Subgroup analysis was performed according to 5 clinical 
categories: 1) non-operatively managed fresh fractures and/or osteotomies, 2) 
operatively managed fresh fractures and/or osteotomies, 3) distraction osteogenesis, 
4) non-operatively managed delayed unions and/or nonunions, and 5) operatively 
managed delayed unions and/or nonunions. Data were sought for a) Radiographic 
union: a healed facture was defined by bridging of three cortices or the equivalent 
to the time to achieve 70% or more bridging of fracture gap (endosteal healing). 
In trials in which the principal investigator and an independent radiologist assessed 
radiographic healing, only the data from the radiologist was used for further analysis; 
b) Clinical healing: return to full weight bearing, pain free, or pain free upon axial 
loading or manual palpating of the fracture site; c) Functional recovery or return to 
active duty; d) Prevention of delayed union/nonunion; e) LIPUS-related complications. 
For the outcome time-to-radiographic healing we carried out meta-analyses by using 
the inverse variance method to combine the natural logarithms of the ratio of the 
mean time-to-healing in the LIPUS-treated group to the mean time-to-healing in the 
sham-treated or placebo control group. 
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Search strategy, trial selection, and data abstraction
The following databases were searched from inception to 10 March 2012: Pubmed/
Medline, Cochrane Clinical Trial Register, CINAHL, Web of Knowledge, Embase, and 
LILACS, to identify relevant studies. The Pubmed/Medline search phrase is shown in 
Figure 1. The search was performed independently by two reviewers (SR and MB). 
The bibliographies of retrieved publications and other relevant articles were manually 
checked to include all studies meeting the inclusion criteria that were missed by the 
electronic search. The following search terms were used: (fracture healing or bony 
callus or bone remod* or fracture*, closed or fracture*, open) AND (ultrasonic therapy 
or ultrasonography or low intensity pulsed ultrasound). Trial registers of Current 
Controlled Trials and the World Health Organization (WHO) database were assessed 
for currently ongoing trials.
((randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized[tiab] 
OR placebo[tiab] OR clinical trials as topic[mesh:noexp] OR randomly[tiab] 
OR trial[ti]) NOT (animals[mh] NOT (animals[mh] AND humans[mh]))) AND 
((((((((fracture healing)) OR (bony callus)) OR (bone remod*)) OR (bone fractures)) 
OR (fracture*))) AND (ultrasonic therapy OR ultrasonography OR low-intensity 
ultrasound OR low intensity ultrasound))
Figure 1. Pubmed/Medline search strategy. 
Trial selection was done by reviewing title and abstract to identify relevant articles 
for our meta-analysis. The full article was retrieved when the title, keywords, and/or 
abstract revealed insufficient information to determine whether inclusion would be 
appropriate. All studies identified were independently assessed for inclusion using the 
above mentioned criteria11 according to the MOOSE guidelines by two reviewers (SR 
and MB). Disagreement was resolved by discussion, with arbitration by a third reviewer 
(PN) when differences remained. 
Data for meta-analysis were extracted from the included studies by one reviewer 
(SR), using a pre-piloted data extraction-tool. Extraction was verified by a second 
reviewer (MB). Disagreements were resolved in a consensus meeting, or if necessary, 
by third party adjudication (PN). Articles were not blinded for author, affiliation, and/
or source. In case of doubt, authors were contacted for additional information.  
Methodological quality
Judgment of the quality of evidence collected with this systematic review required 
assessment of results validity of individual studies for all important outcomes. Explicit 
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criteria were used when making judgment, and we followed the so-called GRADE 
approach to grade the collected evidence for each separate outcome measure12. 
Quantitative analysis
The available data were entered in a database (Review Manager 5.1, Cochrane) and 
analyses were performed with the SPSS software. The results of comparable studies 
were pooled using fixed or random effects models when appropriate. In the presence 
of heterogeneity, a random-effects meta-analysis weights the studies relatively 
more equally than a fixed-effect meta-analysis. Individual and pooled statistics were 
reported as relative risks with 95% confidence intervals for dichotomous outcomes and 
weighted mean differences (WMD) or, when different scales were used, standardised 
mean differences (SMD) and 95% confidence intervals for continuous outcomes 
measurements. When possible, sensitivity analyses were conducted to assess the 
effects of exclusion of the trials in which the quasi-randomization method was used, 
and according the several clinical types pathology. We examined heterogeneity using 
both a χ2 test and the I2 statistic, which is the percentage of variability among studies 
that is due to true differences between studies (heterogeneity) rather than sampling 
error (chance). We considered an I2 value greater than 50% to reflect substantial 
heterogeneity.
RESULTS
The combined search of all databases resulted in a total of 280 eligible articles 
identified. Two additional articles were identified through review of 2 previously 
published systematic reviews3,13, and in total 23 complete articles were retrieved 
(Figure 2)14-36. One research group published 4 articles25-28, representing 2 separate 
trials with similar study protocol and study design. In 2 articles based on one trial the 
early outcomes, and the late outcomes or follow up of the same study population 
were presented26,27. The outcomes of the other trial had also been published earlier in 
a non-Pubmed indexed local trauma journal25,28. Emani et al. reported on the clinical 
outcomes of intra-medullary nailing of tibial fractures17, as well as on the effect of 
serum on bone formation and resorption markers18. Subgroup analysis of patients 
who smoke was performed by Cook et al. for 2 previously published trials14,15,35. 
One trial was excluded since high-intensity pulsed ultrasound (1 W/cm2) was used, 
and this might  represent a different  mechanism of action than LIPUS36. Two 
trials were ongoing at the time of the search: 1) Trial to evaluate ultrasound in the 
treatment of tibial fractures, NCT00667849, and 2) Pilot study investigating the effect 
on therapeutic ultrasound and exercise on active digital flexion following phalangeal 
fractures; ISRCTN79669268.
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The authors included 2 additional clinical trials representing original trials from 
their own institutions. One trial was published as a thesis chapter37, and evaluates 
the effect of LIPUS on internal fixated closed wedge metaphyseal osteotomies around 
the knee, and the non-fixated osteomized fibula as part of a high tibial osteotomy 
procedure. The other trial reports on the clinical outcomes of LIPUS-treatment of 
delayed unions of the osteotomized non-fixated fibula, and is currently submitted for 
publication38. The histological findings of biopsies taken at the fibula delayed union 
site were previously published39,40. In total 20 unique randomized clinical trials were 
included for analysis. For comparison reasons the study of Nolte et al.37 was divided 
in a conservatively managed fibula osteotomy study (Nolte 2002a), and an operatively 
managed internal fixated osteotomy study (Nolte 2002b; Table 1).
In 10 trials patient important outcomes and clinical healing assessment were 
reported, i.e. pain at weight bearing, pain at manual palpation of the the fracture 
site, start of partial and full weight bearing (Table 1). Only 2 trials evaluated the 
time-to-functional recovery. Radiographical fracture union and time-to-union formed 
Figure 2. Flow diagram for identification of randomized controlled trials (RCT) evaluating the effect of 
low-intensity pulsed ultrasound on bone healing.
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the primary study outcome measure in most trials. Plain x-rays were used to evaluate 
fracture union in 16 trials, while other forms of (imaging) methods used to assess 
fracture healing and/or union were computer tomography (CT), dual energy x-ray 
absorptiometry, ultrasonography, high resolution microradiographs, and histological 
analysis of biopsies. Several trials focused on LIPUS-increased bone mineral density 
(BMD) or bone volume (BV) as surrogate for acceleration of bone formation and/or 
healing by LIPUS (Table 1). 
Table 1. Details of randomized controlled clinical trials included in this systematic review and meta-analysis.
# Patients randomised 
Trial Fracture location (# analysed) LIPUS LIPUS treatment
(days)
Primary outcome measure(s) recorded
Non-operative management fresh fracture
Traumatic fracture:
Heckman et al. 199414 Tibia 49(34) 48(33) 140 or healed Radiol. union (x-ray) / Clin healed
Kristiansen et al. 199715 Distal radius 45 (31) 40 (30) 70 Radiol. union (x-ray)  and loss of reduction
Strauss et al. 199916 MT-5 10(10) 10(10) Until healed   Radiol. union (x-ray) / Clin healed 
Mayr et al. 200019 Scaphoid 15(15) 15(15) Until Cast  removal Radiol. union (CT)
Lubbert et al. 200830 Clavicle 59(49) 61(52) 28 Clin. healed  / Funct recovery
Osteotomy:
Nolte et al. 2002a37 Fibula 36(34) 33(29) 140 Radiol. union (x-ray) / Clin healed *
Stress fracture:
Rue et al. 200420 Tibia 12(12) 14(14) Until free of symptoms Funct. recovery
Operative management fresh fracture
Emami et al. 199917,19 Tibia 17(17) 15(15) 75 Radiol. union (x-ray) / Clin healed / SMB
Nolte et al. 2002b37 Tibia/Femur 47(44) 51(46) 140 Radiol. union (x-ray) / Clin healed
Leung et al. 200421 Tibia 14(14) 16(16) 90 Radiol. union (x-ray) / Clin healed / BMD (DEXA) / SBM
Handolin et al. 2005a,b26,27 Lateral malleolus 15(15) 15(15) 42 a, Radiol. union (x-ray)/ BMD (DEXA);  b, Funct recovery / Radiol union 
(MD-CT)
Handolin et al. 2005c28 Lateral malleolus 11(11) 11(11) 42 Radiol. union (x-ray and MD-CT)
Zacherl et al. 200932 MT- 1 26(26) 26(26) 42 Clin.  healing / Funct. recovery / Radiol. union (x-ray) and correction loss
Distraction osteogenesis
Tsumaki et al. 200422 Tibia 21(21) 21(21) Until ex-fix removal BMD (DEXA) / Ex-fix. duration (x-ray)
Schortinghuis et al. 200524 Mandibula 4(4) 4(4) 28 Biopsy (micro x-ray / histology)
El-Mowafi, Mohsen 200523 Tibia 10(9) 10(10) Until ex-fix removal Consolidation index  (x-ray)
Schortinghuis et al. 200824 Mandibula 4(4) 5(5) 28 Biopsy (micro x-ray / histology) / Ultrasonography
Dudda et al. 201134 Tibia 20(20) 16(16) Until ex-fix removal Consolidation index (x-ray) / Ex-fix. duration (x-ray)
Non-operative management delayed union / nonunion
Schofer et al.  201033 Tibia 51(51) 50(50) 112 BMD (CT) / Radiological union (x-ray)
Rutten et al.  2011, 200838,39 Fibula 10(8) 10(7) 150 Radiol union (x-ray) / Clin healing; 2008, BMD (biopsy)
Operative management delayed union / nonunion
Ricardo et al. 200629 Scaphoid 11(11) 10(10) Until healed Radiol  (x-ray) / Clin healing /  Funct  recovery
Radiol. union, radiological union; Clin. healing, clinical healing; Funct. recovery, functional recovery; 
CT, computer tomography; MD-CT, multi directional computer tomography; DEXA, dual energy x-ray 
absorptiometry; SBM, serum bone markers; Ex-fix, external fixator.  
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design. In 5 trials the patients were randomly allocated to the treatment arm, but 
no sham-treatment was given. In one quasi-randomized trial, the sham device was 
visibly different from the active device21. In all others trials the placebo device was 
identical to the active LIPUS-device except for the fact that the placebo device did not 
generate an ultrasound signal. Patients were analyzed according to the treatment they 
were randomly allocated to, and no cross-over was reported. Only one trial explicitly 
reported an intention-to-treat analysis38. Eleven trials showed loss to follow-up; the 
Table 1. Details of randomized controlled clinical trials included in this systematic review and meta-analysis.
# Patients randomised 
Trial Fracture location (# analysed) LIPUS LIPUS treatment
(days)
Primary outcome measure(s) recorded
Non-operative management fresh fracture
Traumatic fracture:
Heckman et al. 199414 Tibia 49(34) 48(33) 140 or healed Radiol. union (x-ray) / Clin healed
Kristiansen et al. 199715 Distal radius 45 (31) 40 (30) 70 Radiol. union (x-ray)  and loss of reduction
Strauss et al. 199916 MT-5 10(10) 10(10) Until healed   Radiol. union (x-ray) / Clin healed 
Mayr et al. 200019 Scaphoid 15(15) 15(15) Until Cast  removal Radiol. union (CT)
Lubbert et al. 200830 Clavicle 59(49) 61(52) 28 Clin. healed  / Funct recovery
Osteotomy:
Nolte et al. 2002a37 Fibula 36(34) 33(29) 140 Radiol. union (x-ray) / Clin healed *
Stress fracture:
Rue et al. 200420 Tibia 12(12) 14(14) Until free of symptoms Funct. recovery
Operative management fresh fracture
Emami et al. 199917,19 Tibia 17(17) 15(15) 75 Radiol. union (x-ray) / Clin healed / SMB
Nolte et al. 2002b37 Tibia/Femur 47(44) 51(46) 140 Radiol. union (x-ray) / Clin healed
Leung et al. 200421 Tibia 14(14) 16(16) 90 Radiol. union (x-ray) / Clin healed / BMD (DEXA) / SBM
Handolin et al. 2005a,b26,27 Lateral malleolus 15(15) 15(15) 42 a, Radiol. union (x-ray)/ BMD (DEXA);  b, Funct recovery / Radiol union 
(MD-CT)
Handolin et al. 2005c28 Lateral malleolus 11(11) 11(11) 42 Radiol. union (x-ray and MD-CT)
Zacherl et al. 200932 MT- 1 26(26) 26(26) 42 Clin.  healing / Funct. recovery / Radiol. union (x-ray) and correction loss
Distraction osteogenesis
Tsumaki et al. 200422 Tibia 21(21) 21(21) Until ex-fix removal BMD (DEXA) / Ex-fix. duration (x-ray)
Schortinghuis et al. 200524 Mandibula 4(4) 4(4) 28 Biopsy (micro x-ray / histology)
El-Mowafi, Mohsen 200523 Tibia 10(9) 10(10) Until ex-fix removal Consolidation index  (x-ray)
Schortinghuis et al. 200824 Mandibula 4(4) 5(5) 28 Biopsy (micro x-ray / histology) / Ultrasonography
Dudda et al. 201134 Tibia 20(20) 16(16) Until ex-fix removal Consolidation index (x-ray) / Ex-fix. duration (x-ray)
Non-operative management delayed union / nonunion
Schofer et al.  201033 Tibia 51(51) 50(50) 112 BMD (CT) / Radiological union (x-ray)
Rutten et al.  2011, 200838,39 Fibula 10(8) 10(7) 150 Radiol union (x-ray) / Clin healing; 2008, BMD (biopsy)
Operative management delayed union / nonunion
Ricardo et al. 200629 Scaphoid 11(11) 10(10) Until healed Radiol  (x-ray) / Clin healing /  Funct  recovery
Radiol. union, radiological union; Clin. healing, clinical healing; Funct. recovery, functional recovery; 
CT, computer tomography; MD-CT, multi directional computer tomography; DEXA, dual energy x-ray 
absorptiometry; SBM, serum bone markers; Ex-fix, external fixator.  
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lost patients were excluded from outcome calculations (both the numerator and 
denominator were excluded). 
Except for 1 trial29, all trials used the Sonic Accelerated Fracture Healing System 
(Exogen, Pitscataway, NJ, US) or its successor the Exogen 2000/3000 (Smith & 
Nephew Inc, Memphis, TN, USA). The LIPUS device produced a 200 μs burst of 1.5 
MHz acoustic sine waves, that repeated at a modulation frequency of 1 kHz, and 
provided a peak pressure of 30 mW/cm². The alternative ultrasound device was the 
Theramed 101-B providing the same peak pressure of 30 mW/cm² (Instituto Nacional 
de Investigaciones en Metrologia, Havana, Cuba). A daily single 20-minute treatment 
was administered on outpatient basis, with the exception of one trial using a twice-daily 
regime16. Total treatment duration varied among the trials, and was determined by 
(radiological) healed fracture, the ability to remove the external fixation, or by a pre-set 
Table 2. Methodological quality of randomized controlled clinical trials included in this systematic review 
and meta-analysis.
Trial Randomization 
Method
Sham-treatment Allocation 
concealment
Blinding Follow-up 
(%)Patients Care-givers Outcome 
assessors
Non-operative management fresh fracture
Heckman et al. 199414 Computer Yes Yes Yes Yes Yes 69
Kristiansen et al. 199715 Computer Yes Yes Yes Yes Yes 72
Strauss et al. 199816 Unclear No Unclear No No Unclear 100
Mayr et al. 200019 Random # generator No Unclear No No Yes 100
Nolte et al. 2002a37 Computer Yes Yes Yes Yes Yes 91
Rue et al. 200420 Unclear Yes Yes Yes Yes Yes 100
Lubbert et al. 200830 Computer Yes Yes Yes Yes Yes 84
Operative management fresh fracture
Emami et al. 1999a,b17,19 Unclear Yes Yes Yes Yes Yes 97
Nolte et al. 2002b37 Computer Yes Yes Yes Yes Yes 92
Leung et al. 200421 Unclear Yes Unclear Unclear Unclear Unclear 100
Handolin et al. 2005a,b26,27 Unclear Yes Yes Yes Yes Yes 100/52
Handolin et al. 2005c28 Unclear Yes Yes Yes Yes Yes 95
Zacherl et al. 200932 Dice Yes Yes Yes Yes Yes 94
Distraction osteogenesis
Tsumaki et al. 200422 Random # generator No Yes No No No 100
Schortinghuis et al. 200524 Computer Yes Yes Yes Yes Yes 100
El-Mowafi, Mohsen 200523 Unclear No Unclear Unclear Unclear Unclear 95
Schortinghuis et al 200824 Computer Yes Yes Yes Yes Yes 100
Dudda et al. 201134 Unclear No Unclear No No Unclear 100
Non-operative management delayed union / nonunion
Schofer et al. 201033 Computer Yes Yes Yes Yes Yes 83
Rutten et al. 2011, 200838,39 Computer Yes Yes Yes Yes Yes 75
Operative management delayed union / nonunion
Ricardo 200629 Unclear Yes Yes Yes Yes Yes 100
#, number 
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time frame, which ranged from 4 weeks up to 5 months (Table 1). No complications 
or adverse events were contributed to the LIPUS-treatment, and most studies reported 
good to excellent treatment compliance to LIPUS.
Bone union (radiographic outcomes)
The primary outcome measure in 9 trials was the time-to-radiographical fracture 
union, which was shown as a proportional incidence of union at several time points 
(1 to 6 week interval), rather than as a time-to-event analysis. The trial by Strauss et 
al. was published as a structured abstract only16. Contacting the author did not result 
in sufficient data information to allow pooling of the data. Data pooling of time-to-
radiographical union was performed for 9 trials, including Nolte et al. a and b (Table 
Table 2. Methodological quality of randomized controlled clinical trials included in this systematic review 
and meta-analysis.
Trial Randomization 
Method
Sham-treatment Allocation 
concealment
Blinding Follow-up 
(%)Patients Care-givers Outcome 
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Nolte et al. 2002a37 Computer Yes Yes Yes Yes Yes 91
Rue et al. 200420 Unclear Yes Yes Yes Yes Yes 100
Lubbert et al. 200830 Computer Yes Yes Yes Yes Yes 84
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Schortinghuis et al. 200524 Computer Yes Yes Yes Yes Yes 100
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Operative management delayed union / nonunion
Ricardo 200629 Unclear Yes Yes Yes Yes Yes 100
#, number 
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1)37. LIPUS reduced (p=0.0006) the mean time-to-radiological union by 42.2 days 
(95% confidence interval 66.3 to 18.1 days; I2=94%; heterogeneity P<0.00001; Figure 
3). In this heterogenic study population, most effect of LIPUS treatment was seen in 
fractures with long natural healing tendency, i.e. non-fixated fibula osteotomies37a, 
and (complex) fractures of the tibia14,21. 
Table 3 presents the GRADE description for the effect of LIPUS on radiographic 
fracture union, providing low quality evidence for acceleration of fracture union by 
LIPUS (Table 3). 
Non-operative managed fresh fractures
The effect of LIPUS on non-operative managed fresh fractures was evaluated in 7 trials 
(Table 1). Clinical healing or functional recovery was evaluated in 5 trials14,16,20,30,37, 
but  2 trials did not report the clinical outcomes separately16,37. In 5 trials, the time-to-
radiological healing was determined. LIPUS treatment was found to significantly 
reduce the time-to-union from 30% to 46% in comparison to the untreated controls. 
The trial of Nolte et al. reported the outcomes of LIPUS-treatment of the 
non-fixated osteotomized fibula37. They showed that LIPUS reduced the mean time-to-
radiographical healing by 37% (p=0.004) (mean reduction of time-to-radiological 
Study or Subgroup
Emami et al 1999
Heckman et al 1994
Kristiansen et al 1997
Leung et al 2004
Mayr et al 2000
Nolte et al 2002a
Nolte et al 2002b
Ricardo 2006
Rutten et al 2012
Total (95% CI)
Heterogeneity: Tau² = 1195.37; Chi² = 141.50, df = 8 (P < 0.00001); I² = 94%
Test for overall effect: Z = 3.43 (P = 0.0006)
Mean
155
102
51
81
42
168
112
56
80
SD
85
28
22
21
11
16
49
10
27
Total
15
33
30
16
15
29
46
10
4
198
Mean
125
190
77
140
60
266
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94
112
SD
45
107
28
31
22
26
86
16
18
Total
17
34
31
14
15
34
44
11
4
204
Weight
8.4%
9.7%
12.2%
11.7%
12.2%
12.4%
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10.4%
100.0%
IV, Random, 95% CI
30.00 [-18.04, 78.04]
-88.00 [-125.21, -50.79]
-26.00 [-38.61, -13.39]
-59.00 [-78.22, -39.78]
-18.00 [-30.45, -5.55]
-98.00 [-108.50, -87.50]
-35.00 [-64.09, -5.91]
-38.00 [-49.31, -26.69]
-32.00 [-63.80, -0.20]
-42.15 [-66.25, -18.05]
LIPUS Placebo Mean Difference Mean Difference
IV, Random, 95% CI
-100 -50 0 50 100
Favours experimental Favours control
Figure 3. Forest plot showing the effect of low-intensity pulsed ultrasound on reduction in radiographical 
healing time (days) of (operatively managed) fresh fractures, delayed unions and  nonunions.
Table 3. Grade evidence profile of randomized controlled trials evaluating LIPUS treatment for accelerated 
radiological fracture union.
# Studies 
(patients)
Limitations Consistency Directness Precision Publication 
bias
Magnitude of 
effect (95% CI)
Overall 
quality
Importance
9 (402) Serious Important 
inconsistency
Direct Adequate Potential 42.2 days 
(66.3 to 18.1)
Low Critical
CI, confidence interval.
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healing: 98 days, 95% confidence interval 87.5 to 108.5 days). LIPUS-treatment 
prevented the occurrence of symptomatic nonunions, whereas in the placebo control 
group 4 symptomatic nonunions required operative treatment, i.e. 12% of the 
controls. In the trial of Strauss et al. LIPUS-treatment reduced the time-to-clinical and 
radiographic healing of fractures of the fifth metatarsal (Jones’s fractures) by 40% 
(p-value not provided) (mean time-to-radiological healing, LIPUS treated fractures: 42 
days, controls: 70 days,)16. No failures were seen in LIPUS-treated patients, whereas 
in the placebo control group 3 failures (30%) required additional operative treatment. 
Time-to-radiological healing of tibial shaft fractures was reduced by 46.3% (mean 
time-to-radiological healing, LIPUS: 102 days, control: 190 days, mean difference 
88 days, 95% confidence interval 50.8 to 125.2 days; p=0.0001)14. Significant 
improvement of the time-to clinical healing as result of LIPUS-treatment (as evaluated by 
site-investigators) showed a mean time-to-healing 86 days in LIPUS-treated fractures, 
compared to 114 days in controls (mean difference 28 days, 95% confidence interval 
4.9 to 51.1 days; p=0.01). LIPUS reduced the mean time-to-radiological consolidation 
by 34% in distal radius fractures, i.e. from 77 to 51 days15 (mean difference 24 days, 
95% confidence interval 13.4 to 38.6 days, p<0.0002). LIPUS prevented progressive 
loss of fracture reduction. LIPUS-treatment reduced the time-to-radiological healing by 
30% in fractures of the scaphoid (mean time-to-radiological healing, LIPUS: 42 days, 
control: 60 days, mean difference 18 days, 95% confidence interval 5.6 to to 30.5 
days; p<0.05)
Data pooling of time-to-radiographical union was performed for 4 trials (combined 
patient population, n=221). LIPUS reduced (p=0.01) the mean time-to-radiological 
union by 57 days (95% confidence interval 11 to 102 days; I2=98%; heterogeneity 
P<0.00001)14,15,19,37, and provided moderate quality evidence for accelerated 
radiological fracture-union.
Two trials only reported patient important outcomes, and data on functional 
recovery did not demonstrate a beneficial effect of LIPUS20,30. Subjective clinical 
signs of fracture healing in isolated clavicle shaft fractures30 showed a mean time-to-
healing of 26.8 days in  LIPUS-treated fractures compared to 27.1 days in controls, 
with a mean difference of 0.3 days (95% confidence interval -5.3 to 5.9 days). In the 
placebo control and active treatment groups, 5 fractures did not heal and received 
operative treatment. LIPUS did not reduce the time-to-return to work (mean difference 
Table 3. Grade evidence profile of randomized controlled trials evaluating LIPUS treatment for accelerated 
radiological fracture union.
# Studies 
(patients)
Limitations Consistency Directness Precision Publication 
bias
Magnitude of 
effect (95% CI)
Overall 
quality
Importance
9 (402) Serious Important 
inconsistency
Direct Adequate Potential 42.2 days 
(66.3 to 18.1)
Low Critical
CI, confidence interval.
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-2.0 days, 95% confidence interval -6.3 to 2.4 days; p=0.38), resumption of household 
activities (mean difference 2.9 days, 95% confidence interval  -1.1 to 6.9 days; p=0.16), 
or participation in sport (mean difference 2.3 days, 95% confidence interval -0.2 to 4.7 
days; p=0.07). Treatment with LIPUS of tibial stress fractures in midshipman (aged 17 
to 20 years) did not result in earlier pain-free full weight-bearing nor return to active 
duty20 (time-to-return to work 31.5 ± 13.2 days for LIPUS-treated stress fractures 
and 27.5 ± 11.6 days for controls; mean ± SD). Both trials provided moderate quality 
evidence of no beneficial effect of LIPUS-treatment on accelerated functional recovery 
in isolated clavicula fractures and tibial stress fractures.
Operatively managed fresh fractures
Six trials reported the outcomes of operatively managed fresh fractures and LIPUS 
treated fractures. LIPUS reduced the mean time-to-radiological healing by 24% 
(mean reduction 35 days, 95% confidence interval 5.9 to 64.1 days) in closed wedge 
metaphyseal osteotomies around the knee (p=0.034)37. The effect of LIPUS was 
most pronounced in distal femur osteotomies (19 osteotomies) resulting in an 8 week 
reduction in time-to-radiological healing (p=0.019), whereas only a non-significant 3 
week reduction in healing time was seen in high tibial osteotomies (71 osteotomies, 
p=0.19). Leung et al. investigated the effect of LIPUS on isolated high energy induced 
complex or open tibial fractures treated by intramedullary reamed  nailing or external 
fixation21. Outcomes showed early disappearance of tenderness at the fracture site, 
early full weight bearing, and early removal of external fixation (time-to-external-
fixation-removal, control: 17.1. ± 8.5 weeks; LIPUS: 9.9 ± 3.8 weeks; mean ± SD; p<0.05). 
Time-to-radiographical union was 43% lower in LIPUS-treated fractures, compared to 
untreated controls (time-to-healing, control: 20 ± 4.4 weeks; LIPUS: 11.5 ± 3.0 weeks; 
mean ± SD; p<0.05). LIPUS significantly increased bone mineral density (BMD) at 6, 
15, 18, and 21 weeks of treatment (p<0.05). Only one delayed union occurred in the 
active group, whereas 2 nonunions occurred in the control group. LIPUS-treatment of 
closed or Grade I (Gustillo) open diaphyseal tibial fracture with reamed intramedullary 
(locked) nailing17, did not affect the time-to-radiographical union (control: 125 ± 11 
days; LIPUS: 155 ± 22; mean ± SEM; p=0.76). Most patients tolerated full weight on 
the fractured leg prior to radiologic healing because of the stability achieved by the 
locked intramedullary nail. No difference was seen in time from fracture to full weight 
bearing. All fractures healed, although in 7 patients (2 controls, and 5 LIPUS-treated 
patients) time-to-union exceeded six months. No difference in serum bone formation 
markers was seen18. Data pooled for radiological time-to-healing from 3 trials17,21,32 
showed that LIPUS reduced (not significant, p=0.22) time-to-radiographical healing 
by 26.7 days (95% confidence interval -69.0 to +15.9 days; I2=83%; heterogeneity 
120
Enhancement of bone healing by LIPUS, a meta-analysis
Chapter
7
P<0.003), and therefore provided very low quality evidence of a lack of beneficial 
effect on operatively managed fresh fractures. 
Two trials with a total of 52 patients focused on LIPUS-treatment of lateral malleolar 
fractures (weber B) fixed with bio-absorbable screws. These trials could not demonstrate 
any difference between active and control groups with plane x-ray evaluation26,28. In 
the 12 week evaluation period, only a gradually fading endosteal fracture was visible 
on the x-rays, rather than cortical bridging callus, due to the rigid fracture fixation and 
anatomical reduction. BMD measurement of a pre-determined area of 50 mm2 of 
the distal fibula, which included the fracture site, could not demonstrate a difference 
in BMD between active and placebo26, but also no difference between BMD at the 
time of surgery and 12 weeks post-operative was seen. Follow-up at 18 months to 
assess functional recovery in 16 participants (47% lost to follow-up) using the Olerud-
Molander-score and clinical examination did not show  a difference between active 
treatment and placebo control treatment27. All fractures healed uneventfully, and no 
re-displacements were observed as evaluated by multidetector-computed tomography 
(MD-CT)27. Another study by Handolin and colleagues utilizing MD-CT scanning for 
more sensitive measurement of fracture union28 could not demonstrate a difference 
between bridged endosteal fracture line of LIPUS-treated and untreated controls. 
Weight-bearing (partial) was allowed according to a preset trial regime, and no 
data was presented for clinical signs of fracture healing. The use of LIPUS in adjunct 
to a chevron osteotomy for hallux valgus correction32 did not show differences in 
subjective outcomes measures as satisfaction, pain experience, reduced sick leave, and 
functional outcome assessment by the hallux-metatarsophalangeal-interphalangeal-
scale. No failures were reported, and only the DMMA stayed more stable from 6 
weeks post-surgery up to 1 year follow-up (p=0.046) as a result of LIPUS-treatment, 
suggesting less loss of correction.
Distraction osteogenesis
Mandible vertical distraction osteogenesis is used to augment the atrophic mandible 
before inserting dental implants. In 2 studies by Schortinghuis et al. (17 patients)24,31, 
biopsies were taken 4 weeks post-mandible distraction osteogenesis. Microradiographs 
taken of the biopsies showed no difference in gap fill length or gap gray percentage 
between LIPUS-treated mandibles and sham-treated controls. Histological analysis 
showed similar type and amount of bone formation towards the center of the 
distraction gap in both treatment groups. Mineral apposition rate, indicative for 
the rate of new bone formation, could not be accurately measured. Additional 
ultrasonographic monitoring of increased mineralization and advanced bridging of 
the distraction gap did not show differences between treatment and control groups 
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during the 4 week distraction period31. All dental implantations were successful after 
augmentation, and no adverse events or failures were reported. 
LIPUS shows acceleration of callus maturation in opening-wedge high tibial 
osteotomies over a 4 week consolidation period, resulting in a mean increase of 54% 
(p=0.02) in BMD22. No difference was found in time-to-safe removal of external 
fixation after the consolidation phase (time-to removal of external fixation, control: 
7.9 ± 2.4 weeks; LIPUS: 7.1 ± 2.6 weeks, Mean ± SD; p-value not provided), nor in 
the total duration of external fixation. Two trials (65 patients) report the outcomes 
of LIPUS-treatment on distraction osteogenesis and bone transportation of (late) 
posttraumatic tibial defects, and congenital anterolateral bowing (2 patients)23,24. 
Both trials report random allocation of LIPUS-treatment versus placebo treatment (no 
sham-treatment), but they do not clarify how this was achieved, nor do they explicitly 
report the blinding of the outcome assessors.  External fixation was removed after 
radiologic consolidation of the distraction gap had occurred. The outcomes were 
expressed as time-to-union (in days) divided by the length of the distraction gap, 
resulting in a distraction consolidation index23,24. The trial by El-Mowafi et al. showed 
a 38% lower mean time-to-consolidation per cm distraction of 30 ± 2.0 days/cm for 
LIPUS-treated defects compared to 48 ± 9.8 days/cm for untreated controls (p<0.001). 
One delayed union occurred in the control group. Dudda and collages found a 
similar24, but non-significant decrease in consolidation index for LIPUS-treated defects 
of 32.8 ± 13.1 days/cm, compared to 44.6 ± 26.8 days/cm for controls (p=0.116). 
The results further indicated a shorter mean fixator gestation period by 45.6 days 
after LIPUS-treatment (control: 262.2 days; LIPUS: 218.6 days)24, but no p-value was 
provided. Pooled data of distraction consolidation index revealed a decrease of 16.8 
days/cm (p<0.001)  as result of LIPUS-treatment (95% confidence interval 10.8 to 
22.7 days/cm; I2=0%; heterogeneity P=0.42). Very low quality evidence indicated that 
LIPUS accelerates callus maturation and/or bone formation in distraction osteogenesis 
and bone transportation of the tibia22-24.
Delayed and/or impaired fracture healing
The effectiveness of LIPUS-treatment in delayed and/or impaired fracture healing is 
evaluated in 3 trials with double-blinding and sham-treatment with a placebo device. 
Ricardo et al. evaluated the combined effect of LIPUS and vascularized pedicle bone 
graft for established scaphoid nonunions29. Clinical and radiological healing combined 
showed a 40% mean reduction in healing time (time-to-healing, control: 94 ± 4.8 days; 
LIPUS: 56 ± 3.2 days; mean ± SEM; p<0.0001). All nonunions healed, and 50% of the 
patients (11) returned to their pre-injury functional and occupational level, although 
active or placebo-treatment was not specified. 
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LIPUS-treatment for 16 weeks resulted in increased bone formation in delayed 
unions of the tibial shaft as demonstrated by a significant increase in BMD of 34% 
(90% confidence interval 14 to 57%; p=0.002)33, and a mean reduction in fracture 
gap area of 0.45 mm2 (90% confidence interval 0.05 to 0.86 mm2; p=0.03). At the 
end of the 16 week treatment period, 65% of the LIPUS-treated delayed unions 
were healed compared to 47% of the sham-treated controls (p=0.07). Rutten et al. 
evaluated the effect of 5 months of LIPUS-treatment as the only treatment option 
for delayed unions of the non-fixated osteotomized fibula38. They found that 57% 
of LIPUS-treated delayed unions healed compared to 50% of controls. One year after 
treatment start, the number of healed cases remained 57% in the LIPUS-treated delayed 
unions, whereas in the control group 88% of the delayed unions showed healing. 
Time-to-union was decreased (not significant) by a mean of 32.0 days after 5 months 
of LIPUS-treatment (95% confidence interval 0.2 to 63.8 days; control: 4, LIPUS: 4; 
p=0.083), and significantly decreased by 107.0 days 1 year after start (95% confidence 
interval 40.2 to 173.9 days; control: 7, LIPUS: 4; p=0.023). Biopsies taken at 2 to 3 
months of treatment indicated increased bone formation after LIPUS-treatment39. At 
the front of new bony callus formation, LIPUS significantly increased osteoid thickness 
by 47% (p=0.04), mineral apposition rate by 27% (p=0.04), and bone volume by 33% 
(p=0.023).
High quality evidence from 2 trials shows enhancement of bone healing through 
increased bone formation by LIPUS-treatment in delayed and/or impaired fracture 
healing33,38. Pooled data of time-to-radiographical union, shows a mean reduction 
in time to healing of 37.3 days (95% confidence interval 26.7 to 50.0 days; I2=0%; 
heterogeneity P=0.73) after LIPUS-treatment in operative and non-operatively treated 
delayed unions and nonunions29,38, providing low quality evidence for accelerated 
bone healing in delayed or impaired fracture healing by LIPUS.
DISCUSSION
A previously performed systematic review and meta-analysis of randomized trials 
demonstrated the need for large trials of high methodological quality, focusing on 
patient important outcomes such as quality of life and return-to-function to determine 
the role of LIPUS in fracture management3. Four trials were published since, and only 
1 reported patient important outcomes such as return-to-function. In our systematic 
review and meta-analysis we evaluated the current evidence of the effectiveness 
of LIPUS in fracture union and functional recovery. Our study is strengthened by 
a comprehensive search of articles in any language, duplicate assessment of study 
quality, and inclusion of only randomized trials. In total 20 trials were included utilizing 
LIPUS for the enhancement of bone healing for varied types of fractures, osteotomies, 
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distraction osteogenesis, and delayed and/or impaired fracture healing. Nonetheless 
the analysis has limitations, i.e. the study quality varied, and some trials provided 
serious methodological limitations. Primary outcome measures were diverse; in 12 
trials LIPUS demonstrated a beneficial effect on bone healing14-16,19-23,29,33,34,37,38, 
whereas in 8 trials no effect was seen1,20,24,26-28,30-32. Low quality evidence was 
found for accelerated fracture union by LIPUS14,15,17,19,21,29,37,38, whereas 2 
trials provided moderate quality evidence of a lack of beneficial effect of LIPUS on 
functional recovery20,30. In general, the clinical goal for fracture healing is the early 
return to patient’s pre-injury functional level. Fracture union is the key factor in the 
restoration of function. Fracture union however does not guarantee a full restoration 
to pre-injury functionality level. Fracture characteristics, initial treatment modality, and 
patient co-morbidity play an important role in time-to-functional recovery or return-to-
pre-injury functional level41. 
Low quality evidence suggests accelerated callus maturization in distraction 
osteogenesis22-24, and high quality evidence from 2 trials suggests enhancement 
of fracture healing through increased bone formation by LIPUS in delayed and/or 
impaired fracture healing33,38. Increase of bone formation and acceleration of callus 
maturation may  result in advanced fracture bridging and increased fracture stability, 
allowing early functional exercise and use. Furthermore it may positively influence 
functional outcome by reducing the chance of loss of fracture reduction as seen in 2 
clinical trials15,32. 
Implications for clinical practice and research
In this heterogenic trial population of fresh fractures and/or osteotomies, distraction 
osteogenesis, and delayed/non-unions, most reduction in time-to-radiological union by 
LIPUS was seen in fractures with long natural healing tendency, i.e. non-fixated fibula 
osteotomies37, and (complex) fractures of the tibia14,21. In operatively managed fresh 
fractures, LIPUS did not accelerate fracture union, i.e. reamed intra-medullary nailing17, 
lateral malleolar fractures26-28, or closed wedge high tibial osteotomies37. In most 
cases the natural healing tendency was already good en no delayed union occurred. 
Occurrence of delayed union/nonunion was reported in 5 studies16,17,21,30,37, but 
only 3 studies suggested a positive effect of LIPUS on prevention of impaired healing.
Ideally any future high quality randomized controlled clinical trial should report on 
subjective signs of clinical healing, functional recovery, as well as radiographical union, 
to determine LIPUS’ effectiveness and clinical role in bone healing. Impaired fracture 
healing in particular may benefit most from LIPUS’ bone healing capacity, since 90% 
of all fractures already heal spontaneously within 3 months after initial surgical or 
nonsurgical treatment1. In contrast to fresh fracture healing, randomized controlled 
trials evaluating the effect of LIPUS on impaired bone healing may still be regarded 
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as unethical, because they withhold the patient in the control group from any form 
of treatment, and it is questionable if these trials will ever be performed. In order to 
determine the role of LIPUS in bone healing in daily clinical practice, large trials of high 
methodological quality are still required, specifically for delayed and/or impaired bone 
healing.
Conclusion
Our systematic review and meta-analysis indicates that LIPUS is effective in reducing 
the time-to-radiographical fracture union. Only few trials report on the effect of LIPUS 
on functional recovery in bone healing, and could not demonstrate a beneficial effect. 
Although decreased time-to-radiographical union may allow for earlier functional use, 
future studies of high quality reporting functional outcome are needed to reliably 
confirm the effectiveness of LIPUS in clinical bone healing. 
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GENERAL DISCUSSION
Bone healing or fracture healing is a proliferative physiological process in which 
the body facilitates the repair of a bone fracture. The majority of clinical fractures 
heal spontaneously after initial surgical or non-surgical treatment, nevertheless 
5-10% of fractures show a delay in healing1. Impairment of fracture healing leads 
to a delay in union or may even result in nonunion. Impaired fracture healing has a 
significant socioeconomical impact, and may lead to a personal tragedy2. Nowadays, 
enhancement and acceleration of fracture healing in order to prevent a delay in union 
or to treat impaired fracture healing forms a multi-billion industry3. Low-intensity 
pulsed ultrasound (LIPUS) forms one of the currently available non-invasive bone 
healing enhancing devices. LIPUS (30 mW/cm2) is a form of mechanical energy 
transmitted transcutaneously at the fracture site by high-frequency acoustic pressure 
waves4. The micro-mechanical stress produced by LIPUS may provide a surrogate for 
the forces normally applied on bone by physical loading according to Wolff’s law5,6. 
The exact mechanism by which LIPUS affects clinical bone healing is however still 
unknown. The general aim of this thesis is to examine the effect of LIPUS-treatment on 
delayed and/or impaired clinical fracture healing at the tissue level, and to determine 
its effectiveness on acceleration and healing of fractures, more specifically on the 
delayed and/or impaired clinical fracture healing, in order to make suggestions for 
future treatment considerations and clinical applications. 
In this general discussion the clinical outcomes and basic science results described 
in this thesis are integrated to enable a better understanding of the effect of LIPUS 
on bone healing, in particular on impaired and/or delayed bone healing. The current 
evidence of the effectiveness of LIPUS in bone healing has led a better specification of 
its clinical role and to new considerations for future scientific investigation. 
LIPUS-treatment for delayed and/or impaired fracture healing
Impaired or delayed fracture healing has a significant impact on the individual and 
can prevent the patient from functioning normally. The primary goal of treatment 
is to establish early bony union, in order to allow fast functional recovery and/or 
resumption of all activities. Fractures of the tibia are the most common fractures in 
long bones, with a relatively high delayed union rate, and a nonunion rate up to 3%7. 
Surgical treatment, providing stabilization with internal or external fixation devices, 
and removing the necrotic bone tissue with or without bone grafting remains the 
choice of most surgeons8. Success is however not always guaranteed, and it is not 
uncommon that more than one surgical intervention is required. In Chapter 2, we have 
evaluated the clinical use of LIPUS for established tibial nonunions in The Netherlands. 
All tibial nonunions were consecutively treated cases in The Netherlands, and patients 
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received LIPUS-treatment from January 2000 to February 2003. LIPUS was the only 
new interventional treatment, and strict criteria of enrollment were set to minimize the 
chance of spontaneous healing. The natural healing percentage ranges from 5% to 
30%9,10. Treatment of tibial nonunions with LIPUS shows a healing rate of 73%, which 
agrees with  previous reports on the effect of LIPUS-treatment of nonunions11-13. The 
major advantage of LIPUS-treatment over surgical therapy is that it is not associated 
with any risk or co-morbidity. Furthermore, daily LIPUS-treatment takes only 20 minutes, 
resulting in a high level of patient compliance. Finally LIPUS-treatment is performed on 
an outpatient basis and therefore does not require hospitalization. The evaluation of 
71 consecutive LIPUS-treated tibial nonunions provided us with new information on 
the use of LIPUS in daily clinical practice in The Netherlands. The outcomes support 
the use of LIPUS-treatment for tibial nonunions, and thus LIPUS-treatment can be seen 
as a good, safe, and cost-effective alternative to surgery. The quality of the self-paired 
study design used is however inferior to a randomized prospective study design. 
Medical ethical considerations play an important role in trial design; it is considered 
unethical to provide placebo treatment over a prolonged period of time when fracture 
healing is already delayed. 
The osteotomized fibula has a tendency of impaired healing resulting in delayed 
union14, thereby providing a unique clinical model, that enables placebo treatment 
without direct negative consequences and/or conflicting ethical issues. By utilizing the 
fibula delayed union model, we conducted a prospective randomized double-blind trial 
to examine the isolated effect of LIPUS-treatment on delayed and/or impaired clinical 
fracture healing (Chapter 3). In contrast to our earlier findings in tibial nonunions, 
LIPUS-treatment of delayed unions of the non-fixated fibula during 5 months only 
demonstrated 57% healed cases compared to 50% healed cases of the untreated 
controls. The cause of impaired fracture healing is multi-factorial, i.e. initial fracture 
severity, stability, as well as patient-related co-morbidity may play an important role in 
the final outcome and time-to-healing15. Although a small amount of the axial-load is 
transferred to the fibula, it will result in shear and translational forces at the oblique 
osteotomy, making it prone for impairment of fracture healing16. Adequate stability 
is one of the principles in fracture healing17. In the case series of tibial nonunions 
that were successfully treated with LIPUS, delayed union stability was maintained 
by earlier performed operative fixation or conservative cast/brace immobilization18. 
The identification of related co-factors negatively influencing fracture healing and 
outcome may provide an indication of the expected success rate of LIPUS-therapy. 
One year after start of LIPUS-treatment, the time-to-(radiological)-healing of fibula 
delayed unions was significantly decreased by LIPUS-treatment (p=0.023), which is 
in line with the previously reported accelerating effect of LIPUS on fresh fracture 
healing19,20. Acceleration of delayed fracture healing by LIPUS was slightly but not 
significantly increased at the end of a 5 months LIPUS-treatment when compared to 
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sham-treatment, which is  probably due to the low number of healed delayed unions 
available for analysis at 5 months of treatment. Functional outcome evaluation was 
biased by the fact that a biopsy was taken during the treatment phase. Although of 
significant importance to evaluate the effectiveness of clinical therapies, functional 
outcome evaluation was less suited to evaluate the effectiveness of LIPUS on the 
enhancement of fracture healing in the delayed unions of the fibula. LIPUS-treatment 
may therefore provide a valuable contribution to the acceleration of delayed and/or 
impaired fracture healing, but when sufficient fracture stability is absent it may not 
result in  enhancement of fracture union, as shown in the non-fixated delayed union 
of the fibula.
Effect of LIPUS on delayed and/or impaired bone healing at the tissue 
level  
Fracture healing is modulated in response to external stimuli, such as growth factors, 
hormones, and mechanical forces1,21. Although the strain induced by LIPUS at the 
tissue level is several orders of magnitude lower than the peak strains generated by 
functional load bearing22, high-frequency low-magnitude strains can result in strong 
regulatory signals to bone tissue23-25. In Chapters 4,5, and 6 we have investigated 
the effect of LIPUS on bone healing at the tissue level in patients with a delayed 
union of the osteotomized fibula, by using histology, immunohistochemistry, and 
histomorphometric analysis, to determine the effect of LIPUS on bone formation and 
resorption parameters, osteogenic cell presence, and  vascularity and angiogenesis. 
In Chapter 4, we report for the first time on the influence of LIPUS-treatment on 
clinical fracture healing at the tissue level, in patients treated in a randomized double-
blind clinical trial. Although clinical fracture healing was delayed, all retrieved biopsies 
showed a vital fracture and new bony callus formation. LIPUS-treatment resulted in a 
significant increase in bone volume of the newly formed bony callus, and a significant 
increase in osteoid thickness at the front of new bony callus formation. The increase 
in osteoid thickness as a result of increased osteoid apposition suggests an anabolic 
effect of LIPUS on the activity of osteoblasts. Cultured mouse bone marrow-derived 
ST2 cells have been shown to respond to LIPUS with elevated levels of IGF, osteocalcin, 
and bone sialoprotein mRNA, suggesting that LIPUS induces a direct anabolic 
reaction of osteogenic cells leading to bone matrix formation26. LIPUS did not affect 
osteoblast activity in the area of cancellous bone nor in the area of cortical bone. 
These findings could relate to LIPUS specifically affecting osteoblast differentiation 
as has been suggested previously27,28, but it is also possible that a large part of the 
given energy remitted by LIPUS does not penetrate the intact bone29,30. Interestingly, 
the biopsy retrieved from one LIPUS-treated delayed union showing partial bridging 
of the fracture ends did not show increased osteoblast activity when compared to the 
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other LIPUS-treated delayed unions. This suggests that LIPUS is effective in stimulating 
osteoid deposition at the front of bony callus formation during the consolidation 
phase, but that it has little or no effect on bone remodeling.
Osteogenic cell proliferation and differentiation play an important role in adequate 
fracture healing, and is target for osteoinductive therapies in delayed fracture 
healing. In Chapter 5, we have investigated how LIPUS would effect the presence 
of RUNX2 immunopositive osteogenic cells in delayed unions of the osteotomized 
fibula. RUNX2 is regarded as the master gene of osteogenic cell differentiation and 
bone matrix production. RUNX2 is a transcription factor, required for the activation of 
osteoblast differentiation and is crucial for the regulation of genes responsible for the 
production of bone specific proteins (collagen type 1, osteocalcin, osteopontin and 
bone sialoprotein)31,32. Without RUNX2 expression no bone will be formed. In this 
study immunolocalization of RUNX2 as an early bone cell marker was performed to 
determine the presence of osteogenic cells. RUNX2 is also thought to be the target of 
a mechanical signal by which physical stimulation dictates the cellular and metabolic 
activities of osteoblasts33. Stimulation of rat bone marrow stromal cells and human 
osteoblasts with LIPUS resulted in a time-dependant increase in cellular RUNX2 
expression34. It is therefore possible that LIPUS affects fracture healing by affecting 
RUNX2 expressing cells. Mechanical adaptive modeling can promote bone tissue 
formation by a proliferative response or by a direct anabolic effect on bone cells26. 
In Chapter 5, histomorphometrical analysis was performed to determine the number 
of cells expressing RUNX2 located within and around the newly formed woven bone 
at the fracture end and up to 3 mm distant from the fracture end. Cells expressing 
RUNX2 were present in all histological sections evaluated in both atrophic and 
hypertrophic delayed unions. Although clinical fracture healing was impaired in the 
delayed unions of the osteotomized fibula, impaired clinical fracture healing therefore 
does not result in impairment of osteogenic cell proliferation and/or osteoblast 
differentiation at the tissue level.  These findings show that the previously reported 
increased bone formation in delayed unions of the human fibula by LIPUS-treatment 
(Chapter 4) is not associated with an increase in the osteogenic cell population. 
Although osteogenic cell proliferation plays an important role in the fracture healing 
response1,35, the enhancement of cell proliferation may be limited to the early phase of 
fracture healing when cell proliferation is most active. LIPUS-treatment of fetal mouse 
metatarsal rudiments in vitro has been shown to stimulate endochondral ossification, 
which resulted from a direct effect of LIPUS on osteoblasts and ossifying cartilage by 
stimulation of cell activity and/or differentiation, but not proliferation27,28. 
No immunopositive staining was seen in osteocytes at 1.2 mm distance from 
the fracture end in LIPUS-treated delayed unions, whereas in the control group 
immunopositive staining of osteocytes remained up to 3 mm distance from the fracture 
ends (Chapter 5). LIPUS may have a direct effect on osteogenic cells by stimulating 
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osteoblastic differentiation, but it may also indirectly affect osteogenic cell proliferation 
and differentiation through affecting osteocytes. Osteocytes are believed to perceive 
the stress put on the bone tissue leading to deformation (strain) and to transfer signals 
through their canalicular network to the effector cells at the bone surface, the bone 
forming osteoblasts and bone degrading osteoclasts38. Therefore our findings may 
illustrate an effect of LIPUS on osteocytes, resulting in terminal differentiation of these 
cells and inhibiting a proliferative response. Among the controls, no difference was 
seen in the number of cells expressing RUNX2 within the soft connective tissue of 
the atrophic delayed union when compared to the other hypertrophic delayed unions. 
The etiology of atrophic nonunion is not well understood; they are often thought to 
be non-reactive and metabolically inactive. However, our findings show that impaired 
fracture healing does not lead to a decline in the number of osteogenic cells, even 
if the fracture is radiographical regarded as atrophic. Furthermore an increase in 
osteogenic cell population does not necessary relate to increased bone formation 
as may be concluded when comparing the outcomes from the studies described in 
Chapters 4 and 5. Inducing fracture healing in atrophic nonunions by osteoinductive 
therapies1, should be carefully considered since the number of osteogenic precursor 
cells in delayed union does not seem to correlate with increased bone formation and 
number of osteoblasts. 
Several studies suggest a relationship between mechanical loading and 
angiogenesis36-38. Treatment of fractures with vascular endothelial growth factor 
(VEGF) improves bone healing, leading to improved mechanical strength and increased 
callus mineralization39. In Chapter 6, we investigated whether LIPUS increases 
vascularity and blood flow in delayed-unions of the osteotomized fibula, and if 
LIPUS-increased bone formation is correlated to increased vascularity and blood flow. 
LIPUS significantly increased blood vessel size, but only slightly increased the number 
of blood vessels within the area of newly formed bony callus. LIPUS increased blood 
flow around the fracture site in a dog osteotomized ulna fracture model, suggesting 
that LIPUS stimulates vascularity during fracture healing40. The rate of the blood flow 
is directly proportional to the fourth power of the vessel radius (Poiseuille’s Law), 
which indicates that the blood vessel diameter is a determinant factor in the rate of 
blood flow through a vessel. LIPUS therefore likely improves blood supply by enlarging 
blood vessel size. Increased blood flow around the fracture site, resulting in a oxygenic 
environment, may lead to intramembranous bone formation through differentiation 
of mesenchymal cells into osteoblasts, but not chondrocytes41, and could provide 
an explanation for the endosteal callus formation without a cartilage intermediate 
as observed in the LIPUS-treated delayed unions, while in untreated controls only 
endochondral bone formation was observed (Chapter 4). 
Excess motion at the fracture site of fibular bone is related to disruption of 
vasculature and blood supply. Alterations in the mechanical environment by advanced 
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union and/or increased bone volume of the bone fracture ends could therefore enable 
blood vessel formation and invasion of the fibrous and/or cartilaginous tissue within 
the fracture gap, leading to a more favorable environment for direct bone formation. 
LIPUS-treatment stimulated bone bridging at the fracture site in a rat closed femoral 
fracture model4. The stimulation of bridging by LIPUS was accompanied by a significant 
increase in maximum torque and stiffness4. The key elements blood supply and 
stability ensure the timely and accurate reconstitution of bone tissue37. Angiogenesis 
is required for osteogenesis37. The failed-to-heal delayed-unions did not demonstrate 
a significant correlation between vessel parameter and osteoid, suggesting that blood 
flow and perfusion was not sufficient (Chapter 6). LIPUS therefore improves blood 
supply in bone from patients with a delayed union of the osteotomized fibula by 
increasing blood vessel size, which is essential for accelerated fracture healing. 
LIPUS stimulation of delayed unions of the osteotomized fibula
Our findings show that the micromechanical energy of LIPUS is effectively delivered 
at the fracture site. It induces an anabolic response by the osteblasts, stimulates 
osteogenic cell differentiation, and increases vascularity. The micromechanical strain 
does not seem to affect osteoblast activity in the older callus or pre-existing bone. 
Interestingly the osteogenic cell presence in delayed unions/or nonunion is not 
diminished, even if in delayed unions with a radiological atrophic aspect. The Increased 
bone formation seen after 2 to 3 months of LIPUS-treatment of delayed unions of 
the osteotomized fibula did not guarantee fracture healing at 5 months, nor at 1 
year. The failed-to-heal delayed-unions did not demonstrate a significant correlation 
between vascularity and bone formation, suggesting that blood flow and perfusion 
was not sufficient. LIPUS-treatment can therefore accelerate delayed and/or impaired 
fracture healing, but when sufficient fracture stability is absent it may not result in 
enhancement of fracture union, as in the non-fixated delayed union of the fibula. 
Current clinical evidence on the enhancement of bone healing by 
LIPUS
LIPUS is frequently used to enhance or accelerate fracture healing, but its clinical 
role and effectiveness as a treatment modality remains uncertain. In Chapter 7, we 
carried out a systematic review and meta-analysis of randomized controlled trials to 
determine the efficiency of LIPUS on bone healing and/or fracture union, as well as 
functional recovery. The search resulted in 20 unique randomized trials, of which 2 
trials were original work by the authors. In 9 studies the time-to-radiographic fracture 
union was the primary outcome measure evaluated, and pooling of the data was 
performed. Evidence of low quality (GRADE42) showed an overall beneficial effect of 
LIPUS-treatment with a mean reduction in radiological healing time of 42.2 days (95% 
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Confidence interval 18.1 to 66.3 days; I2=94%; heterogeneity P<0.00001) in favor of 
LIPUS-treatment (p=0.0006). In the heterogenic study population, LIPUS-treatment 
was most effective in fractures with long natural healing tendency, i.e. non-fixated 
fibula osteotomies14, and complex fractures of the tibia19,43. Operatively managed 
fresh fractures, i.e reamed intra-medullary nailing44, lateral malleolar fractures45,46, 
and closed wedge high tibial osteotomies14 treated with LIPUS did not demonstrate 
accelerated radiographical healing. In most cases the natural healing tendency was 
good en no delayed union occurred. Few studies reported on the effectiveness of 
LIPUS on delayed and/or impaired fracture healing. Only 1 trial (Chapter 3) reports on 
the clinical acceleration and isolated effect of LIPUS, whereas one other trial reports 
on the combined effect of LIPUS and vascularized pedicle bone graft for established 
scaphoid nonunions. Both trials show acceleration of radiographical union as result 
of LIPUS-treatment. High quality evidence from 2 trials suggests enhancement of 
fracture healing through increased bone formation by LIPUS in delayed and/or 
impaired fracture healing. Two trials primarily evaluating functional recovery could not 
demonstrate a beneficial effect of LIPUS. Although decreased time-to-radiographical 
union may allow for earlier functional use, future studies of high quality should focus 
on functional outcome needed to firmly establish the clinical effectiveness of LIPUS in 
fracture healing. 
Clinical implication for LIPUS
LIPUS may form a useful adjuvant to accelerate fracture union. It is save, effective, 
and easy applicable, taking only 20-minutes a day on outpatient basis, and its use 
is accompanied by an excellent rate of patient compliance. Recently The National 
Institute for Health and Clinical Excellence (NICE) has advised healthcare professionals 
in the UK that the use of LIPUS technology represents a safe and effective treatment 
option to reduce the healing time in patients with bone fractures47. Since only 5-10% 
of fractures show a delay, and most fractures heal spontaneously within 3 months 
after initial surgical or nonsurgical treatment1, the need for accelerated fracture 
healing may be limited. For those fractures with prolonged natural healing tendency, 
LIPUS-treatment may result in ~40% decrease in time-to-healing19. LIPUS enhances 
bone formation in delayed and impaired fracture healing (Chapter 4). It may be 
a good alternative to surgical therapy, since it is associated with a reduced risk of 
complications. Numerous factors are known contributing to impaired healing, that 
are related to the initial trauma, fracture treatment, and patient co-morbidity. Careful 
assessment and identification of the co-factors negatively influencing fracture repair 
may be essential to determine the beneficial effect of LIPUS, as demonstrated in the 
non-fixated delayed union of the fibula (Chapter 3). The surgical principle in fracture 
healing, i.e. sufficient fracture stability, remains of vital importance in adequate 
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fracture treatment. LIPUS may form and excellent treatment modality to optimalize 
bone healing, even if fracture healing is delayed and/or impaired.
Conclusions
Impaired fracture healing has a significant socioeconomical impact, and may lead to 
a personal tragedy. Tibia nonunions have a high occurrence rate and  impair daily 
functioning. LIPUS is effective in the treatment of established tibia nonunions and can 
be regarded as a good, safe, and cost-effective alternative to surgery (Chapter 2). The 
osteotomized non-fixated fibula, as part of a high tibial osteotomy, shows a tendency 
of delayed union and forms a unique clinical model enabling sham LIPUS-treatment in 
a randomized controlled double blinded trial. We have shown that LIPUS-treatment is 
effective in accelerating delayed and/or impaired fracture healing. However LIPUS as a 
single treatment option  does not directly contribute to improved fracture union when 
sufficient stability is absent as in the non-fixated delayed union of the fibula (Chapter 
3). The identification of related co-factors negatively influencing fracture healing and 
outcome may provide an indication of the expected success rate of LIPUS-therapy. The 
positive effect of LIPUS on fracture healing is caused by a stimulation of the different 
cellular processes involved in fracture repair and bone formation. 
At the tissue level, LIPUS-treatment accelerates clinical fracture healing of delayed 
unions of the fibula as shown by increased osteoid thickness, mineral apposition 
rate, and bone volume, indicating enhanced osteoblast activity, at the front of new 
bony callus formation (Chapter 4). Improved stability and/or increased blood flow, 
but probably not increased angiogenesis, might explain the differences in ossification 
modes between LIPUS-treated delayed unions and untreated controls. Furthermore 
immunolocalization of RUNX2-positive cells in delayed unions of the fibula reveals 
that delayed clinical fracture healing does not result in impairment of osteogenic 
cell proliferation and/or differentiation at the tissue level, even if delayed unions are 
clinically regarded as atrophic (Chapter 5). Reduced numbers of osteogenic RUNX2 
immunopositive cells within the soft connective tissue, and unchanged numbers 
of RUNX2 immunopositive cells at the bone surface, implicate that LIPUS does not 
increase osteogenic cell presence, but likely affects osteogenic cell differentiation. 
Finally, LIPUS-treatment improves blood supply in bone from patients with a delayed-
union of the osteotomized fibula by increasing blood vessel size, which is essential 
for accelerated fracture healing (Chapter 6). An increased osteoid volume in healed 
delayed-unions, LIPUS-stimulated delayed-unions, and sham-treated delayed-unions, 
can largely be explained by increased blood flow and perfusion. LIPUS only enhances 
fracture healing in patients showing a correlation between vascularization and osteoid 
volume at the tissue level, but not in patients in which this correlation is lacking. 
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Systematic review and meta-analysis of randomized controlled trials shows that 
LIPUS-treatment is effective in reducing the time-to-radiographical fracture union 
(Chapter 7). Most reduction in time-to-radiological union by LIPUS was seen in 
fractures with a long natural healing tendency, i.e. non-fixated fibula osteotomy, 
and (complex) fracture of the tibia. Only few studies evaluating functional recovery 
could not demonstrate a beneficial effect by LIPUS-treatment. A decreased time-to-
radiographical union resulting from LIPUS treatment may allow for earlier functional 
use, but future studies of high quality should focus on the functional outcome to 
reliably confirm the clinical effectiveness of LIPUS in bone healing. Note that fracture 
union is essential for functional recovery, but does not guarantee functional recovery.
In summary, LIPUS treatment provides a valuable contribution to enhancing delayed 
bone healing and/or fractures with long natural healing tendency by increasing bone 
formation and blood flow at and to the fracture site, resulting in accelerated bone 
healing and significant reduction in time-to-healing. Co-factors negatively influencing 
fracture healing, such as insufficient stability, may diminish the enhancing capacities of 
LIPUS on fracture union.
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GENERAL SUMMARY
The bones in our body form a unique organ providing structural support, protection 
of vital organs, housing of marrow, and participation in mineral homeostasis. Bone 
is a living tissue and is characterized by the constant adaptation to its mechanical 
loading environment. Bone cells are sensitive to strains caused by physical loading. 
Mechanoreceptors convert biophysical stimuli into biochemical responses that alter 
gene expression and cellular adaptation. Fracture healing is a complex process 
requiring the recruitment of the appropriate cells and expression of the appropriate 
genes at the right time in the right place. The majority of clinical fractures heal 
spontaneously after initial surgical or non-surgical treatment, nevertheless 5-10% 
of fractures show a delay in healing. Fracture healing is modulated in response to 
external stimuli, such as growth factors, hormones, and mechanical forces. Insight in 
the molecular biological mechanisms involved in fracture healing has resulted in the 
development of new treatment modalities for impaired fracture healing, such as bone 
morphogenic proteins, extracorporeal shock wave treatment, electro-stimulation, and 
low-intensity pulsed ultrasound (LIPUS). LIPUS (30 mW/cm2) is a form of mechanical 
energy transmitted transcutaneously by high-frequency acoustic pressure waves, which 
may provide a surrogate for the forces normally applied on bone by physical loading 
according to Wolff’s law. LIPUS has shown to enhances and/or accelerates (impaired) 
clinical fracture healing, and the positive effect of LIPUS on fracture healing may be 
caused by a stimulation of the different cellular processes involved in fracture repair 
and bone formation, such as angiogenesis, chondrogenesis, and intramembranous 
and endochondral ossification. The exact mechanism by which LIPUS affects clinical 
bone healing is however still unknown. 
This thesis examined the effectiveness of LIPUS-treatment on delayed and/
or impaired clinical fracture healing at the tissue level, as well as determined its 
effectiveness on acceleration and healing of delayed and/or impaired clinical fractures, 
in order to make suggestions for future treatment considerations and clinical 
applications. We hypothesized that low-intensity pulsed ultrasound accelerates and/or 
enhances delayed and/or impaired fracture healing in patients at the bone tissue level 
by positively affecting different stages of cellular processes involved in fracture repair 
and bone formation. To test this hypothesis, we addressed the following scientific 
questions:
1.  Is LIPUS effective in the treatment of tibia nonunions in current clinical practice?
2. Is LIPUS as only treatment effective in the acceleration and/or enhancement of 
fracture union in patients with a delayed union of the non-fixated osteotomized 
fibula?
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3.  How does LIPUS affect bone healing at the tissue level in patients with a delayed 
union of the osteotomized fibula?
4.  Is the presence of RUNX2-immunopositive osteogenic cells affected by LIPUS 
treatment in delayed unions of the osteotomized fibula? 
5.  Does LIPUS increase vascularity and blood flow in delayed-unions of the 
osteotomized non-fixated fibula?
6.  Does current evidence support the use of LIPUS for the treatment of fracture 
healing, and if so for which indication is LIPUS most beneficial?
To find answers to these questions we started by investigating the effectiveness of 
LIPUS treatment on established nonunions of the tibia in current clinical practice, 
since tibia nonunions have a high occurrence rate and significantly impair daily 
functioning. All consecutive LIPUS treated established nonunion cases from January 
2000 until February 2003 in The Netherlands were evaluated in a self-paired study 
design. LIPUS was the only new treatment, and strict criteria of enrollment minimized 
any spontaneous healing chance. The overall healing rate was 52 of 71 cases (73%) 
as result of LIPUS treatment, showing a significant higher healing rate compared to 
spontaneous healing (p<0.0001). The long-term follow-up showed high compliance 
rate and no re-fractures. LIPUS is therefore effective in the treatment of established 
tibia nonunions and can be regarded as a good, safe, and cost-effective alternative to 
surgery (Chapter 2).
In contrast to fresh fracture healing, a randomized placebo controlled trial on the 
isolated effect of LIPUS on impaired bone healing may be seen as unethical, because 
this withholds the sham-treated control patient from any other form of treatment. The 
osteotomized non-fixated fibula, as part of a high tibial osteotomy, shows a tendency 
of delayed union and forms a unique clinical model enabling placebo treatment 
without direct negative consequences and/or conflicting ethical issues. By utilizing the 
delayed union  osteotomized non-fixated fibula as a clinical model, we investigated 
the isolated effect and outcome of LIPUS treatment on delayed and/or impaired 
clinical fracture healing in a randomized double blind trial. No difference was seen 
in number of healed cases between LIPUS-treated (n=7) and sham-treated controls 
(n=8). Independent radiographical assessment showed that LIPUS decreased healing 
time by 29% (not significant) at 5 months, and by 57% (p=0.023) at 1 year after the 
start of LIPUS-treatment. LIPUS-treatment is therefore effective in accelerating delayed 
and/or impaired fracture healing, but as a single treatment option it does not directly 
contribute to improved fracture union when sufficient stability is absent as in the 
non-fixated delayed union of the fibula (Chapter 3).
The accelerating effect of LIPUS on fracture healing may be caused by a stimulation 
of the different cellular processes involved in fracture repair and bone formation, 
such as angiogenesis, chondrogenesis, and intramembranous and endochondral 
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ossification. To better understand how LIPUS affects delayed and or impaired bone 
healing, biopsies of delayed unions of the human osteotomized fibula after a high 
tibial osteotomy were obtained. By using histology and histomorphometric analysis, 
bone formation and bone resorption parameters were determined at the tissue level. 
In LIPUS-treated delayed unions, endosteal callus formation by direct bone formation 
without a cartilage intermediate as well as indirect bone formation was observed, 
while in untreated controls only indirect bone formation was observed. In the area of 
new bone formation, LIPUS significantly increased osteoid thickness by 47%, mineral 
apposition rate by 27%, and bone volume by 33%. No increase in the number of 
blood vessels was seen in the newly formed bony callus. Our results sugest that LIPUS 
accelerates clinical fracture healing of delayed unions of the fibula by increasing osteoid 
thickness, mineral apposition rate, and bone volume, indicating increased osteoblast 
activity, at the front of new bony callus formation. Improved stability and/or increased 
blood flow, but probably not increased angiogenesis, might explain the differences 
in ossification modes between LIPUS-treated delayed unions and untreated controls. 
(Chapter 4). 
Osteogenic cell proliferation and differentiation play an important role in adequate 
fracture healing, and is target for osteoinductive therapies in delayed fracture healing. 
Mechanical adaptive modeling can promote bone tissue formation by a proliferative 
response or by a direct anabolic effect on bone cells. RUNX2 is a transcription factor, 
and is regarded as the master gene of osteogenic cell differentiation and bone matrix 
production. Immunolocalization of RUNX2 as an early bone cell marker was performed 
to determine the effect of LIPUS on the presence of osteogenic cells located within 
and around the newly formed woven bone at the fracture end (area of new bone 
formation), and up to 3 mm distance of the fracture end. LIPUS treatment of fibula 
delayed unions significantly reduced the number of RUNX2 immunopositive cells 
within the soft connective tissue at the fracture ends, whereas the number of RUNX2 
immunopositive cells at the bone surface was not affected. The number of RUNX2 
immunopositive cells were similar for the atrophic and hypertrophic delayed unions. 
Immunolocalization of RUNX2 positive cells in delayed unions of the fibula reveals 
that delayed clinical fracture healing does not result in impairment of osteogenic cell 
proliferation and/or differentiation at the tissue level, even if delayed unions are clinically 
regarded as atrophic. Reduced numbers of osteogenic RUNX2 immunopositive cells 
within the soft connective tissue, and unchanged numbers of RUNX2 immunopositive 
cells at the bone surface, implicates that LIPUS does not increase osteogenic cell 
presence, but likely affects osteogenic cell differentiation. (Chapter 5).
Vascularity is a key factor in fracture healing, and angiogenesis is required for 
osteogenesis. Re-establishment of the circulation is essential in the early stages of 
fracture healing. Whether LIPUS stimulates vascularity by angiogenesis and/or blood 
flow to the fracture site in delayed and/or impaired fracture healing is still largely 
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unknown. Parameters of blood vessel formation were measured and related to 
histomorphometric bone characteristics of newly formed bone in histological sections 
of fibular biopsies. The volume density of blood vessels was increased in LIPUS-treated 
delayed-unions compared to sham-treated controls. LIPUS did not change blood 
vessel number, but significantly increased blood vessel size. Healed delayed-unions 
(LIPUS-treated and sham-treated controls) showed significant correlations between 
blood vessel size and osteoid volume. Our results therefore suggest that LIPUS 
enhances vascularity in delayed-unions of the osteotomized fibula by increased blood 
flow and perfusion through increasing blood vessel size. LIPUS only enhances fracture 
healing in patients showing a correlation between vascularization and osteoid volume 
at the tissue level, but not in patients in which this correlation is lacking (Chapter 6).
Evidence-based medicine forms an important basis to evaluate clinical therapies 
and guide to clinical application. Overall consensus on the effectiveness and indication 
for usage of LIPUS in bone healing remains absent. To obtain the best current 
evidence of LIPUS’ clinical healing capacity, as well as to specify its clinical role by 
identification of those fracture cases most beneficial to LIPUS treatment, we carried 
out a systematic review and meta-analysis of randomized controlled trials. LIPUS is 
effective in reducing time-to-radiographical fracture union. In 9 trials the time to 
radiographic fracture union was the primary outcome measure evaluated. In these 
trials LIPUS treatment resulted in an overall beneficial effect (p=0.0006) after pooling 
the time-to-radiographical healing data in the combined patient population (n=402), 
i.e. LIPUS resulted in a mean reduction in healing time of 42.2 days (95% confidence 
interval 18.1 to 66.3 days; I2=94%; heterogeneity P<0.00001). Most reduction in 
time-to-radiological union by LIPUS was seen in fractures with long natural healing 
tendency, i.e. non-fixated fibula osteotomies37, and (complex) fractures of the tibia. 
Only few studies reported on the effect of LIPUS on functional recovery in fracture 
healing, but could not demonstrate a beneficial effect. Although decreased time-to-
radiographical union may allow for earlier functional use, future studies of high quality 
should focus on reporting functional outcome needed to firmly establish the clinical 
effectiveness of LIPUS in fracture healing (Chapter 7). 
In conclusion, LIPUS treatment provides a valuable contribution to enhancing 
delayed bone healing and/or fractures with long natural healing tendency by increasing 
bone formation and blood flow at and to the fracture site, resulting in accelerated bone 
healing and significant reduction in time-to-healing. Co-factors negatively influencing 
fracture healing, such as insufficient stability, may diminish the enhancing capacities of 
LIPUS on fracture repair (Chapter 8).
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De botten in ons lichaam vormen een uniek orgaan. Het benige skelet geeft het 
lichaam structuur en ondersteuning, beschermt onze vitale organen, herbergt het 
beenmerg en participeert in minerale homeostase. Bot is levend weefsel en wordt 
gekarakteriseerd door een constante aanpassing aan de mechanische belasting 
waaraan het onderhevig is. Botcellen zijn gevoelig voor krachten veroorzaakt door 
lichamelijke belasting. Mechanoreceptoren zetten lichamelijke belasting om in 
biochemische signalen die zorgen voor genexpressie en die cellulaire aanpassingen 
tot gevolg hebben. Fractuurgenezing is een complex proces waarbij de expressie 
van de juiste genen en rekrutering van de juiste cellen vereist is, op de juiste tijd en 
plaats. De meerderheid van fracturen geneest spontaan na de initiële operatieve dan 
wel conservatieve fractuurbehandeling. Vijf tot 10% van de fracturen laat echter 
vertraagde genezing zien. Het fractuurgenezingsproces kan beïnvloed worden door 
diverse stimuli, zoals groeifactoren, hormonen en mechanische belasting. Inzicht in 
de biologische processen betrokken bij fractuurgenezing heeft geleid tot nieuwe 
behandelingsopties om vertraagde en/of verstoorde fractuurgenezing te stimuleren, 
zoals bone morphogenic proteins (BMP), extra-corporeal shock wave, electro-
stimulatie en low-intensity pulsed ultrasound (LIPUS). LIPUS (30 mW/cm2) is een vorm 
van micromechanische energie welke transcutaan wordt doorgegeven doormiddel van 
hoog frequente geluidsgolven. De door LIPUS afgegeven energie kan zodoende een 
alternatief vormen voor de mechanische belasting die normaal op de botten wordt 
uitgeoefend  door lichamelijke belasting (ook wel bekend als de wet van Wolff). LIPUS 
laat versnelling zien van het fractuurgenezingsproces. Het stimulerende effect van 
LIPUS kan veroorzaakt worden door beïnvloeding van verschillende cellulaire processen 
in fractuurgenezing, zoals angiogensis, chondrogenesis en intramembraneuze 
(desmale) of/en enchondrale verbening. Het exacte mechanisme waardoor LIPUS 
botgenezing beïnvloed is echter nog steeds onduidelijk. In het huidige proefschrift 
evalueren we de effectiviteit van LIPUS op de stimulatie van het vertraagde en/of 
verstoorde fractuurgenezingsproces op het weefselniveau, alsmede het effect op 
(versnelde) klinische consolidatie. Door meer duidelijkheid te krijgen omtrent het 
werkingsmechanisme van LIPUS alsmede de effectiviteit op fractuurgenezing, hopen 
we voorstellen te kunnen doen voor toekomstige klinische indicatie en/of gebruik. 
Onze hypothese luidt; LIPUS stimuleert en/of versnelt de vertraagde en/of verstoorde 
fractuurgenezing door beïnvloeding van de verschillende cellulaire processen en stadia 
van fractuurgenezing op weefsel niveau. Om onze hypothese te testen hebben we de 
volgende onderzoeksvragen gedeponeerd:
1.  Is LIPUS effectief in de behandeling van nonunions van de tibia in de huidige 
klinische praktijk?
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2. Is LIPUS als enige behandelingsoptie effectief in het versnellen en/of bevorderen 
van fractuurconsolidatie bij patiënten met een delayed union van de niet gefixeerde 
fibula osteotomie?
3.  Op welke wijze beïnvloed LIPUS botgenezing op weefselniveau bij patiënten met 
een delayed union na osteotomie van de fibula?
4.  Beïnvloed LIPUS behandeling de aanwezigheid van RUNX2-immunopositieve 
osteogene cellen in delayed unions na fibula osteotomie? 
5.  Zorgt LIPUS voor toename van de vasculariteit en bloedtoevoer in delayed unions 
na osteotomie van de fibula?
6.  Ondersteunt het huidige wetenschappelijk bewijs het gebruik van LIPUS voor 
fractuurbehandeling. Zo ja, voor welke indicatie draagt LIPUS het meeste bij?
Om antwoord te vinden op onze onderzoeksvragen, zijn we gestart met het beoordelen 
van de effectiviteit van LIPUS behandeling op de consolidatie van (bewezen) tibia 
nonunions. Tibia nonunions komen relatief vaak voor en vormen voor de patiënt 
een grote beperking in het dagelijkse functioneren. Alle in Nederland met LIPUS 
behandelde tibia nonunions van januari 2000 tot februari 2003, werden geëvalueerd 
in een studie met  self-paired opzet. LIPUS was de enige nieuwe behandelingsoptie en 
strikte criteria van  inclusie zorgden voor een minimale spontane genezingstendens. In 
52 van de 71 (73%) tibia nonunions zorgde LIPUS-behandeling voor genezing, hetgeen 
significant hoger is in vergelijking met de spontane genezing kans  (p<0.0001). Lange 
termijn follow-up laat een hoge therapie trouwheid zien en geen re-fracturen. LIPUS is 
daarom effectief in de behandeling van tibia nonunions en kan gezien worden als een 
goed, veilig en goedkoper alternatief dan operatieve behandeling (Chapter 2).
In vergelijking tot verse fractuurgenezing wordt een gerandomiseerde placebo 
gecontroleerde trial, welke het geïsoleerde effect van LIPUS onderzoekt, als onethisch 
gezien, omdat het met de placebo behandelde controlepatiënt weerhoudt van enige 
vorm van behandeling. De niet gefixeerde fibula osteotomie als onderdeel van een 
tibia kop osteotomie, laat een tendens zien van vertraagde genezing en vormt zo 
een uniek klinisch model welke het mogelijk maakt om een placebo behandeling te 
verrichten zonder negatieve en/of onethische consequenties. Door gebruik te maken 
van de delayed union van de niet gefixeerde fibula osteotomie als klinisch model, 
was het mogelijk om het geïsoleerde effect van LIPUS behandeling te onderzoeken 
op vertraagde en/of verstoorde fractuurgenezing in een gerandomiseerde 
dubbelblinde klinische trial. Uitkomsten laten geen verschil zien tussen het aantal 
genezen delayed unions behandeld met LIPUS (n=7) en zonder (n=8). Onafhankelijke 
radiologische beoordeling liet zien dat LIPUS de tijd tot consolidatie reduceerde met 
29% (niet-significant) na 5 maanden behandeling en met 57% (p=0.023) 1 jaar na 
de start met LIPUS behandeling. LIPUS is daarom effectief in het versnellen van het 
genezingsproces in vertraagde en/of verstoorde fractuurgenezing. Bij gebruik van 
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LIPUS als enige behandelingsoptie zorgt LIPUS niet voor een verhoogd percentage 
fractuur consolidatie, indien voldoende stabiliteit niet is gewaarborgd, zoals bij de niet 
gefixeerde delayed union van de fibula (Chapter 3).
Het genezingsproces versnellende vermogen van LIPUS op fractuurgenezing, 
kan worden veroorzaakt door stimulatie van verschillende cellulaire processen 
betrokken bij fractuurgenezing en botvorming, zoals angiogenesis, chondrogenesis, 
en intramembraneuze en/of enchondrale verbening. Om een beter inzicht te krijgen 
hoe LIPUS vertraagde en/of verstoorde botgenezing beïnvloed, werden biopten 
verkregen van delayed unions van de fibula. Door gebruik te maken van histologische 
en histomorfometrische analyse, werden botvormings een resorptie parameters 
bepaald. In LIPUS behandelde delayed unions was er sprake van directe (desmale) 
botvorming alsmede indirecte botvorming met kraakbenige tussenfase, dit terwijl er 
in de controle groep alleen maar enchondrale verbening werd gezien. In het nieuw 
gevormde bot aangrenzend aan de fractuuruiteinde, laat LIPUS behandeling een 
significante toename zien van osteoid dikte met 47%, minerale appositie snelheid met 
27% en botvolume met 33%. Er werd geen toename gezien in het aantal bloedvaten 
in het nieuw gevormde bot ten gevolge van LIPUS behandeling. Onze bevindingen 
suggereren dat LIPUS fractuurgenezing versneld in delayed unions van de fibula door 
middel van toegenomen osteoid dikte, minerale appositie snelheid en botvolume, 
hetgeen verhoogde activiteit impliceert van de osteoblasten aan de fractuuruiteinden. 
Toegenomen stabiliteit en/of verhoogde bloedtoevoer, maar geen toegenomen 
bloedvat vorming, kunnen de verschillen in verbeningstypen verklaren tussen LIPUS 
behandelde delayed unions en de onbehandelde controles (Chapter 4). 
Osteogene cel proliferatie en differentiatie speelt een belangrijke rol in een 
adequaat fractuurgenezingsproces en is het uitgangspunt van osteoinductieve 
therapieën bij vertraagde botgenezing. Mechanische belasting kan de aanmaak van 
botweefsel stimuleren door een proliferatieve reactie of door een direct anabool 
effect op botcellen. RUNX2 is een transcriptie factor en het RUNX2-gen wordt gezien 
als het belangrijkste regulerende gen voor osteogene celdifferentiatie en botmatrix 
productie. Immunolocalisatie van RUNX2 als vroege botcelmarker is verricht om het 
effect van LIPUS op de aanwezigheid van osteogene cellen te bepalen in en nabij 
het nieuw gevormde bot aan de fractuuruiteinden en tot op 3 mm afstand van de 
fractuuruiteinden. LIPUS behandeling van fibula delayed unions zorgde voor een 
significante reductie in het aantal RUNX2 immunopositieve cellen in het beenmerg 
bij de fractuuruiteinden, terwijl het aantal RUNX2 immunopositieve cellen aan het 
botoppervlak niet veranderd was. Het aantal RUNX2 immunopositieve cellen was 
vergelijkbaar voor atrofische en hypertrofische delayed unions. Immunolocalisatie 
van RUNX2 positieve cellen in delayed unions van de fibula laat zien dat vertraagde 
klinische fractuurgenezing niet leidt tot verstoring van de osteogene cel proliferatie 
en/of differentiatie op weefsel niveau, zelfs als er sprake is van een atrofische 
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delayed union. Verminderd aantal RUNX2 immunopositieve osteogene cellen in het 
beenmerg in combinatie met onveranderd aantal RUNX2 immunopositieve cellen op 
het botoppervlak, impliceert dat LIPUS niet de osteogene cel populatie vergroot, maar 
hoogstwaarschijnlijk osteogene cel differentie beïnvloed (Chapter 5).
Vasculariteit is een zeer belangrijke factor in fractuurgenezing. Herstel van de bloed 
circulatie is essentieel in een vroeg stadium van fractuurgenezing. Vaatvorming is 
nodig voor botvorming. Nog steeds is grotendeels onbekend of LIPUS de vasculariteit 
stimuleert door vaatvorming en/of verhoogde bloedtoevoer naar het fractuurgebied 
in vertraagde en/of gestoorde fractuurgenezing. In coupes van bot biopten van 
delayed unions na fibula osteotomie, werden bloedvatvorming parameters bepaald 
en gerelateerd aan de botvorming parameters alsmede histomorphometrische 
karakteristieken. In vergelijking met placebo behandelde controles, was het 
totale volume aan bloedvaten verhoogd in de LIPUS-behandelde delayed unions. 
LIPUS zorgde niet voor een toename in het aantal bloedvaten, maar zorgde wel 
voor significant grotere bloedvaten. Geconsolideerde (genezen) delayed unions 
(LIPUS-behandelde en placebo behandelde controles) lieten een significante correlatie 
zien tussen bloedvat grootte en osteoid volume. Onze resultaten suggereren daarom 
dat LIPUS de vasculariteit stimuleert in delayed unions van de fibula, door toegenomen 
bloedtoevoer en perfusie, mogelijk gemaakt door vergroting van de bloedvaten. LIPUS 
laat alleen maar stimulering zien van fractuurgenezing bij patiënten die een positieve 
correlatie hebben tussen vascularisatie en osteoid volume op weefsel niveau, maar niet 
bij patiënten waar deze correlatie afwezig is (Chapter 6).
Evidence-based geneeskunde vormt een belangrijke basis voor de effectuering van 
klinische behandelingen en vormt een belangrijke richtlijn voor klinische behandelingen. 
Een algemene consensus over de effectiviteit,  alsmede de indicatie voor gebruik van 
LIPUS voor fractuurgenezing blijft afwezig. Om kwalitatief hoogstaand bewijs te 
verkrijgen omtrent de helende werking van LIPUS, alsmede het indicatiegebied voor 
LIPUS fractuurbehandeling te specificeren, hebben we een systematische review 
en meta-analyse verricht van gerandomiseerde studies. In 9 studies was de tijd tot 
radiologische consolidatie de primaire uitkomstmaat. In deze studies, na pooling 
van de gezamenlijke patiënten populatie (n=402), zorgde LIPUS behandeling voor 
een significante verkorting van radiologische consolidatieduur (p=0.0006). LIPUS 
behandeling resulteerde in een gemiddelde tijdsreductie van 42.2 dagen (95% 
confidence interval 18.1 to 66.3 dagen; I2=94%; heterogeniciteit P<0.00001). Slechts 
enkele studies rapporteerden het effect van LIPUS op functioneel herstel, maar konden 
geen positief effect objectiveren. Ondanks dat verkorting van de tijd tot radiologische 
consolidatie eerder functionele belasting mogelijk maakt, moeten toekomstige 
gerandomiseerde studies van hoge kwaliteit zich meer focussen op functionele 
uitkomstmaten om de totale klinische effectiviteit van LIPUS op fractuurgenezing vast 
te leggen (Chapter 7). 
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Concluderend, LIPUS behandeling zorgt voor een belangrijke bijdrage aan het 
optimaliseren van het fractuurgenezingsproces door verhoging van de botaanmaak en 
bloedtoevoer bij de fracturen met een vertraagde en/of lange genezingsduur. Hierdoor 
treedt een versnelling van het botgenezingsproces en consequente verkorting van de 
tijd tot consolidatie op. Co-factoren die een negatieve werking hebben op fractuur 
genezing, zoals onvoldoende stabiliteit, kunnen het positieve effect van LIPUS op 
fractuurgenezing teniet doen (Chapter 8).
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DANKWOORD
Na 1 decennium “promoveren” is dit boekwerk het tastbare bewijs van mijn 
wetenschappelijke ontplooiing, groei en oogst. Zonder de hulp en ondersteuning van 
velen was het nooit tot dit eindresultaat gekomen. Mijn dank gaat uit naar allen die 
betrokken zijn geweest bij de totstandkoming van dit proefschrift. Tot enkelen in het 
bijzonder wil ik graag nog het woord richten.
Prof. dr. J. Klein Nulend, beste Jenneke, afgelopen decennium voelde als een lange 
wereldreis. Zeilend ben ik vertrokken naar het onbekende, de zeven zeeën bevaren, 
laveren tegen de wind in, stormen getrotseerd, het vak geleerd en uiteindelijk onder 
jouw bezielende leiding voor de wind de thuishaven ingeloodst. Zonder jouw intensieve 
begeleiding, volhardendheid en inzet zou dit proefschrift er nu niet zijn. Vele uren 
hebben wij samen doorgebracht ter verbetering van mijn manuscripten en met succes, 
al kostte het me de nodige roze koeken. Je bent een bevlogen promotor. Ik ben je erg 
dankbaar voor de vele uren die je in mij hebt geïnvesteerd. 
Dr. P.A. Nolte, beste Peter, tien jaar geleden lag er een idee voor een promotie, dankzij 
jouw enthousiasme, steun en vertrouwen zijn de ideeën werkelijkheid geworden. Je 
openheid,  toegankelijkheid en luisterend oor heb ik zeer gewaardeerd. Ik ben trots op 
het eindresultaat dat ik mede dankzij jou heb bereikt. 
Dr. C.M. Korstjens, beste Clara, histologie was voor mij niets meer dan een stem uit het 
verleden. Jij hebt me op weg geholpen in de histomorphometrie en vormde voor mij 
een klankboord. Dankbaar heb ik gebruik mogen maken van jouw kennis en kunde. 
Prof. dr. P.I.J.M Wuisman, beste Paul, helaas heeft onze samenwerking maar kort 
mogen duren. Ik dank je voor je betrokkenheid, interesse en de mogelijkheden die jij 
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